



Frailty Indices and 
Nutritional Screening Tools 
as Predictors of Adverse 
Outcomes in Hospitalised 








Bachelor of Applied Science  
(Human Movement Studies - Exercise Science) (Hons I) 
 
 
A thesis submitted for the degree of Doctor of Philosophy 
in the 
School of Medicine 
Faculty of Health Sciences 





I certify that this work contains no material which has been accepted for the award of any 
other degree or diploma in any university or other tertiary institution and, to the best of 
my knowledge and belief, contains no material previously published or written by another 
person, except where due reference has been made in the text. In addition, I certify that no 
part of this work will, in the future, be used in a submission for any other degree or 
diploma in any university or other tertiary institution without the prior approval of the 
University of Adelaide and where applicable, any partner institution responsible for the 
joint-award of this degree.  
The author acknowledges that copyright of published works contained within this thesis 
(as listed below) resides with the copyright holder(s) of those works: 
1. Dent E, Visvanathan R, Piantadosi C, Chapman I. Use of the Mini Nutritional Assessment 
to Detect Frailty in Hospitalised Older People. Journal of Nutrition Health and Aging. 
2012;16(9):764-7.  
 
2. Dent E, Visvanathan R, Piantadosi C, Chapman I. Nutritional Screening Tools as 
Predictors of Mortality, Functional Decline and Move to Higher Level Care in Older People: 
A Systematic Review. Journal of Nutrition in Gerontology and Geriatrics. 2012;31(2):97-
145.  
 
3. Dent E, Yu S, Visvanathan R, Piantadosi C, Adams R, Lange K, Chapman I. Inflammatory 
Cytokines and Appetite in Healthy People. The Journal of Aging Research & Clinical 
Practice. 2012;1(1):40-3.  
 
4. Dent E, Chapman I., Piantadosi C, Visvanathan R. Frailty and Functional Decline Indices 
Predict Poor Outcomes in Hospitalised Older People. Submitted to Age and Ageing.  
 
5. Dent E, Chapman I., Piantadosi C, Visvanathan R. Nutritional Screening Tools and 
Anthropometric Measures Associate with Hospital Discharge Outcomes in Older People. 
Submitted to Australasian Journal on Ageing.  
 
6. Dent E, Chapman I., Piantadosi C, Visvanathan R. Performance of Nutritional 
„Performance of Nutritional Screening Tools in Predicting Poor Six Month Outcome in 
Hospitalised Older People.‟ Submitted to Journal of Nutrition Health and Ageing. 
 
I give consent to this copy of my thesis when deposited in the University Library, being 
made available for loan and photocopying, subject to the provisions of the Copyright Act 
1968. I also give permission for the digital version of my thesis to be made available on 
the web, via the University‟s digital research repository, the Library catalogue and also 
through web search engines, unless permission has been granted by the University to 






  Keywords 
Barthel Index (BI); Mini Nutritional Assessment; Nutritional Assessment; 
length of stay (LOS); Predictive Value; patient admission; Aged;  Aged, 80 
and over; older adult; geriatric; cohort study; follow-up; prospective study; 
nutritional screen; malnutrition; Mini Nutritional Assessment Short Form 
(MNA-SF); Short Nutritional Assessment Questionnaire; Simplified 
Nutritional Appetite Questionnaire (SNAQ); Simple Nutritional Assessment 
Questionnaire (SNAQ); Malnutrition Universal Screening Tool (MUST); 
Nutritional Risk Screening 2002; Geriatric Nutritional Risk Index (GNRI); 
Screening Tool; Subjective Global Assessment (SGA); mortality; Activities of 
Daily Living (ADL); hospital; Katz; Instrumental Activity of Daily Living 
(IADL); poor discharge outcome; Long-Term Care; Nutrition Index; Nutrition 
Assessment; Prognosis; Frail Elderly; Hospitalization; functional decline; 
Incidence; Nutritional Status; Questionnaires; Geriatric Assessment; Quality 
of Life (QOL); Sensitivity and Specificity; Geriatrics/ methods; ROC Curve; 
Hand Strength; Inflammation; Appetite; healthy aging; successful aging; 
vulnerable; vulnerability; disabled person; Fried; Frailty Index; Study of 
Osteoporotic Fractures (SOF) Index; Frail Elder; Functionally-Impaired 
Elderly; Elderly, Functionally-Impaired; Functionally Impaired Elderly; Gait 




Frailty and malnutrition are two major medical issues influencing the health of 
older people. This doctoral thesis investigated the predictive ability and 
discriminatory power of clinically applicable frailty instruments and their 
malnutrition counterparts - nutritional screening tools (NSTs). The study was 
prospective and observational by design, and included patients aged  70 years 
consecutively admitted to the Geriatric Evaluation and Management Unit 
(GEMU) at The Queen Elizabeth Hospital, South Australia. Thesis aims were to: 
(i) identify the prevalence rates of malnutrition and frailty in hospitalised older 
people and (ii) determine the predictive ability and accuracy of these 
measurements. 
 
The mean (standard deviation) age of patients was 85.2 (6.4) years; 123 (72 %) 
were female, n = 172.  Malnutrition and frailty prevalence rates were high: 
malnutrition was found in 53 (31 %) of patients using the Mini Nutritional 
Assessment (MNA) for classification; and frailty was found in 107 patients (62 
%) by the Cardiovascular Health Study (CHS) frailty index.  
 
When looking at nutritional screening tools as predictors of hospital discharge 
outcomes: the MNA and the MNA-short form (MNA-SF) were associated with 
length of stay (LOS); the Geriatric Nutritional Risk Index (GNRI) and calf 
circumference (CC) were associated with functional decline; and mid arm 
circumference (MAC) was associated with a higher level of care on discharge. At 
six months post-hospitalisation, malnutrition by the MNA (OR = 3.29) and GNRI 
(OR = 2.84) was predictive of poor outcome (defined as mortality or admission to 
high level care). However the discriminative ability of this prediction was 
inadequate (area under Receiver Operating Characteristic curve (auROC) values 




Regarding frailty, almost all frailty and functional decline indices were predictive 
of poor outcome (mortality or high level care admission) at both hospital 
discharge and at six month post-hospitalisation. However when discriminative 
ability was considered, only the Frailty Index of Cumulative Deficits (FI-CD) and 
the adapted Katz score of Activities of Daily Living showed adequate values 
(auROC values of 0.735 and 0.704 respectively). The FI-CD was the only 
instrument to show adequate discriminatory power in predicting poor six month 
outcome (auROC = 0.702, P < 0.001).  
 
Malnutrition shares many characteristics with frailty; however the overlap 
between these two conditions lacks a quantitative foundation. Therefore, this 
doctoral project also looked at the efficacy of nutritional screening tools as frailty 
indices in hospitalised older people. An additional focus of this thesis was the 
association between appetite, body composition and inflammation in healthy 
people of all ages. 
 
This thesis illustrated the high prevalence rate of both malnutrition and frailty in 
hospitalised older people. Results highlight the importance of research into the 
predictive ability of both NSTs and frailty instruments in hospitalised older 
people. Such knowledge will be of assistance in the areas of gerontology research, 
clinical practice and public health policy, particularly in the wake of the global 
expansion of the number of older people. Thesis results may also assist in 
standardising definitions for both frailty and malnutrition, definitions which are 
greatly needed in clinical practice and research.  
iv 
 
Table of Contents 
Keywords ................................................................................................................. i 
Abstract ................................................................................................................... ii 
List of Tables ......................................................................................................... vi 
List of Figures ...................................................................................................... viii 
List of Abbreviations ............................................................................................ ix 
Publications and Presentations ............................................................................ xi 
Conference Presentations .................................................................................... xii 
Background ............................................................................................................ 1 
1 MALNUTRITION ............................................................................................ 3 
1.1 Background ............................................................................................... 3 
1.2 Aetiology of Malnutrition ......................................................................... 3 
1.3 Inflammation and Malnutrition ................................................................. 6 
1.4 Malnutrition Prevalence in the Hospital Setting ....................................... 8 
1.5 Consequences of Malnutrition in Hospitalised Older People ................. 12 
1.6 Nutritional Screening .............................................................................. 14 
1.7 Nutritional Screening Tools .................................................................... 18 
1.8 Nutritional Assessment ........................................................................... 24 
1.9 Anthropometric Measures ....................................................................... 26 
1.10 Sarcopenia ............................................................................................... 29 
1.11 Indices of Nutritional Status and Nutritional Risk .................................. 29 
2 FRAILTY ......................................................................................................... 31 
2.1 Introduction ............................................................................................. 31 
2.2 Frailty Defined ........................................................................................ 32 
2.3 Biological Causative Mechanisms of Frailty .......................................... 34 
2.4 Cognitive Frailty ..................................................................................... 37 
2.5 Frailty Measurement ............................................................................... 37 
2.6 The Predictive Ability of Frailty Instruments ......................................... 47 
3 Research Aims and Questions ........................................................................ 49 
3.1 Thesis Objectives .................................................................................... 49 
3.2 Thesis Outline ......................................................................................... 50 
4 METHODS ...................................................................................................... 52 
4.1 Research Location ................................................................................... 52 
4.2 Approval for the Study ............................................................................ 52 
4.3 Clinical Outcome Measures .................................................................... 53 
4.4 Patient Recruitment ................................................................................. 54 
4.5 Patient Characteristics and Study Outline ............................................... 55 
5 Nutritional Screening Tools as Predictors of Mortality, Functional 
Decline and Move to Higher Level Care in Older People: A Systematic 
Review ................................................................................................................... 58 
5.1 Introduction ............................................................................................. 59 
5.2 Method of Review ................................................................................... 62 
5.3 Results ..................................................................................................... 65 
5.4 Findings from Mortality Papers .............................................................. 67 
5.5 Findings from Functional Decline Papers ............................................... 70 
5.6 Findings from Move to Higher Level Care Papers ................................. 74 
v 
 
5.7 Discussion ............................................................................................... 77 
6 Use of the Mini Nutritional Assessment to Detect Frailty in 
Hospitalised Older People ................................................................................... 85 
6.1 Introduction ............................................................................................. 86 
6.2 Methods ................................................................................................... 88 
6.3 Results ..................................................................................................... 90 
6.4 Discussion ............................................................................................... 95 
7 Nutritional Screening Tools and Anthropometric Measures Associate 
with Hospital Discharge Outcomes in Older People ......................................... 99 
7.1 Introduction ........................................................................................... 100 
7.2 Methods ................................................................................................. 101 
7.3 Results ................................................................................................... 105 
7.4 Discussion ............................................................................................. 110 
8 Performance of Nutritional Screening Tools in Predicting Poor Six 
Month Outcome in Hospitalised Older People ................................................ 115 
8.1 Introduction ........................................................................................... 117 
8.2 Methods ................................................................................................. 119 
8.3 Results ................................................................................................... 122 
8.4 Discussion ............................................................................................. 126 
9 Frailty and Functional Decline Indices Predict Poor Outcomes in 
Hospitalised Older People ................................................................................. 130 
9.1 Introduction ........................................................................................... 132 
9.2 Methods ................................................................................................. 133 
9.3 Results ................................................................................................... 139 
9.4 Discussion ............................................................................................. 147 
10 Inflammatory Cytokines and Appetite in Healthy People ........................ 152 
10.1 Introduction ........................................................................................... 153 
10.2 Methods ................................................................................................. 155 
10.3 Results ................................................................................................... 157 
10.4 Discussion ............................................................................................. 161 
11 Thesis Summary, Limitations and Conclusion ........................................... 164 
11.1 Summary ............................................................................................... 164 
11.2 The Importance of Measuring Frailty in Hospitals ............................... 166 
11.3 The Purpose of Nutritional Screening ................................................... 167 
11.4 Thesis Limitations ................................................................................. 168 
11.5 Overall Significance and Contribution to Knowledge .......................... 169 
11.6 Future Research Directions ................................................................... 170 
11.7 Clinical Practice Recommendations ..................................................... 171 
11.8 Conclusion............................................................................................. 172 
References ........................................................................................................... 173 
vi 
 
List of Tables 
Table 1-1: Factors Contributing to Malnutrition in Older People ........................... 5 
Table 1-2: Factors Influencing Hospital Malnutrition Prevalence in Older People
 ............................................................................................................................... 10 
Table 1-3: Factors Contributing to Decline in Nutritional Status in Hospitalised 
Older People .......................................................................................................... 11 
Table 1-4: Characteristics of a Good Nutritional Screening Tool (NST) for Use in 
Hospitalised Older People. .................................................................................... 16 
Table 1-5: Barriers and Problems with Implementation of Nutritional Screening 
Tools in the Hospital Setting ................................................................................. 17 
Table 1-6: Comparisons of Selected Nutritional Screening Tools and Nutritional 
Risk Indices ............................................................................................................ 22 
Table 1-7: Summary of Items Included in a Nutritional Assessment. ................... 25 
Table 2-1: Factors Reported to Associate with Increased Frailty Incidence in 
Older People .......................................................................................................... 36 
Table 2-2: Qualities of a Frailty Operational Score ............................................... 38 
Table 2-3: Comparisons of Selected Frailty Operational Definitions ................... 46 
Table 4-1: Reasons for Study Exclusion ................................................................ 54 
Table 4-2: Descriptive Characteristics of Patients on Admission (n=172) ........... 56 
Table 5-1: Study Inclusion Criteria ....................................................................... 64 
Table 6-1: Characteristics of Patients for Each Classification by Fried‟s Frailty 
Criteria ................................................................................................................... 92 
Table 6-2: Efficacy Values of Malnutrition Against Frailty Classification by 
Fried's Criteria Using the MNA and the MNA-SF for Malnourishment 
Classification (n=100)............................................................................................ 94 
Table 7-1: Descriptive Characteristics of Patients on Admission (n=172) ......... 107 
Table 7-2: Spearman's Rank Correlations of Nutritional Screening Tools and 
Anthropometric Measures with Nutritional and Functional Measures on 
Admission (n=172) .............................................................................................. 108 
Table 7-3: Association of Nutritional Screening Tools and Anthropometric 
Measures with Discharge Outcomes .................................................................... 109 
Table 8-1: Baseline Characteristics of Patients on Admission (n=172) .............. 123 
vii 
 
Table 8-2: Odds Ratios for Prediction of Poor Six Month Outcome by Nutritional 
Screening Tool Assessment on Admission to the Geriatric Evaluation and 
Management Unit (n =172).................................................................................. 124 
Table 8-3: Prognostic Ability of Nutritional Screening Tools as Predictors of Poor 
Six Month Outcome (n=172) ............................................................................... 125 
Table 9-1: Variables Included in the Frailty Index of Cumulative Deficits (FI-CD)
 ............................................................................................................................. 138 
Table 9-2: Admission Characteristics of Patients (n = 172) ................................ 141 
Table 9-3: Results of Binary Logistic Regression Analyses Indicating the 
Contribution of Frailty Instruments to Study Outcomes
†
, Controlling for Age and 
Gender (n =172) ................................................................................................... 143 
Table 9-4: Diagnostic Values for Frailty, Functional Decline and Co-morbidity 
Indices for the Prediction of Poor Outcomes at Both Discharge and at Six Month 
Follow-Up ............................................................................................................ 144 
Table 9-5: Contrast Values of Area Under Receiver Operating Characteristic 
Curves for Poor Outcome at (A) Hospital Discharge and (B) Six Months Post-
Discharge in Hospitalised Older People (n = 172). ............................................. 146 
Table 10-1: Baseline Participant Characteristics (n=180) ................................... 158 
Table 10-2: Univariate Regression Analysis of relationships between total SNAQ 
appetite score and Continuous Study Variables (n=180) ..................................... 159 
Table 10-3: Multivariate Analysis of relationship between Study Variables and 
total SNAQ score (n=180) ................................................................................... 160 
viii 
 
List of Figures  
Figure 5-1: Flow Diagram Showing Selection of Final Studies Included in the 
Review ................................................................................................................... 66 
Figure 6-1: Flow Diagram of Patient Recruitment from the Geriatric Evaluation 
and Management Unit (GEMU) ............................................................................ 91 
Figure 6-2: Receiver Operating Characteristic Curves for the Identification of 
Frailty by the (A) Mini-Nutritional Assessment (MNA) Total Score and (B) 
MNA-SF total Score Using Fried‟s Frailty Criteria to Classify 
Frailty........................................................ ............................................................. 93 
Figure 9-1: Age and Gender Adjusted Receiver Operating Characteristic Curves 
for Poor Outcome at Discharge (Panels A-C) and at Six Months Post-Discharge 







List of Abbreviations 
ADL  Activity of Daily Living 
AUC   Area Under Curve 
ASPEN American Society for Parenteral and Enteral Nutrition 
BAPEN  British Association of Parenteral and Enteral Nutrition 
BMI  Body Mass Index 
BI  Barthel Index 
CASA  Cytokines, Adiposity, Sarcopenia and Ageing Study 
CC  Calf Circumference 
CCI  Charlson‟s Co-morbidity Index  
CGA  Comprehensive Geriatric Assessment 
CHS  Cardiovascular Health Study (Index) 
CI  Confidence Interval 
CNTF  Ciliary Neurotrophic Factor  
CRP   C-Reactive Protein 
CSHA  The Canadian Study of Health and Ageing 
DAA  Dieticians Association of Australia 
ESPEN The European Society for Clinical Nutrition and Metabolism  
EWGSOP  The European Working Group on Sarcopenia in Older People 
FI-CD  Frailty Index of Cumulative Deficits 
FI-CGA    Frailty Index Based on  Comprehensive Geriatric Assessment 
FNA  Full Nutritional Assessment 
FRAIL  Fatigue, Resistance, Ambulation, Illness, Loss of Weight (Index) 
GDS   Geriatric Depression Scale 
GEMU Geriatric Evaluation and Management Unit 
GNRI   Geriatric Nutritional Risk Index 
HARP  Hospital Admissions Risk Profile 
HPA  Hypothalamic Pituitary Axis  
HLC   High Level Care 
IADL  Instrumental Activity of Daily Living 
IAGG  International Association of Geriatrics and Gerontology 
IANA   International Association of Nutrition and Aging  
IL-1  Interleukin-1 
x 
 
IL-1  Interleukin-1 
IL-6  Interleukin-6 
IFN   Interferon-  
ISCCWG International Sarcopenia Consensus Conference Working Group  
LASA  The Longitudinal Aging Study Amsterdam  
LOS  Length of Stay 
MAC  Mid-Arm Circumference 
MeSH  Medline Search Heading 
MMSE  Mini Mental State Examination 
MNA    Mini Nutritional Assessment 
MNA-SF Mini Nutritional Assessment – Short Form 
MPI  Multidimensional Prognostic Instrument 
MST  Malnutrition Screening Tool 
MUST  Malnutrition Universal Screening Tool 
NCP  Nutrition Care Process 
NPV  Negative Predictive Value 
NRI   Nutritional Risk Index 
NRS-2002 Nutritional Risk Screening 2002 
NST   Nutritional Screening Tool 
PPV  Positive Predictive Value 
ROC  Receiver Operating Characteristic 
SD   Standard Deviation 
SGA  Subjective Global Assessment 
SHERPA Score Hospitalier d‟Evaluation du Risque de Perte d‟Autonomie  
SNAQ  Simplified Nutritional Appetite Questionnaire 
SOF  Study of Osteoporotic Fractures   
SFGG  Society of Geriatrics and Gerontology 
TNF-  Tumour Necrosis Factor- 
TQEH  The Queen Elizabeth Hospital 
WHAS Women‟s Health and Ageing Study 





Publications and Presentations  
Publications, papers submitted for publication and conference presentations 
pertaining to results relating to the thesis are listed below. 
 
Published Journal Articles 
Dent E, Visvanathan R, Piantadosi C, Chapman I. Use of the Mini Nutritional 
Assessment to Detect Frailty in Hospitalised Older People. Journal of Nutrition 
Health and Aging. 2012;16(9):764-7. (Printed version in Appendix D; pre-printed 
version in Chapter 6). 
 
Dent E, Visvanathan R, Piantadosi C, Chapman I. Nutritional Screening Tools as 
Predictors of Mortality, Functional Decline and Move to Higher Level Care in 
Older People: A Systematic Review. Journal of Nutrition in Gerontology and 
Geriatrics. 2012;31(2):97-145. (Printed version in Appendix E; pre-printed 
version in Chapter 5). 
 
Dent E, Yu S, Visvanathan R, Piantadosi C, Adams R, Lange K, Chapman I. 
Inflammatory Cytokines and Appetite in Healthy People. The Journal of Aging 
Research & Clinical Practice. 2012;1(1):40-3. (Printed version in Appendix F; 
pre-printed version in Chapter 10). 
 
Published Abstracts 
Dent E, Visvanathan R, Piantadosi C, Chapman I. Frailty determinants and 
discharge outcomes in hospitalised older persons. Australasian Journal on 
Ageing. 2012; Supplement 2:71. (Appendix: Abstract 1) 
 
Dent E, Visvanathan R, Piantadosi C, Chapman I. Nutritional Status at Admission 
Predicts Functional Decline in Older South Australians Admitted to a Higher 
Acuity Geriatric Evaluation and Management Unit. Australasian Journal on 





Dent E, Chapman I., Piantadosi C, Visvanathan R. Frailty and Functional Decline 
Indices Predict Poor Outcomes in Hospitalised Older People. Submitted for 
publication (Chapter 9). 
 
Dent E, Chapman I., Piantadosi C, Visvanathan R. Nutritional Screening Tools 
and Anthropometric Measures Associate with Hospital Discharge Outcomes in 
Older People. Submitted for publication (Chapter 7). 
 
Dent E, Chapman I., Piantadosi C, Visvanathan R. „Performance of Nutritional 
Screening Tools in Predicting Poor Six Month Outcome in Hospitalised Older 
People.‟ Submitted for publication (Chapter 8). 
 
Conference Presentations 
Frailty and Functional Decline Indices as Predictors of Poor Outcomes in 
Hospitalised Older People. Oral Presentation accepted to present at The 20th 
International Association of Gerontology and Geriatrics (IAGG) World Congress 
of Gerontology and Geriatrics; Seoul, June 23 – 27, 2013 (Appendix: Abstract 3) 
 
„Evaluation of Frailty Indices for the Prediction of Adverse Post-Hospital 
Outcomes in Older People‟. Oral presentation at the Australian Health and 
Medical Research National Conference; Adelaide, 25 – 29 November 2012. 
(Appendix: Abstract 4) 
 
„Frailty determinants and discharge outcomes in hospitalised older persons‟.  
Presented at the 45
th
 National Conference of the Australian Association of 
Gerontology; Brisbane, 20-23 November 2012 (Poster Presentation). (Appendix: 
Abstract 1) 
 
„Evaluation of Frailty Conceptualisations for the Prediction of Adverse Health 
Outcomes in Hospitalised Older Persons‟. Oral Presentation at The Queen 
xiii 
 
Elizabeth Hospital Research Day; Adelaide, October 2012. (Appendix: Abstract 
5) 
 
„Nutritional Status at Admission Predicts Functional Decline in Older South 
Australians Admitted to a Higher Acuity Geriatric Evaluation and Management 
Unit‟. Presented at the Australian and New Zealand Society for Geriatric 
Medicine (ANZSGM) Annual Scientific Meeting; Sydney, 2-6 May 2012 and at 
the Postgraduate Research Day, The University of Adelaide, 31 August 2012. 
(Poster Presentation; Appendix: Abstract 2)  
 
„Nutritional Screening Tools as Predictors of Hospital Outcomes in Older 
Patients‟. Oral Presentation at the Australian Society of Medical Research State 
Conference; Adelaide May 2012. (Appendix: Abstract 6). 
 
„The Mini Nutritional Assessment as a Predictor of Fried‟s Frailty Classification 
in Hospitalised Older People‟. Oral Presentation at The Queen Elizabeth Hospital 
Research Day; Adelaide, October 2011. Awarded „Best Clinical Research 





An Ageing Population 
We are now living longer than at any previous time in human history. The global 
population of older people is expanding at such an unprecedented rate, that by 
2050, it is projected that one fifth of the world‟s population will be aged over 60 
years (1). The oldest old age bracket (aged 85 years and older) is expanding the 
fastest (2). With more older people, it is becoming increasingly important to focus 
on preserving functional independence with age (1, 3). 
 
On the whole, our population is ageing well, at least in developing countries (4, 
5). In Australia, 68 % of adults aged 65 years or older classified their health as 
good or good to excellent according to the Australian Bureau of Statistics in 2004 
– 2005 (6). However, living longer increases the risk of developing chronic 
disease (5). This is especially true in Australia, which has one of the highest 
growth rates of chronic condition prevalence in the world (2). Risk of disability 
also increases with age (5). For example, in Australia, disability is found in 15 % 
of younger adults, 45 % of adults aged 65 – 74 years and 82 % of those aged 85 
years and over (6). Mobility also decreases with age, so that by the age of 85 
years, up to 95 % of people have lost a degree of their mobility (5).  
 
Although an older person‟s function tends to decrease with age, older people are 
extremely heterogeneous with respect to their trajectories of ageing (4, 5, 7). For 
example, some older people may suffer extended decline, whilst others age well 
(7). If we are able to predict which individuals will encounter poor outcomes, this 
will have an enormous impact on prevention, treatment and care given to older 
people. It must be emphasised that identifying older people at risk of poor 
outcome is not used to deny older people treatment; instead, it is used to offer 
appropriate support (8), optimise any medical treatment needed (9, 10) and to 




Major Thesis Topic 
Frailty, a core concept in gerontology, can be used to identify older people at risk 
of poor outcomes (11). Frailty is often linked to malnutrition, which in turn, is 
also predictive of poor outcomes in older people (12). This doctoral thesis focuses 
on the ability of clinically applicable frailty measurements (operationalisations) 
and nutritional screening tools to predict adverse health outcomes in hospitalised 
older people. The hospital is an important location in which to base this research, 
as there is a distinct need to translate epidemiological research on frailty and 










Chapter 1 presents an introduction to the thesis. It begins by describing what 
malnutrition is, its aetiology, prevalence and outcomes. Nutritional screening in 
the hospital setting is then discussed, including an overview of commonly used 
nutritional screening tools applicable to the hospital setting.  Thereafter, this 
chapter identifies and discusses the literature research gap – the extent to which 
nutritional screening tools predict adverse outcomes in hospitalised older people. 
Knowing such information would advance the debate over which nutritional 
screening tool is best suited for the clinical setting. 
 
1.1 Background 
Malnutrition is a geriatric condition (13, 14) affecting up to 10 % of community 
dwelling older people (15). Malnutrition has no gold standard definition, although 
the common international consensus is that malnutrition is an inadequate 
nutritional status associated with adverse clinical outcomes (16). The terms 
malnutrition and undernutrition are frequently interchanged in the literature, and 
for the purposes of this thesis, malnutrition will refer to undernutrition rather than 
over-nutrition (16). Sarcopenia, a concept linked to malnutrition, will also be 
discussed.  
 
1.2 Aetiology of Malnutrition 
Older people are at an increased risk of developing malnutrition (16-23). Table 
1-1 provides a list of malnutrition risk factors that increase with ageing. 
Physiological causes of age-associated malnutrition include appetite loss, 
swallowing difficulties and early satiation (18, 24). Clinical causes of malnutrition 
include polypharmacy and hospitalisation (16). Psycho-social causes include 
depression, dementia, isolation and poverty (16, 20); physical causes of 




Age-related malnutrition risk factors can lead to dysfunctional eating patterns, 
such as slowed eating and eating a non-varied diet (28). Dysfunctional eating 
results in a reduction of energy and nutrient intake which, if left untreated, 
manifests as malnutrition (28). Many older people, particularly those who are 
frail, often have several co-existing risk factors for malnutrition (29). Malnutrition 
also tends to develop at a much faster rate in older people (30). Of note, around 25 
% of malnutrition cases in older people have no known cause (29). 
 
Weight loss attributing to the ageing process is known as the „anorexia of ageing‟ 
(31). Anorexia of ageing is highly influenced by inflammatory molecules (18, 32-





Table 1-1: Factors Contributing to Malnutrition in Older People  
Factors Contributing to Malnutrition in Older People 
Physical Changes 
Frailty and/or Reduced Function (36-38) 
Low Physical Activity (39) 
Inability to communicate food needs (40) 
Poor Oral Health (22, 27, 41-44) including Xerosomia (dry mouth) (28, 44) 
Psychological Changes 
Depression (15, 29, 41, 44, 45) 
Dementia (37, 46-48) 
Confusion (22) 
Anxiety (49) 
Grief (41, 45) 
Several foods are less liked (28, 50)  
Lower motivation to eat (28) 
Physiological Changes 
Lack of Smell (22, 28, 51) 
Lack of Taste (22, 28, 51, 52) 
Lack of Sight (45) 
Dysphagia (Swallowing Difficulty)  (16, 22, 37, 51) 
Reduced Appetite, including faster and longer satiation (22, 28, 38, 53) 
Slower gastric emptying and poorer gut functioning (28, 48, 54, 55) including 
poorer ghrelin secretion (involved in appetite) (54) 
Environmental Changes 
Eating and living alone (15, 28, 36) 
Poverty (39, 56, 57) 
Inadequate Care and Support (15, 28, 57, 58) 
Low Education (39) 
Communication barriers, including language barriers (40) 
Alcohol or Drug Addiction (29) 
Clinical Changes 
Polypharmacy (29, 44) and Medication issues, including nausea/mal-absorption 
(22, 46) 
Hospitalisation (15) 
Co-morbidities and infections (36, 48) 
Changes Due to Disease 
Endocrine disorder (eg Hyperthyroidism) (29) 
More prone to weight change with a reduced ability to recover (22, 29) 
Accelerated metabolism (46) 
Pain (41) 
Constipation (37, 41) 
Greater need for protein (eg inflammation) and a reduced ability to use protein 





1.3 Inflammation and Malnutrition 
The normal ageing process is accompanied by the shortening of telomeres, DNA 
damage and cell senescence (60, 61). The longer we live, the more likely were are 
to accumulate these adverse cellular stressors (62). A major downfall of these 
stressors is that they can trigger an exaggerated inflammatory response, which can 
catabolise proteins (59) as well as lead to appetite suppression, and in turn, bring 
about weight loss (63). 
 
Inflammation is the immune system‟s localised response to acute infection or 
illness and is usually accompanied by an acute phase response (64). This acute 
phase response generates pro-inflammatory cytokines such as Interleukin 1 (IL-
1), IL-6, IL-8, C-Reactive Protein (CRP) and Tumour Necrosis Factor- (TNF-
) (64, 65). Pro-inflammatory cytokines suspected to play a role in malnutrition 
development include TNF-, IL-1 and IL-6 (66). These inflammatory cytokines 
act both centrally and peripherally (46, 66). Centrally, they act on the 
hypothalamus and other brain areas where they interfere with appetite by 
disrupting the regulation of appetite controlling hormones and altering gastric 
function (33, 63, 66); peripherally they interfere with gastric emptying and 
motility (66).  
 
Specifically, Il-1 mediates appetite suppression both peripherally and centrally 
with the assistance of other pro-inflammatory cytokines (63). TNF also plays a 
role, but to a lesser extent than Il-1 (63). IL-6 inhibits food intake centrally and 
one of its family members, ciliary neurotrophic factor (CNTF) is the only 
cytokine acknowldeged to impact on long term (63). Anti-inflammatory 
cytokines, such and IL-4 and IL-10 act to down-regulate pro-inflammatory 
cytokine production (67). 
 
The body‟s pro-inflammatory response is exaggerated when pathophysiology is 




of hospitalised older people by Zamora et al. (2010) (69), malnutrition was found 
to be closely associated with an exaggerated inflammatory response. An 
interesting outcome of this study was that patients who were malnourished had a 
greater incidence of physiological system failure than non-malnourished patients 
(69). Decline in multiple physiological systems is a common premise in frailty 




1.4 Malnutrition Prevalence in the Hospital Setting 
The prevalence rate of malnutrition in hospitalised older people varies 
considerably between studies: from 12 – 79 % according to a recent review (70). 
Much of this difference in prevalence can be attributed to the different nutritional 
assessment and screening measures used to classify malnutrition. This is 
evidenced by several comparative studies of nutritional screening tools in 
hospitalised older people. For example, Drescher et al. (2010) compared the Mini 
Nutritional Assessment (MNA) and the Nutritional Risk Screening 2002 tools, 
and found malnutrition prevalence was 22 % and 34 % respectively in their 
sample of 104 patients (MNA <17 and NRS 2002 moderate to severe malnutrition 
risk) (71). Baccoro and Sanchez (2009) also found large differences in 
malnutrition prevalence rates in their study of 150 women, with malnutrition 
identified by the Subjective Global Assessment (SGA) (rating B + C) and by low 
BMI being 49 % and 10 % respectively (72). A similar trend was also found by 
Kyle et al. (2006), who reported that malnutrition prevalence rates by were 44 % 
with SGA (rating B+C), 28 % by NRS-2002 (moderate to severe malnutrition risk 
(71)) and 37 % by the MUST (moderate to high risk) (73). Also, Bauer et al. 
found variation in prevalence rate between nutritional measures (74), with 
malnutrition by the MNA (<17), SGA (rating B +C), NRS 2002 (moderate to 
severe malnutrition risk) being  33 %, 45 % and 64% respectively (74). 
 
Other factors contributing to the observed inter-study differences in malnutrition 
prevalence include the hospital location, the age distribution of patients and the 
patient characteristics (16). Table 1-2 provides a list of factors influencing the 
prevalence rate of malnutrition in hospitalised older people.  
 
Malnutrition incidence in older people is higher in the hospital setting than in 
other settings (16). This high incidence is generally attributed to the common 
presence of co-morbidities and acute illness found in this population (22). 
Hospitals themselves can also contribute to declines in nutritional status (16). 




older people. Older people also have a much higher prevalence of malnutrition 
than younger people upon hospital admission, ranging from 1.2 – 2.3 times higher 
in patients aged over 65 years than those younger than 65 years based on several 










Factors Influencing Hospital Malnutrition Prevalence
 
(16) 
Malnutrition Assessment Method 
 No reference standard for malnutrition has led to many different 
nutritional assessment and screening tools used 
 Cut-off scores to classify malnutrition (eg by BMI) vary considerably 
Patients „at risk‟ of malnutrition misclassified as malnourished  
 Subjective clinical evaluation used with little reference to nutritional 
parameters 
 Lack of consistent identification of malnutrition 
 Inter-tester differences 
Variations in Patient Characteristics  
 Patients with dementia included/excluded 
 Surgical and/or medical patients included/excluded  
 Gender Imbalance. For example, some studies include a high percentage 
of females (72) 
Hospital Location 
 Country  
 Neighbourhood location of hospital (eg socio-demographics of the 
neighbourhood) 
Age Distribution of Patients 
 Patients with older patients included in their dataset tend to have higher 
malnutrition rates 
† 









Table 1-3: Factors Contributing to Decline in Nutritional Status in 
Hospitalised Older People 
Factors Contributing to Decline in Nutritional Status in Hospital 
1. Insufficient time to eat meals (22) 
2. Inadequate meal service, including no food choice (79) 
3. Difficulty in opening food packaging, using cutlery or in reaching food (22) 
4. Lack of culturally specific food (15) 
5. Unfamiliar environment with foreign sounds, sights and smells (22) 
6. Lack of staff to assist at meal times (22, 79) 
7. Meal delivery often inflexible and at inconvenient times (22) 
8. Disruptions during meal times (80) 
9. Lack of awareness of the importance of malnutrition by hospital staff (81) 
10. Meals not palatable or lacking in energy requirements (82) 
11. Disease (79) 
12. Decreased Food Intake (83) 
13. Missed meals due to examinations (80) 
14. Modified diets prescribed prior to clinical examinations. For example „nil by 
mouth‟ or low sodium diets (79) and fasting prior to blood samples collected. 




1.5 Consequences of Malnutrition in Hospitalised Older 
People 
Malnutrition can have dire consequences for hospitalised older adults. A 
malnourished patient is at an increased risk of many adverse clinical outcomes, 
including mortality (16, 86-93), infection (94, 95), prolonged length of stay (LOS) 
(16, 91, 96, 97), functional decline (86, 98) discharge to higher level care (87, 99), 
falls (100) and rehospitalisation (16, 96, 101). Hospital malnutrition is also costly 
to the health care system (102, 103). Further details as to malnutrition‟s influence 
on mortality, morbidity and health care costs are outlined in the following 
subsections.  
 
1.5.1 Malnutrition and Mortality 
Based on prospective studies, malnutrition in hospitalised older people generally 
increases mortality risk (16, 86-93, 99, 104). However, not all studies agree. For 
example, in a recent study of 444 Swedish patients with a heavy disease burden 
by Vischer et al. (2012) (105), MNA-SF categories were not associated with 
mortality at discharge, nor at 1 or 4 years follow-up. This lack of a relationship 
could potentially be due to the high number of co-morbidities overbearing the 
impact of malnutrition or from the benefits of nutritional care post-hospitalisation 
(105).  
 
In studies that do show malnutrition contributes to mortality, much variation 
exists in the actual contribution of malnutrition to mortality risk. This variation 
can mostly be explained by the differences in nutritional assessment methods 
used, the differences in follow-up time and the lack of covariates controlled for in 
several studies and the potential protective effect of nutritional care post-
hospitalisation. Section 5.4 (Chapter 5) provides a detailed evaluation of 
nutritional screening tools (NSTs) as predictors of mortality in older people from 
all settings, including those who are hospitalised. Of importance, in the limited 
number of studies in which confounders have been controlled for, malnutrition 




1.5.2 Malnutrition and Morbidity  
Only a handful of studies have prospectively looked at the influence of 
malnutrition and functional decline in hospitalised older people in acute care (86, 
98, 108) and sub-acute care (96, 111-113). These studies all suggest that 
malnutrition is associated with a decline in activities of daily living (ADL) both in 
hospital and post-hospital in older people (86, 98). One study also looked decline 
in instrumental activities of daily living (IADL) and found malnutrition was not 
related (86). The extent of functional decline in malnourished patients varied 
between studies, which could be due to the measure of functional decline used, 
the country of the population assessed and the degree of intervention patients 
encountered. The MNA and MNA-SF were used in all identified studies looking 
at malnutrition and functional decline. Further details about the association with 
nutritional screening tools and functional decline is outlined in the Systematic 
Review in Chapter 5 (Section 5.5).  
 
1.5.3 The Financial Burden of Malnutrition 
Malnourished patients cost significantly more than non-malnourished patients as 
highlighted by multiple research studies (77, 102, 103, 114-118). When looking at 
population studies, these costs are enormous. For example, a recent Irish study 
found that adult hospital disease-related malnutrition cost over €1.4 million per 
annum, equating to 10 % of Ireland‟s national health care budget (114). 
Moreover, these costs were computed without factoring in the increased daily care 
cost of malnourished patient (114) which are considerably higher (119). Costs are 
more for malnourished patients primarily because of increased length of hospital 
stay (115, 120). Older malnourished people place further financial burdens as they 







1.6 Nutritional Screening  
Malnutrition in older people is hard to identify (121, 122) and easily missed by 
clinical staff if nutritional screening is not performed (123, 124). Failing to 
identify malnutrition will lead to failing to treat (123); an undesirable outcome. 
Ultimately, to identify malnutrition or risk of malnutrition, a full nutritional 
assessment should be performed (16) (see Section 1.8). A full assessment involves 
a comprehensive review of a patient‟s nutritional status, including medical and 
dietary history, anthropometric measurements, a physical exam and biomarker 
measurement (125). Such an assessment, although comprehensive, is not feasible 
for all patients in the hospital setting due to its costly and time-consuming nature 
(16).  
 
A more practical option is to use nutritional screening for early identification of 
malnutrition. Nutritional screening is a relatively fast and inexpensive means of 
identifying patients who are malnourished or at risk of malnutrition. In the 
hospital setting, nutritional screening is recommended to be accompanied by both 
a full nutritional assessment and an appropriate intervention for any patients 
identified as malnourished or at risk of malnourishment (126, 127). Nutritional 
screening is therefore a crucial precursor to the Nutrition Care Process (NCP) 
(128, 129).  
 
Nutritional screening is recommended for routine use in all hospitalised older 
patients (123, 130). Despite this recommendation, screening does not regularly 
occur in hospitals. Barriers to nutritional screening are outlined in Table 1-5 and 
include costs to the health care system (131), the indecision associated with which 
NST is best to implement (132) and staff shortages (133). 
 
Another potential barrier to nutritional screening is the lack of effectiveness of 
current nutritional intervention strategies (130). For example, a recent review of 




reported patients gained weight with nutritional intervention (predominantly oral 
intervention supplement interventions), 12 out of 16 studies (75 %) reported that 
there was no effect on physical function with nutritional intervention (134). 
Similarly, a systematic review of oral nutritional support in older patients 
discharged from hospital found that whilst all studies found patients gained 
weight and/or increased their energy intake, mortality rates were not affected by 
nutritional supplementation in any studies (135). However, despite these findings, 
a recent randomised control trial in Australia found that if nutritional screening 
was paired with an early intervention malnutrition care plan in malnourished 
patients (MNA score < 17), then patient length of stay was reduced from an 
average of 19.5 to 10.6 days (124). 
 
Currently no reference standard for nutritional screening in older people has been 
agreed upon for clinical application and accordingly, various nutritional screening 
tools (NSTs) have been developed. NSTs tend to include body mass index (BMI) 
(weight/height
2
) and a short string of questions regarding recent weight loss, food 
intake and risk of accelerated nutritional decline due to chronic disease (127). 
Several recent reviews of NSTs in older people have been conducted, including an 
evaluation of their validity and reliability (16, 127, 136-138). NSTs suitable for 
identifying older hospitalised people with malnutrition or risk of malnutrition are 




Table 1-4: Characteristics of a Good Nutritional Screening Tool (NST) for 
Use in Hospitalised Older People.  
Characteristics of a Good Nutritional Screening Tool 
Tested for Validity in Hospitalised Older People  
 Criterion Validity – how well the NST compares to either (1) an objective 
assessment by a professional (138),  (2) full nutritional assessment (137, 
138) and anthropometric measures (138) (3) MNA or SGA (138) 
 Construct Validity – how well the NST compares to other NSTs and 
laboratory values (138) 
 Content (Face) Validity – includes relevant components (139) 
 Population specific (137) 
 Sensitivity and specificity (137) 
Tested for Reliability in Hospitalised Older People (137, 140) 
Cost Effective (137) 
Fast and Easy to Use (137, 140) 
Accepted into the Clinical Setting (137) 
 No laboratory tests needed (16) 
 Uses routinely collected information (16) 
 No complex computations (16) 
Identify older people with malnutrition or at risk of becoming malnourished (137) 
Leads to referral for a Full Nutritional Assessment (126, 127) 
Non-invasive (16) 
Accepted by patients (16) 
Bonus Features 
Doubles as a Nutritional Risk Index – that is, predicts nutritional related outcomes 
(138) 





Table 1-5: Barriers and Problems with Implementation of Nutritional 
Screening Tools in the Hospital Setting  
Barriers and Problems to Implementation 
1. Lack of time and staff to implement the NSTs (133) 
 
2. Health Care Costs (131) 
 
3. Nutritional screening not seen as a important for all patients on admission (141)  
 
4. Not a standard, routine procedure in a patient‟s hospital admission (142, 143) 
 
5. Discussion over which NST to use can hinder implementation (132) 
 
6. Results of nutritional screening is not always documented in patient charts 
(130) 
 
7. Patients who do not outwardly look malnourished are often not screened with a 
NST (133) 
 
8. Most NSTs use BMI computations, which require the often difficult 
measurement of patient height and weight (133). Moreover, weight and height are 
commonly not measured in the hospital setting (131) 
 
9. The use of BMI may be masking malnutrition (144) 
 
10. Lack of information on validity and reliability (132) 
 
11. NSTs are validated against many reference standards of malnutrition 
assessment as there is not one set reference standard for malnutrition 
assessment/diagnosis (145) 
 
12. Nutritional screening is often not performed with a validated screening tool 
(146) or is performed with a screening tool not validated in that specific 
population (133) 
 
13. The common belief by nurses that individual judgement of a patient being 
underweight is superior to a nutritional screening tool in detecting malnutrition or 
risk of malnutrition (133) 
 
14. Multiple referral pathways for a full nutritional assessment often can result in 
a „verbal‟ referral rather than a NST being utilised for referral (133) 
 
15. Because nurses report that patients not in the hospital for very long do not 
need to be screened (133) 
 
16. Limited information for health practitioners on how to implement the NST 
appropriately (16) 
 
17. Health Care professionals report that there are too many screening tools to 
choose from, so they choose none (139). 
18. Interventions as the result of nutritional screening may not always be 
beneficial to patients, particularly in the short term (143) 
 






1.7 Nutritional Screening Tools  
A multitude of nutritional screening tools are in existence today. Described in this 
section are some of the most commonly used nutritional screening tools 
applicable to the hospital setting. Table 1-6 provides a comparison of selected 
NSTs including studies looking at their validation and reliability in older people. 
 
1.7.1 The Mini Nutritional Assessment (MNA) 
The Mini Nutritional Assessment (MNA) (Appendix 1) is an eighteen question 
nutritional screening and assessment tool specifically developed for use in older 
people (147-149). Its methodology is described in detail in Sections 7.2.2.2, 8.2 
and 6.2. The MNA has undergone extensive validity and reliability testing, 
particularly in community based studies, and is popular for use in older people 
globally (147, 150). Table 1-6 lists validity studies of the MNA, including studies 
specifically looking at hospitalised older people. From this table it can be seen 
that there are only a limited number of studies looking at the validity of the MNA 
in hospitalised older people, with sensitivity and specificity values appearing low 
overall. Recently, the MNA has also been improved for specificity by using 
population specific cut-offs for its anthropometric measures of BMI, calf 
circumference (CC) and mid arm circumference (MAC) (151, 152) but these 
studies have yet to be applied to acute care geriatric wards. Also evident from 
Table 1-6 are the mixed results of studies of hospitalised older people looking at 
the construct validity of MNA, that is, how well it compares against components 
of a full nutritional assessment.  
 
MNA has many advantages, including identification of malnutrition before severe 
weight loss occurs (147) and its ability to monitor changes in nutritional status 
(147). However, the MNA has disadvantages. It includes subjective questions, 
which are more suited to community-dwelling rather than hospitalised older 
people (127) and which can result in a lack of inter-tester reliability (125, 153) It 
can over-diagnose risk of malnutrition in frail, older people (154), perhaps 




disadvantages of the MNA include its lack of ability to predict future malnutrition 
(154) and its inability to be used in patients with cognitive impairment (16) or in 
those with enteral feeding (156). 
 
1.7.2  The Mini Nutritional Assessment Short Form (MNA-SF)  
The MNA short form (MNA-SF) (157, 158) (see Appendix) comprises six 
questions from the full MNA, and is described in further detail in Sections 7.2.2.2, 
8.2 and 6.2. The MNA-SF is the first step of a two part process: the MNA-SF for 
screening for malnutrition or risk of malnutrition, followed by referral for MNA 
assessment (159). The MNA-SF is generally considered to be user friendly in that 
it takes less than 5 minutes to apply, at least in community dwelling older people 
(16). It also provides the option of assessing calf circumference (CC) in lieu of the 
difficult to measure BMI (157). The MNA-SF has a high sensitivity and 
specificity when compared against the full MNA (157, 160), although this is a 
form of incorporation bias as the MNA-SF contains questions from the MNA 
(138). When the MNA-SF has been compared against nutritional assessment or 
professional assessment of nutritional status in hospitalised older people, it has 
shown poor specificity (161, 162). Table 1-6 provides an outline of studies 
validating the MNA-SF against various reference standards. Like the MNA, very 
few studies have looked at construct validity of the MNA-SF; that is, how well it 
compares against components of a full nutritional assessment.  
 
1.7.3 The Malnutrition Universal Screening Tool (MUST) 
The Malnutrition Universal Screening Tool (MUST) was designed by the British 
Association for Parenteral and Enteral nutrition (BAPEN) (163). It classifies 
patients as either at low, medium or high malnutrition risk based on a patient‟s 
BMI, history of unintentional weight loss and the probability of future weight loss 
based on acute disease (163, 164). MUST is a popular screening tool in UK 
national surveys of malnutrition (165) and has been found to have a similar 
reliability to the MNA in screening for nutritional risk in geriatric populations 
(139). When compared to the MNA, MUST has been reported to take less time, 




its disadvantages. It was recently found to have a low completion rate (47 % 
missing data) in a study of hospitalised older people, with the authors of this study 
rendering it less clinically applicable than other nutritional screening tools (162). 
MUST also includes BMI which is complicated to measure in older people (see 
Section 1.9.3) as well as having a BMI cut-off point that has been suggested to be 
too low for older people (166). Table 1-6 shows validity and reliability studies 
incorporating MUST. From this table it can be seen that MUST has been found to 
have a low agreement with both weight loss and BMI (139, 162) and has been 
found to have low sensitivity (61 %) and specificity (76 %) in a large study of 
hospitalised older people of all ages (73). 
 
1.7.4 Simplified Nutritional Appetite Questionnaire (SNAQ) 
The Simplified Nutritional Appetite Questionnaire (SNAQ) (See Appendix) (167) 
consists of 4 questions: one each on appetite, taste, satiety and meal frequency 
(167). Responses to each question are reported on a Likert scale ranging from 
„very poor‟ to „very good‟. A score of 14 or less out of a possible 20 predicts 
future weight loss in older people (167, 168). SNAQ is advantageous as it is quick 
and easy to implement and requires no specialist equipment or training of 
assessors. SNAQ has been validated against weight loss in older people (167). It 
has also been validated against the MNA in a recent study of hospitalised older 
people, where it shows modest sensitivity and specificity values of 71 % and 74 % 
respectively (169). Considerable more work is needed to validate the SNAQ, 
particularly against components of nutritional assessment (see Table). 
 
1.7.5 Geriatric Nutritional Risk Index (GNRI) 
The Geriatric Nutritional Risk Index (GNRI) was recently developed as a 
nutritional-risk index for older people, based on the „Nutritional Risk Index‟ for 
younger people (170). Since its development, it has also be validated against the 
MNA, although its agreement is low (kappa = 0.29) (97). The equation for 






GNRI = (1.489 x albumin (g/L)) + (41.7 x (weight/WLo)) 
With WLo = Ideal Weight, using Lorentz equations as described by 
Boulianne et al. (170): 
Men: WLo = H -100 – ((H - 150)/4)  
Women: WLo = H - 100 – ((H - 150)/2.5)  
With H = height in cm; g = grams; L = Litre 
 
GNRI categories are: major risk (scores < 82), moderate risk (scores < 92), low 
risk (scores 92 to  98) and no risk (> 9) (170). The GNRI can be considered as a 
nutritional screening tool, although more validation studies are needed, as evident 
from reviewing Table 1-6. 
 
1.7.6 Other Nutritional Screening Tools 
Multiple other nutritional screening tools exist for older people, including the 
Malnutrition Universal Screening Tool (163), Malnutrition Screening Tool (171), 
the Determine Your Health Nutritional Screening Initiative (NSI) checklist (172), 




Table 1-6: Comparisons of Selected Nutritional Screening Tools and Nutritional Risk Indices 
Feature 
Nutritional Screening Tool 



















Mode of Feeding 



























1. Validated in multiple studies of community dwelling 
older people where it has shown good sensitivity and 
specificity against a full nutritional assessment (147, 
175). 
 
Hospitalised Older People: 
2.Validated against nutritional assessment by physicians: 
Se = 79 %; Sp = 90 % in 65 patients aged  65 years. 
Visvanathan et al. 2004 (174).  
 
3. Validated against nutritional assessment by dieticians: 
Se = 57 %; Sp = 69% in 160 patients aged  65 years. 
Azad et al. 1999 (176). 
 
4. Validated against full nutritional assessment: Se = 77 
%; Sp = 36% in 60 patients aged > 65 years. Thorsdottir 
et al. 2005.(177).  
 
 
1. Validated against nutritional assessment by physicians: 
MNA-SF-BMI: Se = 89 %; Sp = 82 %, MNA-SF-CC: Se 
= 85 %, Sp = 84 % in 2032 people aged  65years; 1346 in 
residential care, 490 community dwelling, 127 hospitalised, 
65 in rehabilitation. Kaiser et al. 2009 (157). 
 
2. Validated against MNA: Se = 98 %, Sp = 100 % in 
881people (mean aged 76.4 years); with 650 community 
dwelling, 105 hospitalised, others not defined. Rubenstein 
et al. 2001 (158).  
 
Hospitalised Older People: 
3. Validated against MNA: Se = 100 %, Sp = 70 % in 408 
patients aged  60 years. Cohendy & Rubenstein, 2001 
(160).  
 
4. Validated against nutritional assessment by clinical 
nutritionist: Se = 100 %, Sp = 38 % in 69 patients aged  
70 years. Rahnoff et al. 2005 (162). 
 
5. Validated against nutritional assessment (low BMI & 
weight loss): Se = 100 %, Sp = 39 % in 171 patients aged 
> 60 years. Neelemaat et al. (162) 
 
6. 85 % agreement with MNA in 444 patients aged  75 
years. Vischer et al. 2012 (105).  
1. Validated against SGA: Se 
= 61 %. Sp = 76 % in 995 
patients of all ages. Kyle et al. 
2006 (73).  
 
Hospitalised Older People: 
2. Validated against SGA: Se 
and Sp not reported. 
Agreement = 92 % (kappa = 
0.783) in 50 patients (mean 
age 45 years). Stratton et al. 
2004 (163). 
 
3. Agreement with MNA 
(Kappa = 0.790 ) in 531 
patients aged  65 years by 




against MNA: Se 
= 71 %, Sp = 74 




people aged  65 
years. Rolland et 








Cereda et al. 
2009 (97). 
 
Abbreviations: BMI = Body Mass Index; CC = Calf Circumference; MNA = Mini Nutritional Assessment; MNA-SF = MNA short form; MNA-SF-BMI = MNA-SF with BMI; MNA-SF-CC = MNA-SF with 
CC substituted for BMI; MUST = Malnutrition Universal Screening Tool; SNAQ = Simplified Nutritional Appetite Questionnaire; GNRI = Geriatric Nutritional Risk Index; Se = sensitivity; Sp = Specificity; 





Table 1-6: Comparisons of Selected Nutritional Screening Tools and Nutritional Risk Indices (continued) 
Feature 
Nutritional Screening Tool 




Hospitalised Older People: 
1. Agreement with % Weight Loss (kappa = 0.293), BMI 
(kappa = 0.063) and MUST (Kappa = 0.790) in 531 patients 
aged  65 years (139) 
 
2. No association with BMI or CRP, iron, cholesterol, vitamin 
D, Albumin, Prealbumin and Haemaglobin showed a weak 
relationship. 444 patients aged  75 years. Adjusted for 
confounders. Vischer et al. 2012 (105).  
 
3. Associated with low BMI and low levels of albumin, serum 
cholesterol, Vitamin A, Vitamin D. Se and Sp not reported. 
Univariate analysis in 106 patients aged  65 years (178).  
 
4. Associated with triceps skinfold thickness, CC and BMI and 
Mid-Arm muscle circumference. Multivariate analysis in 109 
patients aged > 70 years (179). 
 
5. Associated with BMI, arm muscle area, albumin, transferrin, 
haemoglobin, lymphocyte count, total cholesterol & creatinine 
in 358 older people (77 % in hospital). Univariate analysis. 
Mean age = 84.6 years (180) 
Hospitalised Older People: 
1. Associated with weight, BMI, Mid-Arm muscle 
circumference & grip strength in patients aged 65 – 
99 years. Univariate analysis (181). 
Hospitalised Older People: 
1. Agreement with % Weight 
Loss (kappa = 0.275), BMI 
(kappa = 0.111) and MNA 
(Kappa = 0.790) in 531 
patients aged  65 years by 
Cansado et al. 2009 (139). 
 
2. Associated with weight, 
BMI, Mid-Arm muscle 
circumference, grip strength, 
albumin and pre-albumin in 
patients aged 65 – 99 years 
(181). 
 
3. Validated against low BMI 
and weight loss): Se = 67 %, 
Sp = 82 % in 171 patients 
aged > 60 years. Neelemaat 





Loss (5 %): Se = 
81 %, Sp = 76% 
and Weight Loss 
(10 %): Se = 88 
and Sp = 84 % 













in 358 older 










< 23 < 23 < 20 n/a 
Continuous 
Variable 
Abbreviations: BMI = Body Mass Index; CC = Calf Circumference; MNA = Mini Nutritional Assessment; MNA-SF = MNA short form; MNA-SF-BMI = MNA-SF with BMI; MNA-SF-CC = MNA-SF with 
CC substituted for BMI; MUST = Malnutrition Universal Screening Tool; SNAQ = Simplified Nutritional Appetite Questionnaire; GNRI = Geriatric Nutritional Risk Index; Se = sensitivity; Sp = Specificity; 




1.8 Nutritional Assessment 
Without a gold standard definition or assessment method for malnutrition, a 
reference standard is often used to diagnose malnutrition. This reference standard 
is usually a Full Nutritional Assessment (FNA) or an assessment by a trained 
professional such as a dietician, researcher, nurse or doctor (138, 182). Table 1-7 
outlines components commonly used in a full nutritional assessment. Basically, a 
nutritional assessment includes four main components, summarised as „ABCD‟: 
Anthropometric Measures, Biochemical and laboratory measures, Clinical 
Methods and Dietary Evaluation Methods (183). Functional capacity is also an 
important component of a nutritional assessment (16, 184). Other validated 
reference standards for nutritional assessment in older people include the 
Subjective Global Assessment (SGA) (184, 185) and the Mini Nutritional 






Table 1-7: Summary of Items Included in a Nutritional Assessment. Modified 
from Lim (2010) (16) 
Anthropometric Measures (16, 186) 
 Height 
 Weight: usual weight, ideal weight, BMI, weight loss (absolute and 
percentage) 
 Fat and Tissue Measures: calf circumference (CC), mid arm 
circumference (MAC), triceps skinfold thickness. 
Biochemical and Laboratory Measures (16, 186) 
 Iron: haemoglobin, hematocrit, serum transferrin 
 Vitamins and Minerals: Vitamin D, Folate 
 Cholesterol 
 Plasma Proteins: C-Reactive Protein, serum albumin, serum total 
protein, retinol binding protein 
 Total lymphocyte count  
 Skin test reactivity  
Clinical Methods 
 Physical Exam: detection of signs associated with malnutrition and 
nutrient deficiency, especially protein-energy deficiency (temporal 
wasting), oedema, hydration level and micronutritient deficiency  
(observation of the condition of hair, gyms, nails, bones, skin, eyelids, 
eyes, muscles and thyroid gland) (186) 
 Medical History: assessment of any factors which may be inhibiting 
digestion, absorption or excretion (186) 
Dietary Evaluation (16, 186) 
 24 hour dietary recall 
 Food frequency questionnaire 
 Dietary history across the lifespan 
 Food diary method 
 Observed food consumption 
Functional Capacity (16) 
 Grip Strength 
 Walking Speed  




1.8.1 Subjective Global Assessment (SGA)  
The Subjective Global Assessment (SGA) (185, 187) is a multidimensional 
nutritional assessment instrument evaluating: weight loss history, change in 
dietary intake, persistent gastro-intestinal symptoms (> 2 weeks), functional 
capacity (optimal, sub-optimal, ambulatory or bedridden), disease diagnosis and 
its influence on nutritional requirements (none, low, moderate or high stress), 
physical features of the patient (low subcutaneous fat levels, muscle wasting, 
ankle and/or sacral oedema and ascites) (185). The SGA has no numerical scoring 
system, rather it is used by professionals to subjectively classify patients as being 
well nourished (SGA A), with mild-moderate malnutrition (SGA B) or with 
severe malnutrition (SGA C) (184, 185). SGA was initially developed for use in 
people of all ages (185), but has since been validated for use in older hospitalised 
patients (188-190). However, one downfall of these validation studies is that 
reference standard the SGA was compared against (anthropometric measure/s 
with or without biomarkers) falls short of a full nutritional reference standard (16, 
138) 
 
The SGA has been endorsed by several organisations, including The American 
Society for Parenteral and Enteral Nutrition (ASPEN) (191), by The European 
Society for Clinical Nutrition and Metabolism (ESPEN) (192) and the Dieticians 
Association of Australia (DAA) (193). However, the SGA is not objective like the 
MNA, thereby rendering it impractical for intervention and follow-up studies. 
 
1.9 Anthropometric Measures  
1.9.1 Weight 
Weight assessment is often overlooked in geriatric wards. A recent study of a 
geriatric ward in Germany found weight was only documented in 54 % of 
geriatric patients (13). Even nutritional studies of older hospitalised patients have 
reported not measuring patient weight due to difficulties in assessing. For 
instance, Stratton and colleagues (91) were only able to weigh 56 % of patients in 
their study validating the MUST. Additionally, Tsai and colleagues (194) did not 




equipment available as the reason they did not measure weight. Multiple other 
reasons exist why weight measurement is difficult to perform in older people, 
including issues such as hearing or vision loss, dementia, incontinence, language 
barriers, delirium and frailty (16). It could also be that a patient is simply too ill to 
be weighed (195).  
 
1.9.2 Weight Loss  
Weight loss is incorporated as part of many NSTs, including the MNA (148) and 
MUST (91). Weight loss in older people is associated with many detrimental 
outcomes (18), including prolonged hospital admissions (139), increased infection 
risk (95), functional decline (196) and reduced life expectancy (147). A five year 
follow-up study of the Cardiovascular Health Study (CHS) also reported that 
weight loss was the best predictor of mortality in older people (197).  
 
1.9.3 Body Mass Index (BMI) 
Body Mass Index (weight(kg)/height(m)
2
) is an established part of clinical 
nutrition screening and is often used as a screening tool for malnourishment on 
hospital admission (16). It is included as part of many NSTs of older people, 
including the MNA (148) and MUST (91). BMI is quantitative and has the further 
advantages of being correlated with both fat mass (144) and MNA (198) in older 
people.  
 
Nevertheless, the use of BMI as a NST in older people is contentious for several 
reasons: it may not be a sensitive, reliable or valid measure of nutritional status in 
older people due to inaccuracies in assessing both height and weight (144); it does 
not correlate with weight loss in geriatric inpatients (139); it is overestimated in 
those who are well nourished and underestimated in those with risk of 
malnutrition (198); it is not an indicator of protein-energy malnutrition (16); and 
its correlation with fat mass is significantly lower in older people compared to 





The optimal BMI for older people is also disputed and until this is defined, a 
broad range of BMI cut-offs for malnutrition detection in older people will exist. 
Even screening tools do not have standard BMI cut-offs, with the MUST and the 





the ideal BMI for older people may be significantly higher than the commonly 
accepted 20-25 kg/m
2
 for younger adults (144). This higher optimal BMI may 
mean BMI cut-offs for malnourishment detection in both the MNA and MUST are 
currently too low. These low BMI cut-offs may impede diagnoses of malnutrition 
based on weight loss. For instance, a recent study found many patients with a BMI 
above 25 kg/m
2
 who had unintentional weight loss were not identified as being 
malnourished (200).  
 
1.9.4 Limb Circumference Measures  
Circumference measurements reflect body levels of both lean and fat mass (201). 
Therefore these measures can be used to assess nutritional status in older people 
without needing to rely on height or weight measures. Commonly used 
circumference measures in the hospital setting include mid-arm circumference 
(MAC) and calf circumference (CC). Both of these measures are included in the 
MNA, and CC has recently been included in the MNA-SF as an option in lieu of 
BMI (157). CC and MAC measures are popular with hospital staff as they are 
simple and easy to measure (16). 
 
CC is measured as the widest girth of the calf; MAC as the mid-point 
circumference of the upper arm, mid way between the acromion process and 
lateral epicondyle of the elbow (202). CC has been found to be more accurate at 
identifying malnutrition than MAC, except in people with end-stage functional 
decline (203). Despite their advantages, CC and MAC do have limitations. For 
example, MAC, although correlated with BMI (196) has been found to be a poor 






Sarcopenia refers to the change in body composition that occurs with ageing, 
particularly with regards to loss of skeletal muscle mass (205). This muscle mass 
loss was termed „Sarcopenia‟ by Rosenburg in 1989; a derivation from the Greek 
„sarx‟ meaning „flesh‟ (muscle) and „penia‟ meaning „loss‟ (206). Since then, 
multiple definitions of sarcopenia have been proposed.  
 
Sarcopenia is a global problem in older people, with epidemiological research 
reporting that around 50 % of people aged over 75 years of age are affected (207). 
Sarcopenia is a core component of frailty (208-210), and like both malnutrition 
and frailty, is a major cause of functional decline, loss of independence and 
mobility reduction in older people (211).  
 
Although no reference standard definition of sarcopenia yet exists, several 
advances in the form of consensus definitions have been developed. These 
definitions do not all agree however.  For example, sarcopenia is defined as both 
muscle mass and strength loss by the European Working Group on Sarcopenia in 
Older People (EWGSOP) and the ESPEN; as an age-associated loss of muscle 
mass and function by the International Sarcopenia Consensus Conference 
Working Group (ISCCWG) (212); and as loss of muscle mass alone (205, 213). 
Of note, sarcopenia was awarded Medline Seach Heading (MeSH) status in 2010, 
described as a „progressive decline in muscle mass due to ageing which results in 
decreased functional capacity of muscles‟ (214). 
 
1.11 Indices of Nutritional Status and Nutritional Risk  
A NST has additional clinical value if it can predict the likelihood of an adverse 
clinical outcomes occurring (170). However, the ability of a NST to predict 
adverse clinical outcomes in older people is not yet clearly known (215). Chapter 
4 presents a systematic review of NSTs as predictors of adverse outcomes in older 




acute hospitalisation. This systematic review identifies several gaps in the 
literature: (i) very few studies have been conducted in the hospital setting; (ii) the 
comparative ability of NSTs in outcome prediction is largely un-researched; and 
(iii) whilst many studies look at predictive ability per se there is a distinct shortage 
of studies looking at predictive accuracy: that is, the ability of NSTs to correctly 
identify individuals likely to encounter adverse clinical outcomes. Chapters 5 and 
6 focus on using nutritional screening tools as predictions of adverse clinical 
outcomes.  
 
Important to note is the following differentiation: an index of nutritional status, 
also commonly known as a NST, screens for malnutrition or risk of malnutrition; 
an index of nutritional risk predicts nutrition related outcomes (170).  
 
The following chapter describes frailty, a concept related to both malnutrition and 


















‘Frailty: Someone who is weak and has tiny muscles’ 
– Urban Dictionary 
 
This chapter presents the concept of frailty, its various models and operational 
definitions. It then identifies and discusses the research gap, which is that the 
predictive ability and discriminatory power of frailty instruments in the hospital 
setting has received little attention in the literature.  This is similar to the research 
gap of NSTs in the hospital setting from Chapter 1. Knowing such information 
would advance the debate over which frailty operationalisation definition is the 
most optimal in the clinical setting. 
 
2.1 Introduction 
Amid the rapid global expansion in the number of older people, frailty will 
become an increasingly important challenge for health and aged care systems 
worldwide. It is estimated that over a quarter of people older than 85 years are 
frail, with the greatest frailty burden being found in women (210, 217, 218). 
Frailty is characterised by a general weakness, thinness and a reduced ability to 
cope with stressors (210). An individual classified as frail has an elevated risk of 
mortality (219-225), disability (226-228), falls (221, 222, 229, 230), 
hospitalisation (228, 231), admission to a nursing home  (224, 232, 233) and 
health care system use (231, 234). Frailty also detracts from quality of life (235, 
236).  
 
Research into frailty has shown an unprecedented level of growth over the last 
two decades (237). However, frailty research is still in its infancy. The underlying 




Moreover, frailty does not have an international consensus definition, despite 
multiple reviews highlighting the need for such a definition (8, 238-252). Such a 
definition is urgently needed for consistent recognition of frailty. 
 
2.2 Frailty Defined 
Frailty was first clinically described in the 1970s as older patients needing 
permanent care (253). By the 1980s, frailty was thought of as a disability caused 
by chronic disease (254, 255). In 1991, the phrase „frail elderly‟ was assigned a 
Medline Search Heading (MeSH), described as „older adults or aged individuals 
who are lacking in general strength and are unusually susceptible to disease or to 
other infirmity‟ (256). During the 1990s, definitions of frailty inclined towards 
including measures of dependence on others to perform Activities of Daily Living 
(ADLs) (257, 258). 
 
In 2001, Fried et al. (210) proposed their landmark frailty phenotype definition, 
which describes frailty according to its physical, and measureable, components. 
The following year, Rockwood and Mitnitski released their accumulated deficits 
model of frailty, which considers not only the physical components of frailty, but 
also the psycho-social aspects of frailty (259). Both Fried‟s and Rockwood‟s 
frailty models are highly regarded and are in common use today. Fried‟s 
phenotypic model has also been expanded to include cognitive frailty, as 
discussed in Section 2.4. 
 
Nowadays, a plethora of theoretical definitions for frailty exist. By and large,  
frailty is considered to be a geriatric syndrome (65, 248, 249, 253, 260-263) 
reflecting multi-system dysfunction (210, 257, 264) and in which individuals are 
able to dynamically transition between severity states (242, 265, 266). Frailty is 
associated with an increased risk of adverse outcomes (253). It is different 




related to these factors. For example, although frailty incidence increases with 
age, it occurs independently from chronological age (233, 267, 268).  
 
Frailty can occur without disability. For example, in the Cardiovascular Health 
Study (CHS), only 6 % of those who were frail were also disabled (210). 
Following from this and other similar observations, frailty has been considered as 
a pre-disability by several research groups (245, 252, 269, 270). However, 
disability is often strongly intertwined with frailty (260, 271, 272) and other 
research groups have used frailty definitions incorporating disability (241, 242, 
270, 273-277). Interestingly, the World Health Organisation (WHO) defines 
disability as a dynamic interaction between a person‟s health condition and their 
environment (226). Therefore, frailty could perhaps be an „unstable disability‟ as 
proposed by Woodhouse et al. (1997) (267).  
 
Frailty also occurs without the presence of co-morbidities. For example, in the 
CHS study, 32 % of frail older people did not have any co-morbidity (210). 
Conversely, people with one of more co-morbidities may not be frail (278, 279).  
 
Multiple reasons exist as to why it is so difficult to define frailty, including its 
complex aetiology (65, 280), the independent work of frailty researchers (244, 
256) and the inherent difficult in distinguishing frailty from both ageing (281, 
282) and disability (260). Regardless of these issues, and perhaps because of 
them, international consensus groups such as the WHO and the International 
Association of Geriatrics and Gerontology (IAGG) are currently working on a 
framework for an internationally accepted frailty definition (9, 252). The most 
recent consensus for a theoretical definition of frailty is by the Frailty Operative 
Definition-Consensus Conference (FOD-CC) project who defined frailty „a 
multidimensional syndrome characterized by decreased reserve and diminished 





Nonetheless, what is needed is a now, as recent literature has highlighted, is a 
translation of frailty measurement into clinical practice (9, 10, 245, 246, 252, 284, 
285), the topic of the section 2.5. 
 
2.3 Biological Causative Mechanisms of Frailty 
Much debate exists around the biological causative mechanisms underpinning 
frailty (240, 286). There are multiple biological pathways that can lead to frailty, 
and many of these are similar to those causing malnutrition (11, 210, 287) and 
sarcopenia (288). Inflammation is one such pathway, and is well established as a 
causal factor for frailty (65, 209, 238, 289-301). Pro-inflammatory cytokines can 
influence frailty directly, for instance by promoting protein degradation (34), or 
indirectly by metabolic actions on physiological processes (65). The impact of 
inflammatory cytokines on frailty has also been recently reported to be stronger in 
women than in men (302).     
 
The biological causative mechanisms of frailty are different from those processes 
causing the ageing process (303). Frailty occurs when not one, but multiple 
physiological systems decline (11, 62, 303, 304): the more physiological systems 
that are in a declined state, the greater the frailty incidence (305). Although, 
physiological systems do lose their homeostatic reserve with ageing, there is an 
inherent reserve buffer, suggested to be around 30 %, in which an individual can 
lose and still function well (306). Frailty results when this threshold is surpassed 
in multiple physiological systems - so much so that repair mechanisms cannot 
maintain system homeostasis (303). Pre-frailty (or latent frailty) (303) is thought 
to be the silent precursor to frailty, and will result in frailty if adverse events, such 
as acute illness, injury or psychological stress occur (303).  
 
Frailty can also result from undernutrition (303) (11, 210, 287) and from factors 
associated with undernutrition, such as such as poor appetite (307), poor oral 
health (308), anaemia (280), vitamin deficiencies (309-311) and endocrine 




(LASA), incident frailty was linked with low serum levels of 25-hydroxy-vitamin 
D (25(OH)D) and elevated serum C-Reactive Protein (CRP) levels (314). In the 
Women‟s Health and Ageing Study II, the gut-derived hormone, ghrelin was 
found to be lower in those women classed as frail (315). Glucose and insulin 
dynamics have also been found to be abnormal in frail older women (316).  
 
Other factors linked with frailty include inactivity, diabetes mellitus, osteopenia, 
oxidative stress, an imbalance between parasympathetic and sympathetic tone,  
and polypharmacy (216, 280, 317). Table 2-3 outlines factors associated with 





Table 2-1: Factors Reported to Associate with Increased Frailty Incidence in 
Older People 
Factors Associated with Increased Frailty Incidence in Older People 
Psychological Factors 
Cognitive Impairment (218) 
Depressive Symptoms (218) 
Nutritional Factors 
Poor Oral Health (308) 
Malnutrition (11, 210, 287, 303) 
Anaemia (280) 
Lower 25-hydroxy-vitamin D (314) 
Environmental Factors 
Cigarette Smoking (318) 
Lower Education (218) 
Living Alone (218) 
Low Physical Activity  (216, 280) 
Poverty (319) 
Clinical Factors 
Polypharmacy  (216, 280) 
Diseases 
Diabetes Mellitus  (216, 280) 
Endocrine disorders (312, 313) 
Impaired cardiac autonomic control (320) 
Osteopenia (216, 280) 
Factors Resulting From Disease 
Glucose and Insulin Abnormalities (316) 
Lower ghrelin levels (315) 
Inflammation 
       
    
     
Oxidative Stress (216, 280) 
Cancer (317) 




2.4 Cognitive Frailty 
Cognitive impairment refers to a decline in cognitive tasks such as remembering, 
reasoning and planning (321). A bi-directional association occurs between 
cognitive impairment and frailty (321). As such, there is an emerging debate over 
whether cognitive impairment should be included in an operational of frailty. That 
is, in addition to the physical phenotype of frailty proposed by Fried et al. (2001) 
(210), frailty can also be considered as a cognitive phenotype. Cognitive frailty 
shows promise as an operational measure of frailty. For example, a recent study of 
6030 community dwelling older people reported that adding impaired cognition to 
the CHS frailty phenotype increased the predictive ability for adverse outcome, 
particularly 4-year mortality (322). However, cognition has been found to lack 
association with other aggregate components of frailty, such as depression, energy 
intake, mobility and physical activity (323). Therefore, based on this finding, 
Robertson et al. 2013 (321) suggested that frailty and cognitive impairments are 
perhaps best treated as separate concepts rather than as the same condition.  
 
2.5 Frailty Measurement 
Regardless of what definition of frailty is used, to be applied in gerontology 
research and clinical practice, it first needs to be operationally defined. An 
operational definition for frailty has been identified as one of ten crucial areas for 
advancement in frailty research (244). There is currently much debate as to which 
operational definition of frailty is most suitable for practical application (245, 251, 
324). Nonetheless, several advances have been made in identifying what 
components it should contain. For example, a recent study by Rodriguez-Manas et 
al. (283) found that although experts disagreed on the details of an operational 
definition of frailty, there were frequent items identified for inclusion: namely 
reduced gait speed, mobility, nutritional status, mental health and cognition (283).  
 
These single components of frailty can be used to predict adverse outcomes in 




However, in the mid-1990s, it was verified that when these frailty components 
were grouped together to form combination scores, prediction of adverse clinical 
outcomes was higher than when components were considered alone (326, 327). 
Frailty combination scores have been used to operationally define frailty ever 
since, and a plethora of these operational frailty scores are in current use (328).  
 
Frailty operational scores should fulfil a number of criteria. First and foremost, 
they should be able to identify frailty. Additional qualities they should have, as 
identified by Clegg et al. (11) using Bell‟s (329) disease classification guidelines 
(329) include: 
1. An ability to reliably predict adverse clinical outcomes 
2. An ability to reliably predict patient response to potential therapies 
3. Be supported by a biological causative theory 
In the clinical setting, frailty operationalisations, like nutritional screening tools, 
should also be quick and easy to apply (245). Table 2-2 outlines qualities a frailty 
operational score should ideally have. 
 
 
Table 2-2: Qualities of a Frailty Operational Score 
Qualities of a Frailty Operational Score 
1. Identifies frailty and pre-frailty 
2. Reliably predicts outcomes  (11) 
3. Reliably predicts patient responses to potential therapies  (11) 
4. Supported by a Biological Causative Theory  (11) 






Frailty instruments suitable for use in the hospital setting and discussed in this 
thesis include: the Cardiovascular Health Study (CHS) Index, the Study of 
Osteoporotic Fractures (SOF) Index, the Frailty Index of Accumulated Deficits 
(FI-CD), the Frailty Index derived from Comprehensive Geriatric Assessment 
(CGA) (FI-CGA), and the Fatigue, Resistance, Ambulation, Illness, Loss of 
Weight (FRAIL) Index and the Multidimensional Prognostic Index (MPI) (330).  
 
Although frailty is not the same as disability, functional decline indices can be 
considered to be frailty instruments (274). Examples including the Katz score of 
activities of daily living (ADL) (331), Lawton‟s Instrumental ADL (IADL) scale 
(332), the Score Hospitalier d‟Evaluation du Risque de Perte d‟Autonomie 
(SHERPA) (333) and the Hospital Admissions Risk Profile (HARP) (327). 
Walking speed and grip strength can also be used in isolation to measure frailty in 
older people. An outline of frailty operationalisations, functional decline indices 
and individual markers of frailty is discussed in the following section. Table 2-3 
presents a comparison of frailty instruments included in thesis with regards to 
their clinical operation. 
 
2.5.1 The Cardiovascular Health Study (CHS) Index 
The first operational definition of frailty was proposed by Fried et al. (2001) and 
is often known as the Cardiovascular Health Study (CHS) index from the study it 
was originally applied to (210). The CHS index considers frailty by its physical 
characteristics, or „phenotype‟, defining the condition as the presence of three or 
more of: shrinking (unintentional weight loss of 4.5kg or more in the last year), 
weakness (low grip strength), exhaustion (self reported), slowness (slow walking 
speed) and low physical activity (210). It has a solid foundation of biological 
causative theory (210, 334) and has been applied to multiple epidemiological 
studies where it is predictive of adverse clinical outcomes (222, 311, 335, 336). 
The CHS index however does not include psycho-social components of frailty. 
Additionally, a major factor inhibiting its clinical application is its inclusion of 
measurements not routinely used by clinicians for patient assessment (337) – grip 




2.5.2 Study of Osteoporotic Fractures Index 
The Study of Osteoporotic Fractures (SOF) frailty index, like the CHS index, 
considers frailty to be phenotypic in nature (221). It is simpler to apply clinically 
than the CHS index, as it needs no specialist equipment and only contains three 
frailty components. To be defined as frail by the SOF criteria, two or more of 
weight loss (more than 5 % in the last year, either intentional or unintentional), 
exhaustion (an answer of „no‟ to the question „do you feel full of energy?‟) and 
low mobility (inability to perform a chair rise five times) need to be present. The 
SOF criteria has been found in epidemiological studies to predict falls, disability 
and premature mortality in both men (229) and women (221) to a similar extent as 
the CHS index. It also has an underlying biological causative theory (221). 
 
2.5.3 Frailty Index of Accumulative Deficits (FI-CD) 
The Frailty Index of Accumulative Deficits (FI-CD) was first proposed by 
Rockwood and Mitnitski as a way to incorporate the multidimensional nature of 
frailty into an operational definition (284, 338). The FI-CD is underpinned by 
biological causative theory (242, 273, 339) and involves the accumulation of 30 or 
more co-morbidities, symptoms, diseases, disabilities or any deficiency in health 
with the idea that a greater number of health deficits indicates higher frailty (340). 
The FI-CD is expressed as a ratio. For instance, if a list of possible health deficits 
obtainable on a study cohort is 50, a person with 5 of these deficits has a frailty 
index of 0.1. The exact list of health deficits for inclusion in the FI-CD does not 
matter other than they should: increase in incidence but not have a ceiling effect 
with age; be reflective of a range of physiological systems; and be associated with 
health and not age per se (340). Comprehensive guidelines for creating a FI-CD 
have recently been provided by Searle et al. 2008 (340). These guidelines also 
give cut-off points for continuous variables that are used in the index. Section 
9.2.3.1 provides further details of FI-CD computation. 
 
The FI-CD has been found to be related to the adverse outcomes of frailty 
including falls and early mortality (284, 340). Importantly, it is the FI-CD score, 




adverse outcomes (242). An upper limit the FI-CD is believed to exist at around 
0.67, beyond which survival is unlikely (341).  
 
The FI-CD can be time consuming to calculate and its mathematical nature, 
although simple, renders it unpopular clinically (342). However, as highlighted by 
Jones et al. (343), a FI-CD, when derived from data already collected in a 
Comprehensive Geriatric Assessment (CGA), can be time-efficient.  
 
2.5.4 Frailty Index Derived From Comprehensive Geriatric Assessment 
(FI-CGA) 
The frailty index derived from Comprehensive Geriatric Assessment (FI-CGA) is 
simply a FI-CD using data from a CGA. CGA is the global standard clinical 
assessment for older people, and includes medical, nutritional, functional and 
psychological assessments by a multidimensional team (11).  
 
The FI-CGA was initially developed as a ten-domain index, with 14 CGA 
components included (343, 344). It was later expanded out by Rockwood and 
colleagues (339) to include 52 CGA components. The CGA is used as a clinical 
standard for frailty assessment and has been found to be highly associated with 
the FI-CD (343). Scoring is described in Section 9.2.3.2.  
 
2.5.5 Multidimensional Prognostic Instrument (MPI)  
The Multidimensional Prognostic Instrument (MPI) was developed as a 
prognostic tool for hospitalised older patients (330) and has been judged to be a 
multidimensional frailty instrument, albeit with a simpler nature than the FI-CD 
(345). The MPI is derived from eight components of the CGA: medication 
number, IADLs, ADLs, cognitive status, nutritional status by the MNA, risk of 
developing pressure sores, co-morbidity and living status (330). Problems for each 




and none (0 points) (330, 345). Scores are then summed and divided by eight,  
with scores > 0.66 graded as frailty (330, 345).  
 
2.5.6 Fatigue, Resistance, Ambulation, Illness, Loss of Weight (FRAIL) 
Index 
Proposed by the International Association of Nutrition and Ageing (IANA), 
FRAIL (245, 346) comprises four components of the CHS index, and one 
component of the FI-CD (337). The FRAIL instrument classifies frailty as three or 
more of: fatigue (self report), resistance, ambulation (slow walking speed); illness 
and loss of weight of 5 % or more in the past year (337). FRAIL is judged to be 
clinically advantageous due to its simple nature and ability to be obtained from 
data already included in a patient CGA (337). 
 
2.5.7 Functional Decline Indices 
Functional decline is defined as „the loss of independence in self care activities or 
a deterioration in self care skills‟ (347). After observing that functional decline is 
an outcome of frailty, functional decline risk was deemed by de Saint-Hubert et 
al. in their recent systematic review to approximate frailty (274). Functional 
decline is known by many terms including: decline in Activities of Daily Living 
(ADL), status decline and functional impairment (347). Commonly used in the 
hospital setting to measure functional decline in older people are the Katz Index 
of Independence in ADL (331) (331) and Lawton and Brody‟s instrumental ADL 
(IADL) scale (332). Functional decline indices which can be used as screening 
tools in the hospital setting include the HARP (327) and the SHERPA (333). The 
Katz ADL score, Lawton and Brody‟s IADL scale, HARP and SHERPA are 
described in the following sections.  
 
2.5.7.1 Katz Score of Activities of Daily Living 
The original Katz ADL score (331) considers dependency in six ADLs: bathing, 




ADL is a two part process. Firstly each ADL is graded according to three 
categories: no assistance, some assistance and assistance needed. Secondly, these 
categories are then converted into two categories: either „dependent‟ or 
„independent‟ (331). Since its inception in 1963, the Katz score has been modified 
dozens of times to include different ADLs and different scoring systems (348). 
Notably, a recent systematic review of functional decline in hospitalised older 
people (Buurman et al. 2011), found that only one out of 22 studies referring to 
the original Katz index, in fact used the original version (348).  
 
The Katz scale is easy to apply, taking around 10 minutes to assess for each 
hospital patient. It is the most commonly used functional decline assessment 
measure in hospitalised older people (348) and assessment either by patient self-
report of by visual observation have been found to give similar results (349). 
 
2.5.7.2 Lawton’s Instrumental Activities of Daily Living Scale 
Lawton‟s Instrumental ADL (IADL) scale was developed around the same time as 
the Katz ADL index and assesses dependency in eight ADLs: phoning, shopping, 
food preparation, housekeeping, laundry, transportation, medication use and 
ability to handle finances (332) (see Appendix). Lawton‟s IADL scale, like the 
Katz ADL score, takes around 10 minutes to complete for each hospital patient. 
Scoring is more accurate if IADLs are assessed by direct observation rather than 
asking the patient themselves (349). One limitation of Lawton‟s IADL is that it is 
gender biased towards older women, as older men are more likely to be dependent 
in performing IADLs such as food preparation (350).  
 
2.5.8 Hospital Admissions Risk Profile (HARP)  
The Hospital Admissions Risk Profile (HARP) (327) is a weighted mortality risk 
tool that incorporates three frailty components: age, cognition and IADL (327). 
Scoring is descibed in Section 2.5.8. It is predictive of functional decline (327, 




2.5.9 Score Hospitalier d’Evaluation du Risque de Perte d’Autonomie   
(SHERPA) 
The Score Hospitalier d‟Evaluation du Risque de Perte d‟Autonomie (SHERPA) 
(333) is both a mortality index, and because it contains components underlying 
frailty, a frailty instrument. It was designed and validated in acutely hospitalised 
older people (333). SHERPA contains five weighted components: falls in the 
previous year (no = 0 points, yes = 1 point), MMSE score < 15 (first 21 questions) 
(no = 0 points, yes = 2 points), bad self perceived health (no = 0 points, yes = 1.5 
points), age (years) (< 75 y = 0 points, 75 – 84 = 1.5 points, > 84 = 3 points), 
impairments in instrumental ADL score (332). Scores > 6/15 correspond to „high 
risk of functional decline‟ (333).   
 
2.5.10 Individual Frailty Measurements  
Individual factors underlying frailty can also be used to measure frailty. For 
example, gait speed is recognised as an indicator of frailty (325, 352-354) and has 
been found to link closely with adverse health outcomes in older people (353-
357). Gait speed is applicable clinically, although problems with measuring out a 
walking course can be a barrier to its use (262). 
 
Low grip strength can also be used as a single measure of frailty, having been 
linked with poor mobility (358), longer hospital LOS (359) and disability in older 
people (360). Interestingly, grip strength has been found to associate with 
nutritional status in both community dwelling (361) and hospitalised older people 
(362).  
 
2.5.11 Other Frailty Instruments 
Multiple other frailty indices exist in the literature but are beyond the scope of this 
thesis, including many recently developed such as the: Tilburg Frailty Indicator 
(270), Groningen Frailty Indicator (GFI) (363), The Edmonton Frail Scale (EFS) 
(364), the Frailty Instrument of the Survey of Health, Ageing and Retirement in 
Europe (SHARE-FI) (365, 366), the Clinical Frailty Scale (284), PRISMA-7 




rated Health Deficits Index (370), the Frailty Risk Score (371), and the Self 

































 Frailty Indices 
CHS(210) < 10 5 
Weight Loss, Low Physical 
Activity, Exhaustion, Slowness, 
Weakness 
Fraily  3 items; Pre-frailty 
1-2 items; Robust = No 
Items 
x       
SOF(221) < 5 3 
Weight Loss, Exhaustion, Unable 
to Rise from Chair 5times 
Fraily  2 items; Pre-frailty 
1 items; Robust = No Items 
x x x  x   
FI-CD(284, 
338) 
< 10† 30 + 
Accumulated health deficits: score 
of 0 (no deficits) to 1.0 (all 
deficits)  
A continuous score. Cut-off 
point suggested as Frailty > 
0.25 (373) 
 x      
FI-CGA(339, 
343, 344) 
< 10† 30 + 
10 domains, 52 items (originally 
14): including ADL, IADL, Co-
morbidities, Mood & Cognition 
A continuous score. Cut-off 
point suggested as Frailty > 
0.25 (373) 
 x      
MPI(330) < 10 8 
Co-morbidity, Nutrition, 
Cognition, Medication number, 
Pressure Sore Risk, Living Status, 
ADL, IADL  
Severe risk (frailty) > 0.66; 
moderate risk (pre-frailty) 
0.34 - 0.66; Robust = Scores 
< 0.34 
 x      
FRAIL(245) < 10 5 
Fatigue, Resistance, Ambulation, 
Illness, Loss of Weight 
Frailty  3 items; Pre-frailty 
1-2 items; Robust = No 
Items 
 x x     
Functional Decline Indices 
Modifed 
Katz(331) 
< 10 7 
ADLs: eating, washing, grooming, 
dressing, toileting, transferring, 
walking 
  ADL  x   x x x 
LB(332) < 10 8 
IADLS: phoning, shopping, food 
preparation, housekeeping, 
laundry, transportation , 
medication use, finances 
  ADL  x   x x x 
HARP(327) < 10 3 
Weighted Items: age, cognition, 
IADL 
Scores > 6/15 correspond to 
„high risk of functional 
decline‟ (231).   
 x x x  x x 
SHERPA(333) < 10 5 
Weighted Items: falls, cognition, 
bad self perceived health, age, 
ADL 
High Risk of Functional 
Decline: Scores > 6/15  
(231).   
 x x   x  
† If the Comprehensive Geriatric Assessment (CGA) has already been collected. Abbreviations: CHS = Cardiovascular Health Study Index; SOF = Study of Osteoporotic Fracture (SOF) Index; FI-CD = 
Frailty Index of Accumulated Deficits; FI-CGA = Frailty Index derived from Comprehensive Geriatric Assessment; MPI = Multidimensional Prognostic Index; FRAIL = Fatigue, Resistance, Ambulation, 
Illness and Loss of Weight Index; Katz = Adapted Katz Index of Activities of Daily Living (ADL) score; LB = Lawton and Brody‟s Instrumental ADL (IADL) scale; HARP = Hospital Admissions Risk 




2.6 The Predictive Ability of Frailty Instruments 
As outlined in Section 2.2, an ideal frailty operationalisation should not only be 
diagnostic, but should also be predictive of adverse clinical outcomes and be 
underpinned by biological causative theory (11). The majority of frailty 
operationalisations in use today claim an underlying biological causative theory. 
However, the predictive ability of frailty instruments is largely unknown.    
 
Predictive validation has been judged as the most important area to assist in 
establishing a standard and precise operational frailty definition (340). Moreover, 
by being predictive of outcomes, a frailty operationalisation will be a valuable 
tool for patient care (225) and surgical and medical treatment planning (374). 
However, in spite of these important needs, relatively few epidemiological studies 
comparing frailty measurements have been conducted (229, 230). In the hospital 
setting, comparative studies are even scarcer, with only two known studies 
comparing the predictive ability of frailty measurements (275, 345).  
 
Even hospital-based studies looking at the predictive ability of one frailty 
instrument are scant, with only two studies identified. Khandelwal et al. (2012) 
found frailty identified by the CHS index was associated with an increased risk of 
mortality and a longer length of hospital stay, highlighting that their study was the 
first of its kind (225). Singh et al. (2012) study of acute geriatric rehabilitation 
patients in a tertiary hospital found frailty identified by the FI-CD associated with 
LOS, poor functional gain and poor outcome (admission to residential care or 
death) (375). 
 
It should be emphasised that the need for an operational measurement of frailty 
originated in the clinical setting, but its application has mostly been in 
epidemiological research. There is a definite need to bring back frailty research 
into the clinical setting, particularly with comparative and risk-prediction studies. 




(376) and a better ability to predict patients at risk of adverse clinical outcomes is 
urgently required (10, 376). Such knowledge will assist is selecting a standard 
frailty assessment tool/s for the hospital setting. 
 
Moreover, similar to the literature of Nutritional Screening Tools (see Chapter 1), 
there is a need to design studies looking at predictive accuracy, rather than solely 
predictive ability. Chapter 9 looks at the comparative ability of frailty and 
functional decline indices in predicting poor outcome in hospitalised older people. 




















3 Research Aims and Questions 
Sections 1.11 and 2.6 identify the thesis literature gap, which is the need for 
knowledge of the predictive ability of nutritional screening tools and frailty 
measurements in the hospital setting. Of additional clinical importance is the 
overlap between malnutrition and frailty, with similarities existing in their 
consequences, pathological pathways and prevalence rates. Nutritional status has 
also been judged to be a marker of frailty (12, 150), with the MNA proposed as a 
measure of frailty (12, 150, 155, 377). However, no studies to date have yet 
looked at the efficacy of the MNA as a measure of frailty (see Chapter 6).  
 
3.1 Thesis Objectives 
This doctoral thesis examined the ability of frailty instruments and nutritional 
screening tools to predict adverse health outcomes in older people. Main research 
aims were to: 
 Ascertain the prevalence rates of malnutrition and frailty in hospitalised 
older people as determined by various nutritional screening tools and 
frailty operational measurements, respectively.  
 Determine the predictive ability and accuracy of nutritional screening tools 
and frailty operationalisations in predicting adverse clinical outcomes in 
hospitalised older patients. These outcomes are described in detail in 
section 4.3. 
Secondary thesis aims were to: 
 Determine the efficacy of two nutritional screening tools, the MNA and 
MNA-SF, in identifying frailty in the hospital setting. 
 Assess the association between appetite, body composition and 




3.2 Thesis Outline 
This thesis addresses the study objectives and research gaps outlined in Section 
3.1. Each chapter consists of a research manuscript, either published or submitted 
for publication. Studies are inter-related, focusing predominantly on the predictive 
ability of nutritional screening tools and frailty instruments. 
 
Nutritional screening tools have an advantage clinically if they are predictive of 
adverse clinical outcomes. However, this predictive ability is not clearly known. 
Chapter 5 addresses this issue, presenting a systematic review of the ability of 
nutritional screening tools to predict adverse clinical outcomes; „Nutritional 
Screening Tools as Predictors of Mortality, Functional Decline and Move to 
Higher Level Care in Older People: A Systematic Review‟. Uncovered in this 
review was the distinct lack of comparative studies performed in the hospital 
setting, a setting in which nutritional screening is of utmost importance.  
 
Taking this issue to hand, Chapters 7 and 8 evaluate the ability of nutritional 
screening tools to predict adverse clinical outcomes in hospitalised older people; 
„Nutritional Screening Tools and Anthropometric Measures as Predictors of 
Hospital Discharge Outcomes in Older People‟ (Chapter 7) and „Nutritional 
Screening Tools and Anthropometric Measures as Predictors of Discharge 
Outcomes in Older People‟ (Chapter 8). Chapter 9 continues on the clinimetric 
research trail, and investigates frailty and functional indices as predictors of poor 
hospital outcomes; „Frailty and Functional Decline Indices Predict Poor Outcomes 
of Hospitalised Older People‟. The comparative ability of frailty indices to predict 
hospital outcomes is largely unknown, and thus Chapter 9 will provide additional 
information needed to advance a definition of frailty.  
 
As malnutrition and frailty are inter-connected, it has been proposed that the 
MNA can potentially double both as a nutritional assessment/screening tool and a 




the efficacy of the MNA in identifying frailty in hospitalised older people; „Use of 
the Mini Nutritional Assessment to Detect Frailty in Hospitalised Older People‟.  
 
Linking the two geriatric conditions of malnutrition and frailty is inflammation. 
Chapter 10 explores the relationship between inflammation, body composition 
and appetite in a healthy population across the adult age range; „Inflammatory 
Cytokines and Appetite in Healthy People‟. Chapter 11 provides a general 





















This chapter describes the project‟s methodology, including its location, ethical 
approval and patient recruitment. There were two study cohorts used for this 
thesis: (i) a cohort of hospitalised older patients and (ii) a cohort of healthy people 
from the Cytokines, Adiposity, Sarcopenia and Ageing (CASA) study. Further 
details of the methods used are described in Sections 6.2, 7.2, 8.2, 9.2 and 10.2. 
 
4.1 Research Location 
The setting for this study was the 20-bed Geriatric Evaluation and Management 
Unit (GEMU) at The Queen Elizabeth Hospital, Adelaide, South Australia. The 
GEMU is a specialised sub-acute hospital ward focusing on the multi-disciplinary 
rehabilitation of older people with the view to maximising functional 
independence and discharging patients home where possible (378). GEMU 
patients have a lower rate of functional decline than their counterparts admitted to 
general hospital wards, according to a recent systematic review of GEMUs (378). 
They also have a reduced likelihood of residential care (nursing home) admission 
one year post-hospitalisation (378). 
 
At the TQEH, patients are generally admitted to the GEMU within a few days of 
their admission to the Acute Medical Unit. Patients are selected for GEMU 
admission based on the clinical judgement of hospital geriatricians based on the 
likelihood of benefiting from the GEMU intervention. Patients selected are those 
aged over 80 years or those aged over 70 years with geriatric syndromes. All 
GEMU patients receive a Comprehensive Geriatric Assessment (CGA) by 
consulting geriatricians during their time in the ward.   
 
4.2 Approval for the Study 
The study was approved by the Human Research Ethics Committee at The Queen 
Elizabeth Hospital: protocol number 2010105. Patients were not offered any 




influenced by study participation. All patients (or their authorized proxy) gave 
their informed consent, in accordance with ethical standards from the 2000 
Declaration of Helsinki as updated in 2008 (379) and the Australian 
Government‟s National Statement on Ethical Conduct in Human Research 2007 
(380). 
 
4.3 Clinical Outcome Measures  
Clinical outcome measures are important for geriatric medicine, gerontology 
research and for guiding public health policy. Moreover, outcomes such as 
admission to high level care are important for the older patient themselves as, on 
the whole, they prefer not to be placed in high level care. Two outcome time-
points were considered for analysing clinical outcomes: hospital discharge and six 
months post-hospitalisation. Clinical outcome measures were: 
Chapter 7: 
1. GEMU length of stay (LOS)  
2. Functional decline during GEMU stay  
3. Discharge to higher level care 
Chapter 8: 
1. Poor outcome six months after hospital discharge. Poor outcome was 
defined as a composite measure of mortality and new admission to higher 
level residential care.  
Chapter 9: 
1. Poor outcome at hospital discharge (as defined above) 






4.4 Patient Recruitment  
Consecutive patients aged  70 years (or their authorized proxy where applicable) 
were approached within their first 72 hours of GEMU admission for inclusion in 
the study. The study period was between October 22, 2010 and December 23, 
2011. 427 new patients were admitted to the GEMU during the study period. 172 
patients (40.3 %) of these patients were included in the study. The most common 
reason for study exclusion was the lack of understanding of the consent forms 
without an authorized proxy to approach for study consent.  Table 4-1 outlines 





Table 4-1: Reasons for Study Exclusion  
Reason for Exclusion n (%) 
1. Dementia or unresolved delirium within 72 hours of GEMU 
admission without proxy to approach for study consent 
77 (18) 
2. Language barrier without proxy 
 
67 (16) 
3. Declined participation 
 
63 (15) 
4. Treating physician advised against patient inclusion: elder 





5. Missed by researcher 
 




4.5 Patient Characteristics and Study Outline 
Data collection from the GEMU was performed by the doctoral candidate. 
Chapters 7 - 9 used the data from the 172 patients recruited from the GEMU. The 
mean (standard deviation) age of these patients was 85.2 (6.4) years, with 123 (72 
%) of these patients female. Details of patient characteristics are found in the 
Table 4-2 and in the result sections of each chapter. Chapter 6 used the data 
obtained from the first 100 patients recruited into this study.  
 
Chapter 10 uses data obtained from a different dataset. For this chapter, 180 
healthy community dwelling people of all ages (age range 18 – 82 years), were 
recruited from the North-Western suburbs of Adelaide into the Cytokines, 
Adiposity, Sarcopenia and Ageing Study (CASA).  Telephone numbers from the 
Electronic White Pages were randomly selected and willing participants aged 18 
years and over (with no exclusion criteria) were invited to participate. Further 
details as to participant recruitment and baseline characteristics for this study are 
outlined in Chapter 10. 
 
Data were collected during the first 72 hours of GEMU admission. Patient (or 
proxy) interview was used to obtain socio-demographic and health data, including 
nutritional status by the Mini Nutritional Assessment (MNA) (147). Patient 
clinical records were used to obtain CGA items including medications, admission 
diagnosis, Geriatric Depression Scale-15 (GDS-15) (381), Mini-Mental State 





Table 4-2: Descriptive Characteristics of Patients on Admission (n=172) 
Variable n (%) 
Gender (female) 129 (72) 
Age Group  
     70 -79 years 31 (18) 
     80-89 years  100 (58) 
     90-101 years 41 (24) 
BMI Category  
     < 22 kg/m
2 
58 (34) 
     22 – 30 kg/m
2
 75 (44) 
     > 30 kg/m
2
 39 (23) 
Calf Circumference (cm) 31.8 (5.0)
 †
 
Mid Arm Circumference (cm) 26.1 (4.9)
 †
 
Charlson's Co-morbidity Index 3 (Range 0-12)
‡
 
Cognitive Impairment (MMSE Score < 24)  74 (43) 
Lives Alone 97 (56) 
Polypharmacy (≥ 6 Medications) 131 (76) 
Primary GEMU Admission Diagnosis¶   
     Chronic Condition 71 (41) 
     Infection  52 (30) 
     Injury or Musculoskeletal Condition 28 (16) 
     Non-musculoskeletal Symptoms 6 (4) 
     Unclassified  15 (9) 
†




 Classifications based on Hastings et al. 2010 (384) 
Abbreviations: MMSE = Mini Mental State Examination Score; BMI = Body Mass 
Index (weight/height
2













5 Nutritional Screening Tools as Predictors of Mortality, 
Functional Decline and Move to Higher Level Care in 
Older People: A Systematic Review  
Published as „Dent E, Visvanathan R, Piantadosi C, Chapman I. Nutritional 
screening tools as predictors of mortality, functional decline, and move to higher 
level care in older people: a systematic review. Journal of Nutrition in 
Gerontology and Geriatrics. 2012;31(2):97-145.‟ 
This systematic review assessed whether nutritional screening tools (NSTs) 
predict mortality, functional decline, and move to higher level care in older adults 
residing in the community or in institutions. In total, 37 prospective studies 
published between 1999 and 2012 met inclusion criteria and were included in this 
review. The most commonly used NST in these studies was the Mini Nutritional 
Assessment (MNA). Comparison of NSTs was limited by variation in follow-up 
time, lack of uniform definition of functional decline, and biases in many studies. 
Results of the MNA, MNA-Short Form (MNA-SF) and Geriatric Nutrition Risk 
Index (GNRI) assessments were significantly associated with subsequent 
mortality, with good negative predictive power (0.83), but only modest positive 
predictive power (PPV0.32). Both the MNA-SF and MNA results had a low to 
moderate association with functional decline (PPV0.34). Move to higher level 
care was less strongly associated with NST scores (PPV0.25). Overall, there is 
evidence that NSTs can predict those at low risk of mortality, functional decline 
and, to as lesser extent, move to higher level care in older people.   
Keywords: Systematic Review, malnutrition, functional decline, mortality, aged, 
nutritional status, residential care, older persons, nutritional screening tools, 
sensitivity, specificity. 
Erratum: In this review, the word prediction has been used to describe the 
sensitivity, specificity, positive (PPV) and negative (NPV) predictive values of 
Nutritional Screening Tools. However, rather than the word prediction, the term 
predictive accuracy is the correct statistical expression. Prediction refers to the 
predictive ability (such as odds ratio (OR) and hazard ratio (HR) values), values 
of which are also reported in this review. The heterogeneity of functional decline 




5.1 Introduction  
Undernutrition is a major health problem in older adults worldwide, with an 
estimated 22-68% of hospitalised (87, 104) and 9-32% of institutionalised older 
adults (157, 385) affected. Undernutrition develops when there is a deficiency of 
energy intake relative to energy expenditure. This often unrecognised, and 
consequently undetected, condition is associated with increased mortality (87, 88, 
386) and has been linked with increased functional dependence in several cross-
sectional studies (37, 196, 387-389).  
 
Loss of functional independence results in loss of quality of life (390). In fact, a 
recent survey of older persons found having better health and physical mobility 
was the most desired event to improve quality of life (391). Many older people 
decline in function as the result of one or a combination of chronic conditions 
such as heart disease, stroke, dementia, injuries from falls, osteoarthritis, diabetes 
and sight and hearing loss (392). Low muscle strength, a factor related to 
undernutrition, can compound the functional decline from these conditions (393).  
 
Functional decline refers to the change in function that occurs during two time-
points (112) and is generally defined as an increased dependency in Activities of 
Daily Living (ADL), such as walking or showering. Common scales used to 
measure ADL include Barthel‟s Index (BI) (394) and the Katz score (395). 
Functional decline is also defined as an increased dependency in Instrumental 
ADL (IADL), which includes components such as shopping, managing finances 
and cooking (332). Move to higher level care (for example, from the community 
to a nursing home, or from a nursing home to a hospital) can also indicate 
functional decline (274). Functional decline is closely associated with 
hospitalisation rates in older people (352, 396-398). In older populations, 
functional decline has been found to be a better predictor of mortality and nursing 





The ability to predict those at risk of functional decline would allow for earlier 
intervention.  Many studies have looked at risk factors for functional decline, and 
there are several systematic reviews of such studies of predictors of functional 
decline, including examination of both individual predictors (347, 400-402) and 
screening tools (274, 347, 400, 403). However, few reviews have assessed the 
ability of nutritional screening tools (NSTs) to predict functional outcome, and 
only three screening tools identified by one of the systematic reviews (274) had a 
nutritional component (224, 404, 405).  
 
When single measures of nutritional status, such as body weight or food intake, 
are combined to form an NST, they may be better predictors of clinical outcomes 
than single measures. A variety of NSTs have been developed as rapid, easily 
administered, mass screening tools which aim to identify individuals who are 
malnourished or at risk of malnourishment, and thus ascertain their necessity for 
further assessment and interventions (406). Examples of widely used screening 
tools include the Mini Nutritional Assessment (MNA) (148) and the Malnutrition 
Universal Screening Tool (MUST) (163).  NSTs usually involve a combination of 
questions regarding appetite, food intake and weight loss, plus or minus simple 
anthropometric measures such as body weight, Body Mass Index (BMI) 
(weight/height
2
) and limb circumference. These tools are being used increasingly 
in clinical practice and there are a large and growing number of studies in a 
variety of settings examining their associations with outcomes such as functional 
decline and mortality. NSTs are used to screen the nutritional status of older 
people in settings such as hospitals, the community and in residential care and it 
would be cost-effective for time-pressured clinicians to use one screening tool to 
predict those at risk of both undernutrition and functional decline.  
 
There has been limited systematic examination of the ability of NSTs to predict 
outcomes. A systematic review of six studies by Beck and colleagues (154) 
looked at the MNA and found it was not a predictor of mortality or move to a 




excluded many studies due to their lack of sub-classification into the MNA sub-
groups. 
 
Thus a systematic review of the ability of NSTs to predict outcomes, particularly 
functional status, is warranted. The objective of this paper is to review the ability 
of NSTs to predict mortality, functional decline, and move to a higher level care 




5.2 Method of Review 
Standard guidelines for reporting systematic reviews were followed (407). For the 
purposes of this review, a NST was defined as a test that includes a combination 
of two or more measures or questions related to malnutrition risk, and that 
categorizes this nutritional risk.  
 
5.2.1 Literature Search and Screening Strategy 
The literature search strategy was devised in conjunction with the University of 
Adelaide research librarian. Databases searched were PubMed, EMBASE and 
CINAHL. Search limitations were set to „Human‟ and „English‟. Age limits were 
not set so as to include studies potentially using older people in a subset analysis. 
No date limitations were set. The search involved 4 subsets: older people; study 
design (prospective; nutritional screening tools; and functional outcome 
(functional decline, mortality, admittance to higher level care). The complete 
search strategy is shown in the appendix.  
 
Titles and abstracts were screened by one researcher (ED) and full papers of 
relevant articles were screened for eligibility using a data extraction form. A priori 
study inclusion criteria are shown in Table 5-1. The primary literature search was 
performed during November-December 2011. Emails of updated database 
searches were sent weekly to the reviewers with the last date of the literature 
search being 20
th
 January 2012. Components of a „lateral search‟ (408) were also 
performed, including cross-referencing reference lists and tracking citations. 
 
5.2.2 Analysis of Studies 
Where possible, data were extracted from published tables or figures. Otherwise, 
data from the text of the paper were used. The methodological quality of studies 
was rated using a scale devised in a recent review of frailty and functional decline 
(402), with a maximum score of 27. Two aspects of each paper were looked at 
with respect to outcome: (1) association and (2) predictive ability. Association 




(154). Predictive ability refers to the level that the NST will predict outcome, that 
is, the number of people who are correctly and incorrectly screened and involves 
knowing sensitivity and specificity values (123, 136, 154). Sensitivity is the 
probability a person who is malnourished (or at risk of malnourishment) is 
screened positive, whereas specificity is the probability that a person who is not 
malnourished (or at risk) is screened negative (136, 409).  It is useful to know 
predictive ability from a clinical point of view so that older persons at risk of 
decline can be accurately identified. 
 
In this review, sensitivity and specificity were recorded for those studies reporting 
these values and computed using contingency tables for other studies where 
possible. Additionally, positive predictive value (PPV) and negative predictive 
value (NPV) were also computed. PPV is the proportion of those malnourished 
(or at risk) who have an adverse outcome, whereas NPV is the proportion of those 
who are not malnourished (or at risk) who have no adverse outcome (409). 
 
5.2.3 Population Settings  
To assess if the location of residence of the older person influenced outcomes, 4 
location sub-sets were established: 
(1) Acute Hospital – includes Emergency Departments, Medical and Surgical 
Wards 
(2) Sub-Acute Care - Rehabilitation hospitals, Geriatric Evaluation and 
Management Units 
(3) Residential Care (nursing home – low and high level care) 




Table 5-1: Study Inclusion Criteria  
Study Inclusion Criteria 
Nutritional Screening Tool: incorporates more than one nutritional component and 
identifies an individual who is malnourished or at risk of malnourishment. 
Outcomes include one or more of (1) mortality (2) Higher level of care or nursing 
home admission (3) functional decline. 
Prospective study design 
Data reported from an original study (ie not from a review) 
Studies incorporating people aged 65 years or older, or outcome results separately 
reported for those aged 65 years or older. 
Article published in peer reviewed journal  
Full article not available  
Admission functional status included as a covariate or with all patients at baseline 






Details of selection of papers for the review are shown in Figure 5-1. A total of 37 
studies were identified. Malnutrition prevalence varied between settings, with 
malnourishment being more frequent in settings with increased dependency 
levels: 0-4.9% in community dwelling older persons; 18.6 - 68.0% for those in 
acute care; 42-47% for sub-acute care and 5.7-39% for residential care.    
 
NSTs used in the identified studies were: the MNA (149), the MNA-short form 
(SF) (158) MUST (163), the 'Determine Your Nutritional Health' (Nutritional 
Screening Initiative, NSI) checklist (172), Geriatric Nutritional Risk Index  
(GNRI) (170), Nutritional Status Score (NSS) (173), Chinese Nutritional 
Screening Tool (CNS) (410), Birmingham Nutritional Risk (BNR) (411) and the 
Rapid Screen (RS) (174). Population specific versions of the MNA and the MNA-
SF were also identified: the MNA (Chinese Version) (112), the MNA-Taiwanese 
version 1 (MNA-T1), version 2 (MNA-2) (412) and the short form of version 2 
(MNA-T2-SF) (413). One study looked at MNA sub-scores, including the MNA-
3, which contains 9 of the possible 30 points of the MNA that specifically 
assesses appetite and food intake pertaining to assessment of dietetic habits (88). 
One study looked at the time dependent MNA (MNA-td) which baseline 
information and data collected at different time-points (113) and another looked at 
the MNA-Proportional and Objective (104). The total score of NSTs was 
compared against outcomes in some studies, whereas others compared categories 
of the screening tools.  
 
MNA categories include malnourished‟ (M) (scores <17), „at risk of malnutrition‟ 
(AR) (scores 17-23.5) and „well nourished‟ (scores 24-30) (WN). MNA-SF 
categories consisted of (Scores 11) and WN (Scores 12-14). For the MUST, 
GNRI and NSI, categories identified were „high nutritional risk‟ (HR), „moderate 





The quality of studies was similar for those that assessed mortality, functional 
decline and move to higher level care (means of 22, 22 and 20 respectively). 
Results are described separately below in three sections according to outcome 










5.4 Findings from Mortality Papers 
28 papers reporting the relationship between NST assessments and subsequent 
mortality were identified (see Table 5.2, Appendix). Seven studies were 
performed in the acute hospital setting (86-89, 99, 104, 414), six in sub-acute care 
(90, 91, 113, 170, 173, 415), seven in residential care (97, 153, 385, 386, 416-
418), seven in the community (172, 412, 419-423) and one in both acute and sub-
acute settings (424). Eleven studies excluded people with acute and/or chronic 
illnesses such as cancer and renal failure (97, 113, 153, 170, 386, 416-418, 420, 
422, 423), seven excluded those with cognitive impairment and/or dementia (88, 
89, 172, 414, 416, 421, 423), six did not mention exclusion criteria (90, 91, 104, 
173, 385, 415) and the remaining studies had either limited or no exclusion 
criteria.  
 
5.4.1 Nutritional Screening Tools Used 
Nine studies looked at more than one NST. The most common NST used was the 
MNA, which was used by 17 studies. Four studies used population-specific 
versions of the MNA and three used the MNA-SF. Three studies apiece used 
GNRI, with the MUST, NSS, CNS and BNR all used by one study each (see 
Table 5.2, Appendix). One study compared both the MNA and population specific 
versions of the MNA against mortality (412). 
 
5.4.2 Mortality: Outcomes 
Follow-up periods ranged from time-to-hospital-discharge (usually < 1 month) to 
five years, with 1 year being a common follow-up period. Two studies did not use 
a standardised follow-up period (86, 423). Mortality rates varied from 2.5% to 
64% (Appendix: Table 5.3). 
 
5.4.3 Relationship between NST results and Mortality 
There was clear evidence of a relationship between NST scores indicating lower 




statistically significant relationship was present in 23 of the 28 studies (see 
Appendix: Table 5.3). Seven studies reported odds ratio (OR) (26 %) and seven 
studies (26 %) reported Hazard Ratios (HR) or Risk Ratios (RR).  
 
In those studies reporting odds ratios (ORs), OR values ranged from 5.29 to 30.5 
for GNRI severe nutritional risk (values < 82) when compared to those classified 
as „no risk‟, from 6.6 to 30.5 for moderate risk GNRI classification, 0.93 to1.80 
for the MNA total score, 2.19 to 2.39 for the MNA (AR) category, 1.35 to 3.03 for 
the MNA (M) category, and 1.35 for the MNA-SF. Due to the heterogeneity of 
studies it was difficult to compare different NSTs for the strength of their 
associations with mortality. Nonetheless, one study compared the MNA and 
MNA-SF and found the MNA-SF showed the highest association against 
mortality (90). Additionally, when the GNRI and MNA were directly compared 
by Cereda et al. (2009) (97), the MNA (M) showed a higher association with 
mortality than the GNRI (HR). This is in contrast to the overall higher OR values 
of the GNRI against mortality. 
 
Significant associations between NST measures and mortality were present less 
often in studies of community-dwelling-older people (3 of 7 studies) than for 
those in higher levels of care (19 of 20 studies).  A significant association was 
present in 12 of 13 studies with a follow-up period greater than one year, 
compared, to 11 of 15 with follow up of one year or less.  The association 
between mortality was similar between the MNA and its population-modified 
versions (MNA-T1 and MNA-T2) according to Tsai et al. (412). Additionally, 
although there was no comparison within studies, studies using continuous MNA 
scores appeared to have higher ORs for association with mortality than studies 
that used MNA categories. 
 
One study (88) looked at the MNA-3 (the subset of questions within the MNA, 
accounting for 9 of the possible 30 points, that specifically assesses appetite and 




and MNA respectively) as well as higher Area Under the Curve (AUC) values 
(0.755 vs 0.744 respectively) than the full MNA, which also assesses other factors 
such as quality of life and anthropometric measures.  This suggests that appetite 
and food intake measures may have a particular association with mortality.  
 
All three studies looking at the NSI found no significant association with 
mortality (172, 419, 423). The NSI tool results are probably therefore not be as 
closely related to subsequent mortality as are the other tools, particularly the 
MNA and GNRI. Although 3 studies that used the MNA found no association 
with mortality (414, 420, 421), there was a significant association in the other 17 
studies using the MNA. Two of the 3 „negative‟ studies involved community-
dwelling older people, the setting in which the ability of NSTs to predict mortality 
appears to be weakest (see above) and in one of those studies the mortality rate 
was close to zero. 
 
5.4.4 Ability of Nutritional Screening Tool Results to Predict Mortality 
Sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV) for each study, where able to be computed, are shown in Table 5.3 
(Appendix). In general, the NPVs are almost always higher than the PPVs, with 
mean (SD) values of 0.83 (0.18) and 0.32 (0.23) respectively. This is particularly 
true for studies that used the MNA screening tool, with NPV values often close to 
1 whilst PPVs were often low. This indicates that the rate of death during the 
follow-up period is very low if the person is classified as well-nourished by the 
NST, but that the majority of people classified as undernourished using the tool, 
do not die during the study. Due to the variability of the studies, we were not able 
to determine if the different NSTs differed in their predictive ability for mortality. 
 
5.4.5 Summary of Papers looking at Mortality  
Allowing for the great heterogeneity of studies assessed, it is clear that the results 
of NST assessments of older people are associated with their subsequent mortality 




in more acute settings or higher level of care settings and less so for community-
dwelling older people. It is unclear which NST is the best in this regard, possibly 
the MNA (although that impression may result from its more frequent use in the 
studies we analysed). The NSI tool did not appear to be able to predict mortality. 
It is difficult to be conclusive if the MNA or the GNRI is better at predicting 
mortality. Although the associations observed were significant, often highly, the 
ability of a score or category on a given NST is at best only moderate, with 
substantially better negative than positive predictive ability. This is not 
unexpected given the multiple other factors that contribute to mortality in older 
people, of which nutritional status is only one. Nevertheless, it appears that the 
MNA and GNRI can be used to largely rule-out those at low risk of mortality and 
therefore in less need of further assessment and intervention.  
 
5.5 Findings from Functional Decline Papers 
Twelve studies using NSTs and assessing subsequent functional decline were 
identified (Table 5-4, Appendix). Two studies were conducted in acute settings, 
four in sub-acute care (96, 111-113), four in the community (172, 413, 419, 420) 
and two looked at populations in more than one setting (425, 426). There were no 
papers conducted in the residential care setting. Three studies contained over two 
thirds women in their dataset (113, 420, 422). A number of studies included in the 
mortality section of this review and which also looked at function, were excluded 
from analysis as they did not adjust for baseline function (87, 412, 422). The most 
common participant exclusion criteria in the studies analysed were acute/chronic 
illness such as terminal illness or infection (5 studies) (96, 98, 111-113) followed 
by cognitive impairment/dementia (4 studies) (96, 111, 112, 172). Two studies 
used the same dataset (425, 426). High participant retention rates (>80 %) were 
found in all but three studies (172, 419, 420). The mean quality of functional 
decline studies (22/27) was comparative to a recent systemic review of individual 
frailty components and their influence on functional decline by Vermeulen et al. 
(22.5/27) (402). Additionally, the low percentage of papers with high attrition rate 
in the present review (25 %) was much lower than that of papers identified by 





5.5.1 Nutritional Screening Tools Used 
Five studies assessed more than one screening tool. The most frequently used 
NST was the MNA (8 studies), with two of these studies using a population 
version of the MNA (112, 413). Five studies used the MNA-SF. Other NSTs 
included the NSI checklist (2 studies) (172, 419).  
 
5.5.2 Functional Decline Measures: Outcomes 
The methods/tools used to measure change in function varied widely between 
studies (see Table 5.4 (Appendix). The Barthel Index (BI) was the most frequently 
used ADL measure and was used in seven studies (58 %). Katz ADL score was 
used in two studies (17 %), whilst one study combined mortality and functional 
decline as a composite score (425) and another looked at Physical Functioning 
Dimension of the Sickness Impact Profile (PDF:SIP) as their measure of 
functional decline (172). Lee and Tsai (413) used both a functional status ADL 
and Instrumental Activity of Daily Living (IADL) scores described by Johnson et 
al. (427). IADL decline, using Lawton and Brody‟s score (332) was reported in 
one study (86), while two community-based studies looked at utilisation of home 
care services (419, 420). Most studies used phone call survey for follow-up. The 
majority of studies looked at changes between two time-points, with only two 
studies examining functional change over more than two time points (functional 
trajectory) (112, 113). 
 
The duration of follow-up in the studies varied from time-to-hospital-discharge to 
up to five years, with six months being a common duration for follow-up. 
Outcome was reported as OR in five studies (38 %) and as hazard ratio in two 
studies (15 %). In both of these latter studies, more functional decline occurred in-
hospital than post-hospitalisation (112, 113). Functional decline was reported in 
eight (67 %) of studies, with a prevalence range from 9 – 74%. More IADL 
decline was observed than ADL decline and the most functional decline occurred 





5.5.3 Relationship between Nutritional Screening Test (NST) Results and 
Functional Decline 
Nine studies (75 %) showed a significant association between NST scores 
indicating poor nutrition and subsequent decline in function (86, 96, 98, 112, 113, 
172, 413, 419, 425); with five of these showing an association after adjusting for 
confounders (96, 98, 112, 113, 413), three losing their association after adjustment 
(86, 172, 425) and one not controlling for confounders (419). One study found a 
non-significant association between poor nutrition scores and subsequent decline 
in function (420) while two found no association (111, 426). 
 
The heterogeneity of studies makes it difficult to assess the strength of association 
between NST scores and functional decline. Nevertheless, significant ORs ranged 
from 1.07 to 16.19 for ADL decline, with all but one of these studies using the 
MNA. One study reported a significant OR value of 0.94 for reduced (rather than 
increased) risk of ADL decline using the MNA (86). All five studies utilising the 
MNA-SF showed an association with ADL decline. MNA-SF OR values for the 
two studies that reported it, were 4.25 and in acute care (98) and 1.08 (413) in 
community older persons, with the latter using MNA-T2-SF. Thus, overall, both 
MNA and MNA-SF showed a weak to moderate association of with ADL decline. 
The MNA-SF outperformed the MNA with respect to association with ADL 
decline when directly compared in the study by Lee and Tsai (2011) (413) but 
when comparing studies in Table 5.5 (Appendix) the MNA-SF appeared better. 
 
Studies finding no association with functional decline include the two studies 
using the NonaSantfeliu Study, which a population study is exclusively looking at 
adults aged over 89 years at baseline and using the MNA-SF (425, 426): Formiga 
et al. (426)‟s paper found no association with BI decline, and Ferrer et al. (425) 
found no association when controlling for confounders using a composite measure 
of BI decline and mortality for their outcome measure. Ferrer and colleagues, 




Other studies finding no association between nutritional screening tools and ADL 
outcome include papers by Chen et al., (111), who looked at MNA in sub-acute 
care populations, and Boult et al. (172) looking at the NSI.  
 
Of the two studies looking at IADL decline, the study by Chang et al. (86) found 
no association with MNA, and Lee and Tsai (2011) (413) found both the MNA-
T2 and MNA-T2-SF showed no association with IADL decline when looking at 
all older persons, but when looking at those who were disability free at baseline 
and then who declined in IADL, both MN-T2 and MNA-T2-SF showed 
significant associations, with OR values of 1.13 and 1.12 respectively.  
 
5.5.4 Ability of Nutritional Screening Tool Results to Predict Functional 
Decline 
Sensitivity, specificity, PPV and NPV for each study, where able to be computed, 
are shown in Table 5.7 One study reported sensitivity and specificity values for 
the NSI (172) and two other studies using the MNA (413, 420) provided sufficient 
data for these values to be computed.  
 
In general for studies assessing ADLs, the NPVs were higher than the PPVs with 
mean (SD) values of 0.83 (0.10) and 0.34 (0.28) respectively, although these 
values could not be calculated for the acute care study of Salvi et al. (98) where a 
significant OR of 4.25 was found.  The one study which looked at  instrumental 
activities of daily living (IADL) (413), found a high PPV value (0.81) and also a 
moderately high  NPV (0.67). These results suggest that NSTs are good at 
excluding those at risk of functional decline, but not as good at detecting those at 
risk of functional decline, particularly if ADLs are assessed.  
 
5.5.5 Summary of Papers Looking at Functional Decline 
Allowing for the heterogeneity, limitations and small number of studies assessed, 




nutritional status was associated with an increased rate of subsequent functional 
decline over periods of up to 5 years. The strength of this relationship was low to 
moderate. It is not possible to say which NST was the best, although the MNA 
and MNA-SF provided the most evidence of an association. Additionally, 
although the associations observed were significant, the ability of a score or 
category on a given NST to predict declines in ADL was only at best only 
moderate, with substantially better negative than positive predictive ability. The 
ability to predict declines in IADL may be better, but there are not enough quality 
studies to draw firm conclusions in this area. 
 
5.6 Findings from Move to Higher Level Care Papers  
Seven studies using nutritional screening tools and assessing subsequent moves to 
higher level care were identified (Table 5-6, Appendix). Two were conducted in 
the acute hospital setting (87, 99), three in sub-acute care (91, 96, 174) and two in 
the community (421, 428).  The majority of papers looking at move to a higher 
level care contained around two thirds women or more (87, 91, 99, 414, 421, 428). 
Two studies excluded those with acute and/or chronic illnesses (96, 428), three 
excluded those with cognitive impairment and/or dementia (96, 174, 421) and one 
did not report exclusion criteria (91). 
 
5.6.1 Nutritional Screening Tools Used 
MNA was used in all but one study which used the MUST (91). The MNA-SF 
(96) and RS (174) were both used in one study apiece together with the MNA. 
One study compared MNA scores below the median (<25.2) against scores above 
the median (428). 
 
5.6.2 Move to Higher Level Care: Outcomes 
Discharge destination from acute or sub-acute care hospital was the outcome 
measure used in most studies. The two community-based studies looked at living 




domiciliary services (421)and the other in a population with Alzheimer‟s 
dementia (428). OR values were reported in two studies (29 %) (96, 428) and 
relative risk (RR) was reported in one study (14 %) (421). One study did not 
specify how many people already in higher level care at baseline returned to 
higher level care at discharge (91). Overall, five studies (71 %) reported rates of 
move to higher level care, with rates ranging from 20-32%.  
 
5.6.3 Relationship between Nutritional Screening Test (NST) results and 
need to move to Higher Level Care 
Four studies found a significant association between NSTs and move to a higher 
level care (96, 99, 174, 428). All four of these studies used the MNA, with one 
using both the MNA and MNA-SF (96). The OR for move to higher level care 
was 2.22 for the MNA-SF  (M + AR) and 2.29 for the MNA (M + AR) according 
to Neumann et al. (96) who looked at older persons in sub-acute care. Andrieu and 
colleagues (428) looked at MNA scores less than the median score (<25.2) and 
found the age-adjusted OR was 2.19 and age-gender adjusted OR was 2.3 in their 
study of community residing older persons with Alzheimer‟s Dementia. The 
studies by Visvanathan et al. (2004) (174) and Van Nes et al. (2001) (99) also 
found those with worse malnutrition were more likely to go into higher level care 
post-discharge from acute and sub-acute care respectively.  
 
Of the three studies finding no association with nutritional screening and move to 
higher level care, one used the MUST in the sub-acute care setting (91) whilst the 
two used the MNA; one in the acute care setting (87), the other in the community 
(174). No studies allowed comparison of the time-dependent association of NSTs 
and move to higher level care. Overall, when settings were compared, there 
appeared to be no differences between with respect to the association of MNA or 





5.6.4 Ability of Nutritional Screening Tool Results to Predict Move to 
Higher Level Care 
Sensitivity, specificity, PPV and NPV, where able to be computed, are shown in 
Table 5.7 (Appendix). PPV was generally low across all settings, with overall 
PPV scores lower than NPV (mean (SD) of 0.25 (0.17) and 0.83 (0.15) for PPV 
and NPV respectively. Two studies allowed comparison of MNA categories; with 
both revealing the MNA (AR + M) showed higher NPV and around the same PPV 
than the MNA (M) category (87, 99). 
 
5.6.5 Summary of Papers looking at Move to Higher Level Care 
There was a trend for NSTs to be associated with admission to higher level care (4 
out of 7 studies). All studies in which there was a significant association used the 
MNA, with one also including the MNA-SF. As with mortality and functional 
change, the NPVs of the NSTs for this outcome were substantially higher than 
their PPVs. Additionally, based on predictive values, it appeared that when the 
two MNA categories, malnourished (M) and at risk (AR) were combined together, 
they showed a greater predictive value than the malnourished (M) category. 
Overall, findings were not influenced by study setting. Of note, it is likely that 
factors other than nutrition are influencing move to a higher level care. For 
instance, the presence of dementia, low social support or lack of finances could 





5.7 Discussion  
5.7.1 Major Findings 
This review of 37 published studies was undertaken to assess current evidence 
about the relationship of nutritional screening tool (NST) scores to subsequent 
mortality, functional decline and move to a higher level care, and the ability of 
NST scores to predict these outcomes.  The studies were conducted in a variety of 
settings and in several different countries. There were considerable differences 
between studies in methods used and duration of follow-up, precluding direct 
comparisons between different NSTs difficult and/or a meta-analysis. 
Nonetheless, significant associations were identified between poor NST scores 
indicating worse nutrition and mortality, functional decline and to a lesser extent, 
move to a higher level care.  
 
With regards to mortality, the strongest association with NST scores tended to be 
in the most unwell people, that is, for those in acute, sub-acute and residential care 
rather than those residing in the community. While perhaps not surprising, this 
does suggest a role for targeted screening. There was no definite difference in the 
ability of NST scores to predict functional decline across the different population 
settings, although cross study comparisons, using different versions of the MNA 
suggested a possibly stronger association between NST scores and decline in 
IADL scores in the  community (413) than acute setting (86). 
 
The most frequently used nutritional tool examined in this review was the MNA. 
This tool has been validated in a variety of settings, including hospitalised and 
community welling older people (150). The MNA has also been proposed as the  
best NST to use in hospitalised older people, because it contains relevant 
prognostic components (74). Moreover, the MNA contains ADL components 
(422) and has recently been reported to predict ADL (BI) in a cross-sectional 
study of older adults (430).  However, cross-sectional studies, by their nature, 





In the present review we examined predictive ability by looking at positive 
predictive value (PPV), negative predictive value (NPV), sensitivity and 
specificity. Sensitivity and PPV were low in the majority of studies and specificity 
and NPV generally substantially higher. The low PPVs signify that many older 
persons identified as being under-nourished are at low risk of the endpoint; death, 
functional decline or move to a higher level care.  Low PPVs were also noted by 
Beck and colleagues in their systematic review of MNA (154). As with our 
review, they found that MNA was not highly predictive of adverse outcomes, 
even though many of their included studies reported a significant relationship with 
adverse outcome (154). In contrast, specificity and negative predictive ability (the 
ability to detect those who will not go on to have the adverse outcome) was 
moderate to high for the outcomes assessed in the papers reviewed. High 
sensitivity values are essential for screening tests (431) and are dependent on the 
methodological quality of the papers themselves (274). High specificity values are 
important for accurately ruling out who is not at risk of poor outcome.  
 
In this review, the most successful NST in significantly associating with and 
predictive of (at least with respect to negative predictive ability) the outcomes of 
interest in most studies appeared to be the MNA. The MNA was certainly the 
most frequently studied NST. The NSI was least predictive of any outcome, 
perhaps because as outlined by Beck (419), it was validated in US populations but 
used in European populations. The NSI has not seen much use in the last decade. 
The GNRI appeared to be closely associated with and good at predicting mortality 
(at least with negative predictive ability) (97, 170, 417) but its comparison with 
other outcomes is limited.  
 
There are a number of possible explanations for the relatively low positive 
predictive ability of NSTs in the studies included in this review. NSTs are 
generally validated in the general population of older persons, most of whom are 




or sub-acute care (154, 432). It could also be that cut-off scores for nutritional 
status classification have been selected based on cross sectional studies, rather 
than clinical outcomes in longitudinal studies (154), and also not on the particular 
outcomes assessed in this review, namely death, functional decline and move to a 
higher level care. If the cut-off scores to define undernutrition were set lower than 
they are for these NSTs the sensitivity and PPV values would likely have been 
higher. This could also explain why, in the present review, that MNA total score 
tended to show a higher association with mortality than MNA categories. 
Additionally, and very likely, factors other than nutritional state, such as acute or 
chronic illnesses, social situation, and cognitive function, influence the likelihood 
of the three outcomes assessed (418). 
 
While quite a few studies have examined NSTs and mortality, little has been 
reported about the ability of NSTs to predict functional decline. If they could, this 
would be useful as it would allow identification of older persons at greatest risk of 
functional decline. Identification of these individuals would allow, in conjunction 
with comprehensive geriatric assessment, appropriate management to be 
undertaken. The current review has indicated that NSTs do have some use in this 
area, probably more so for the MNA than for the other tools we assessed. As with 
mortality the negative predictive power exceeds the positive predictive power, 
enabling identification of those who do not need further workup and assistance 
more effectively than it does those who do.  
 
5.7.2 Strengths and Weaknesses of Included Studies 
A limitation of this review is that the variety of methods used in the studies 
assessed, particularly regarding NST used, scoring and sub-categorization of the 
NSTs, assessment of functional decline and duration of follow-up periods, made it 
more difficult to draw general conclusions from the results. Sufficient information 
was not always provided and a number of studies were excluded for this reason. 
Some studies did not use regression analyses, and some of those that did failed to 
adequately adjust for influencing confounders. This may have weakened the 




Another limitation could be that nutrition information collected in the NSTs was 
not always complete and/or accurate. For example, in a number of studies a proxy 
for the older person was used to help complete the NST. This could have affected 
score results. Indeed, Tsai and Ku (2008) (418) found that MNA score was 
associated with mortality in those older persons who used a proxy, but not in 
cognitively-normal older persons who did not use a proxy. In most studies looking 
at functional decline, this outcome was examined between two time points only, 
rather than over multiple time-points. Change over multiple time-points, known as 
„functional trajectory‟ (112), is a relatively new concept which can allow 
detection of transient changes in functional status both during hospitalisation and 
post-hospitalisation, which can often occur (397).  
 
Various biases may also have affected the quality of results assessed.  A number 
of studies did not control for gender in their analysis. Although it is unlikely that 
gender influenced the MNA score (147), this may not be true for functional 
outcomes. Espaulella et al. (2007) (113) found the MNA was associated with 
functional decline in female, but not male older persons.  Additionally, many 
studies reported that excluded participants were more likely to be older and sicker, 
so selection bias may also have been a factor. Cognition bias was also present in 
some studies, which included older people with impaired cognition without 
adjusting for this in the analyses. A further common type of bias was population 
bias, with many studies excluding patients who could not communicate well (for 
example, because of poor hearing or sight) and/or looking at one population group 
(Caucasian or Asian for instance). There were also high levels of self-reporting 
and recall bias in many studies. While it is possible that these biases may have 
affected the associations between NST scores and the outcomes reported in these 
studies, we doubt this would have affected these relationships in any particular 
direction. 
 
5.7.3 Strengths and Weaknesses of Review Methods  
There were limitations with respect to review methods. Only papers in English 




were searched, and while it is believed that the majority of articles pertaining to 
this review were in these databases, other papers were almost certainly missed. 
Only peer-reviewed published articles were included and retrospective studies 
were excluded to increase the accuracy of studies included. All studies assessed 
were observational, so no inferences about causation can be made.   
 
5.7.4 Protocol Limitations 
This systematic review is comprised of cohort studies of prognosis. Therefore, it 
would be appropriate to analyse the relative risks, hazard ratios and/or odds ratios. 
However, this review focused on reporting descriptive measures, such as 
sensitivity, specificity, PPV and NPV which are important for looking at the 
accuracy of predictive ability.  
 
5.7.5 Suggestions for Future Research 
Further work is needed to clarify and hopefully support our findings, particularly 
in populations at risk of becoming malnourished. While the Barthel‟s Index was 
the most widely used tool for assessment of ADLs in the studies we reviewed 
(394), allowing some  comparison between studies, there is no widely accepted 
means of assessing functional decline. It would be ideal if there was. Additionally, 
studies looking at functional decline as a primary rather than a secondary outcome 
measure and studies undertaken in older people without substantial functional 
impairment at baseline would also improve the accuracy of studies. Future studies 
of function would also benefit from a focus on multiple time points (functional 
trajectory) rather than two time points. Ideally, large scale studies, comparing 
sensitivity, specificity, PPV and NPV of NSTs against functional decline are 
needed. Such studies will ensure adequate statistical power to accurately identify 
which cut-off scores are optimal. 
Future studies would ideally ensure the following: 
1. Ethics guidelines are adhered to, as older people are a vulnerable 
population     group. 




3. The administrator of the assessment, be it the researcher, clinical, nurse, 
dietician or other health professional, is identified in the report. 
4. Inclusion and exclusion criteria are reported. 
5. Statistical analyses controls for confounding variables such as age, 
cognitive impairment, co-morbidities and gender.  
 
It may also be appropriate to consider using composite end-points as 
recommended by McCusker and colleagues (400), who suggest combining 
mortality and functional decline in studies with a low incidence of studied 
outcomes. This would allow a consistent statistical handling of deaths, rather than 
the range of different methods used currently.   
 
Future research into barriers of implementation to NSTs is also warranted, as is 
research on the effect, if any, on rates of death, functional decline and move to a 
higher level care of interventions arising from NST assessments.  Randomised 
clinical trials looking at nutritional and clinical interventions are needed to 
address the problems identified in the prospective, observational studies reported 
in this review.  
 
5.7.6 Take Away Points 
We conducted a systematic review of nutrition screening tools (NSTs) as 
predictors of mortality, functional decline, and move to a higher level care in 
older adults residing in the community or in institutions. The majority of studies 
used the MNA. 
A direct comparison of screening tools was limited by the large variation in 
follow-up time period, a lack of uniform definition of functional decline, and the 
biases inherent in many studies, including selection, confounding (such as gender 




There is evidence that NSTs can predict mortality, functional decline and, to as 
lesser extent, move to a higher level care in populations of older people, although 
they are better at identifying those at low risk of these outcomes.   
Further studies are warranted to establish more clearly whether NSTs can predict 
functional decline and mortality. Different NST cut-off scores may be required to 
improve their predictive ability.  Standardising outcome measures with respect to 
functional decline will allow better comparison between research studies. 
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6 Use of the Mini Nutritional Assessment to Detect Frailty 
in Hospitalised Older People 
Published as: „Dent E, Visvanathan R, Piantadosi C, Chapman I. Use of the mini 
nutritional assessment to detect frailty in hospitalised older people. Journal of 
Nutrition Health and Aging. 2012;16(9):764-7.‟ 
Objectives: The aims of this study were to: (1) determine the prevalence of 
undernutrition and frailty in hospitalised older patients and (2) evaluate the 
efficacy of both the Mini-Nutritional Assessment (MNA) screening tool and the 
MNA short form (MNA-SF) in identifying frailty. Setting and Participants:  A 
convenient sample of 100 consecutive patients (75.0 % female) admitted to the 
Geriatric Evaluation and Management Unit (GEMU) at The Queen Elizabeth 
Hospital in South Australia. Measurements: Frailty status was determined using 
Fried‟s frailty criteria and nutritional status by the MNA and MNA-SF. Optimal 
cut-off scores to predict frailty were determined by Youden‟s Index, Receiver 
Operating Characteristic Curves (ROC) and area under curve (AUC). Results: 
Undernutrition was common. Using the MNA, 40.0% of patients were 
malnourished and 44.0% were at risk of malnutrition. By Fried‟s classification, 
66.0 % were frail, 30.0 % were pre-frail and 4.0 % robust. The MNA had a 
specificity of 0.912 and a sensitivity of 0.516 in predicting frailty using the 
recommended cut-off for malnourishment (< 17). The optimal MNA cut-off for 
frailty screening was <17.5 with a specificity of 0.912 and sensitivity of 0.591. 
The MNA-SF predicted frailty with specificity and sensitivity values of 0.794 and 
0.636 respectively, using the standard cut-off of < 8. The optimal MNA-SF cut-
off score for frailty was < 9, with specificity and sensitivity values of 0.765 and 
0.803 respectively and was better than the optimum MNA cut-off in predicting 
frailty (Youden Index 0.568 vs. 0.503).  
Conclusion: The quickly and easily administered MNA-SF appears to be a good 
tool for predicting both undernutrition and frailty in older hospitalised people. 
Further studies would show whether the MNA-SF could also detect frailty in other 
populations of older people. 






Undernutrition, with its manifestation of weight loss is common in older 
populations. This problem is worse in hospitals, with as many as 50 % of 
hospitalised older people undernourished (147, 433). The Mini-Nutritional 
Assessment (MNA) is a common nutritional screening tool used to assess 
nutritional status in older people (150). It takes approximately 10-15 minutes to 
administer (147) and measures 18 items in 4 components, assessed by asking 
questions and measuring Body Mass Index (BMI), calf and mid-arm 
circumference. Older people identified as malnourished by the MNA have an 
increased risk of in-hospital mortality (88, 99), delayed post-operative wound 
healing (434), an increased likelihood of nursing home admission (99) and longer 
lengths of hospital stay (99).  
 
Recently a more easily administered short form (SF) of the MNA, the MNA-SF, 
has been introduced (157, 158). It comprises BMI measurement and the 
assessment of the first six of the 18 MNA items, using questions related to food 
intake, weight loss, mobility, psychological problems and dementia. It takes 
approximately 4-5 minutes to administer. Its diagnostic accuracy in detecting 
malnourishment is similar to that of the full MNA (157). 
 
Frailty is also a substantial problem in older people. It is characterised by a 
general lack of strength and increased susceptibility to disease (256), and is 
associated with increased mortality (222) and morbidity (228, 245). Frailty is also 
associated with an increased risk of adverse events occurring during 
hospitalisation (435) and functional decline post-hospitalisation (228, 436, 437). 
Identification of frailty in hospitalised older people allows for optimisation of a 
multidisciplinary subjective global assessment (SGA) to manage frailty and its 
associated problems both in hospital and post-hospitalisation (438).  The Fried‟s 
frailty score is often used to identify frailty (222, 228, 233). 
While frailty and undernutrition are not the same, older people who are 




these conditions, particularly in hospitalised patients (196). The use of one 
screening tool for these two common conditions would be of benefit for time-
pressured acute care clinicians. The MNA nutritional screening tool has recently 
been proposed as a possible screening tool for frailty (12, 150) but has not yet 
been assessed for this use.   
 
In this study, results from an ongoing study of hospitalised older patients were 
used to (1) determine the prevalence of undernutrition and frailty in hospitalised 








Consecutive patients (or their proxy where applicable) were approached within 72 
hours of admission to the geriatric evaluation and management unit (GEMU) at 
The Queen Elizabeth Hospital (TQEH) in Adelaide, Australia. The GEMU 
generally admits patients a few days after admission for an acute illness. Study 
exclusion criteria were: unable to comply with the study protocol, a lack of 
understanding of the consent forms without a proxy, aged <70 years and not 
wishing to be part of the study. Study participants were recruited as part of a 
larger study. The study had ethics approval from TQEH Human Research Ethics 
Committee.  
 
Frailty, MNA and MNA-SF assessments were performed in all subjects by the 
same investigator (ED). Weight (kg) was measured using a calibrated weigh chair 
(FVCS-150) to two decimal points. Height was measured to the nearest centimetre 
using a stadiometer for patients who were able to stand. For other patients, self-
reported height was used. Circumference measures were performed using standard 
anthropometric procedures (439).  
 
Frailty was diagnosed using a modified Fried‟s frailty criteria, assessing five 
frailty components – shrinking, weakness, exhaustion, slowness and low physical 
activity levels. (210). Shrinking and exhaustion were defined as per Fried‟s 
original study (210), with shrinking being unintentional weight loss of 4.5kg or 
more in the last year and exhaustion established by responses to the questions „I 
felt that everything I did was an effort’ and „I could not get going in the last 
week‟. Weakness was defined as a grip strength <30kg for males and <18 kg for 
females as per the frailty intervention trial (FIT) (12). Low physical activity was 
defined as per FIT criteria, which was a „yes‟ response to all three of „did not 
perform and weight bearing physical activity‟, „spent more than 3 hours per day 
sitting‟ and „went for a short walk once per month or less‟. Slow walking speed 
was defined as > 30s to complete 6m or unable to complete 6m as defined by the 




of the five frailty components; pre-frailty as one or two components; and robust as 
the absence of all frailty components. 
 
Nutritional Status was determined using the MNA (2, 3) and the MNA-SF (7). 
MNA scores < 17 out of 30 were classified as „malnourished‟, scores 17 – 23.5 as 
„at risk of malnourishment‟ and scores > 23.5 as „well nourished‟ (3). For the 
MNA-SF, scores of 0-7 were designated as „malnourishment‟, scores 8-11 „at risk 
of malnutrition‟ and scores 12 – 14 as „well nourished‟ (7). Body Mass Index 
(BMI) (weight/height
2
) was computed for each patient and so MNA-SF did not 
use calf circumference measures in lieu of BMI.   
 
6.2.1 Statistical Analysis 
Normality of data was assessed using both Kolmogorov-Smirnov tests and 
histograms. Associations between MNA scores and frailty classifications were 
determined by Spearman‟s correlations.  The accuracy of MNA and MNA-SF 
scores in identifying frailty was assessed by Receiver Operating Characteristic 
Curves (ROCs) and area under curve (AUC) using sensitivity and specificity 
values for each MNA cut-off point.  
 
The ability of malnourishment classification by MNA and MNA-SF to detect 
frailty ( > 3 criteria) was analysed by calculating MNA‟s sensitivity, specificity, 
Positive Predictive Value (PPV) and Negative Predictive Value (NPV) for each 
MNA cut-off point.  The maximum Youden Index (YI) (sensitivity + specificity – 
1), was computed to determine the most accurate MNA cut-off score to reflect 
frailty.   
 
Statistical analysis was carried out using PASW Statistics 18 (IBM SPSS 
Statistics; Chicago, IL) and Microsoft Office Excel 2007 (Microsoft Software, 





Figure 6-1 shows patient recruitment. One hundred consecutive patients were 
included. Mean (SD) age of patients was 85.2 (6.1) years (range 72 – 98). 75 (75.0 
%) of the patients were female. 31 (31.0 %) patients had a proxy assist with data 
collection. Height was self-reported in 28 (28.0 %). By the MNA, inadequate 
nutritional health was present in 84 (84.0 %) patients, with malnourishment 
(score<17) in 40 (40.0 %) and risk of malnutrition (score 17-23.5) in 44 (44.0 %). 
The MNA and MNA-SF scores were both normally distributed. Using Fried‟s 
criteria, 66 (66.0 %) patients were frail, 30 (30.0 %) as pre-frail and 4 (4.0 %) as 
robust. Table 6-1shows patient characteristics. 
 
Fried‟s frailty classification was negatively associated with both the MNA (r = -
.479, P < 0.001) and MNA-SF (r = -.510, P < 0.001). MNA correlated highly with 
MNA-SF (r = .868, P < 0.001). Age showed no association with MNA, MNA-SF 
or frailty status. 
 
Receiver Operating Characteristic curves (ROC) for detection of frailty are shown 
in Figure 2. The AUC of the ROC demonstrated that both the MNA (0.780, 
P<0.001) and the MNA-SF (0.802, P<0.001) had good accuracy in identifying 
frailty, with the MNA-SF outperforming the MNA.  
 
Table 6-2 shows measures of the ability of the MNA and MNA-SF tools to detect 
frailty at selected cut-off scores. For the MNA, the standard malnourishment cut-
off score (<17) showed a high specificity (0.912) but lower sensitivity (0.561). 
The optimal MNA cut-off score to predict frailty (as determined by the highest 
YI) was <17.5, with a sensitivity of 0.591 and specificity of 0.912.  
 
For the MNA-SF, the standard malnourishment cut-off point (<8) had a specificity 




frailty based on the YI was <9, with a sensitivity of 0.803 and specificity of 0.765. 
This optimal MNA-SF had a higher sensitivity than that of the optimal MNA cut-
off (0.803 vs. 0.591) and was also a better predictor of frailty as indicated by a 




Figure 6-1: Flow Diagram of Patient Recruitment from the Geriatric 
Evaluation and Management Unit (GEMU)
New Patients Admitted 
 to GEMU (n = 256) 
Eligible for Study 
(n=149) 
Included in Study 
(n=100) 
Excluded (n=47) 
Said no to study participation (n=45) 
Missed by Researcher (n=2) 
 
Excluded from Study  (n = 107) 
   Reasons:  
Low Cognition without proxy (n = 48) 
Language Barrier with no proxy (n = 43) 
Treating Physician advised not to include 
(medically unwell, elderly abuse) (n = 12) 





Table 6-1: Characteristics of Patients for Each Classification by Fried’s 
Frailty Criteria 












Age (years) 85.2  6.1 86 ± 5.9 84.0 ±  6.6 82.5 ± 4.5 0.209 
BMI (kg/m
2
) 25.8  6.1 25.9 ± 7.2 25.4 ± 5.5 25.5 ± 3.0 0.944 
Hospital Days 
prior GEMU 
6.0  8.2 6.6 ± 9.6 4.7 ± 4.0 4.3 ± 3.0 0.539 
Days in 
GEMU 





      53 (80.3 %) 19 (63.3 %)  3 (75%)  0.209 
Grip Strength 
(kg) 
14.9 ± 6.4 12.9 ± 5.6 18.2 ± 6.1 23.8 ± 4.7 <0.001 
CC (cm) 31.8 ± 4.9 31.4 ± 5.0 32.0 ± 4.4 34.5 ± 5.0 0.445 
MAC (cm)  26.4 ± 4.6 26.2 ± 5.1 26.6 ± 3.3 27.4 ± 4.5 0.853 
MNA  
 
18.3  5.0 16.7  5.0 21.1  3.4 23.1  3.3 <0.001 
MNA-SF  
 
7.8  2.8 6.8  2.6 9.4  2.2 11.5  1.7 <0.001 
Data are expressed as Mean  SD. Abbreviations: BMI = Body Mass Index; GEMU = 
Geriatric Evaluation and Management Unit; MAC = Arm Circumference; CC = Calf  
Circumference; MNA = Mini Nutritional Assessment; MNA-SF = MNA Short Form. 
 Significant differences between groups occur between (i) the Frail and Robust Group 
and (ii) the Frail and Pre-Frail Group. No significant differences occurred between the 
pre-frail and robust group. 
†





Table 6-2: Efficacy values of Malnutrition against Frailty Classification by 
Fried's Criteria Using the MNA and the MNA-SF for Malnourishment 
Classification (n=100) 
 
MNA Cut-off Scores 
< 16.5 < 17.0 < 17.5 < 18.0 <18.5 <19 <19.5 
Sensitivity 0.515 0.561 0.591 0.591 0.621 0.652 0.682 
Specificity 0.912 0.912 0.912 0.882 0.824 0.765 0.706 
PPV 0.919 0.925 0.929 0.907 0.872 0.843 0.818 
NPV 0.492 0.517 0.534 0.526 0.528 0.531 0.533 
Youden Index 0.427 0.472 0.503 0.473 0.445 0.416 0.388 
 
MNA-SF Cut-off Scores 
<6 <7 <8 <9 <10 <11 <12 
Sensitivity 0.333 0.515 0.636 0.803 0.879 0.909 0.924 
Specificity 0.971 0.912 0.794 0.765 0.500 0.412 0.235 
PPV 0.957 0.919 0.857 0.869 0.773 0.750 0.701 
NPV 0.429 0.492 0.529 0.667 0.680 0.700 0.615 
Youden Index 0.304 0.427 0.430 0.568 0.379 0.321 0.160 
Abbreviations: PPV, Positive Predictive Value (the proportion of patients with 
positive test results that are correctly identified); NPV, Negative Predictive Value 






The rate of inadequate nutritional health, as assessed by the MNA, was high in our 
study (84.0%, with 40.0% malnourished and 44.0% at risk of malnourishment). 
Frailty, as determined by Fried‟s criteria was also common (66.0 %). The high 
rates of both conditions is probably not surprising, given the high age of the 
subjects, the contribution of both frailty (228) and undernutrition (441) to 
increased risk of hospitalisation in older people and reported substantial rates for 
both conditions in healthier groups of older people (336, 421).  
 
Our study also found malnourishment, identified by MNA, was significantly 
associated with frailty status identified by Fried‟s frailty criteria. Although this 
finding is probably not surprising, as undernutrition and frailty can contribute to 
each other, as far as we know this is the first time the link has been reported using 
validated screening tools for these conditions. Using either the standard cut off 
score for malnourishment of <17 or the optimal cut-off of <17.5 identified in this 
study, the MNA score had a high specificity (>90 %) but lower sensitivity (<60 
%) in detecting frailty. This high specificity is good as it indicates few false 
positive results with its associated burdens, including increased costs of further 
assessments and unnecessary patient stress. Nonetheless, sensitivity should also 
be high in a good screening tool (fewer false negatives), and this could limit the 
use of the MNA as a screening tool for frailty. 
 
In contrast, the MNA-SF score had a higher sensitivity than the MNA score: 
0.636 at the standard cut-off (<8) and an even higher sensitivity of 0.803 at the 
optimal identified cut-off score (<9), with a specificity of 0.765 at this cut-off.  
Based on these values, as well as its higher YI and AUC, the MNA-SF 
outperforms the MNA score in detecting frailty and appears to be suitable for 
identifying undernutrition and frailty.  It has the added advantage of being quicker 





Our results suggest that the MNA-SF, with a cut-off of <9 can be used to identify 
hospitalised older people at risk of both undernutrition and frailty. More detailed 
testing, including a complete geriatric assessment and Fried scale testing, can then 
be undertaken on these undernourished people so that individualised management 
programs can be implemented. These should target both undernutrition and 
problems associated with frailty, including reduced muscle strength and falls risk 
(438) where both conditions are present. If only one of undernutrition and frailty 
is identified, management could focus more on that issue.  
 
6.4.1 Limitations 
Height was self-reported by 28 % of study patients. This could have resulted in an 
overestimation of height (442) and thus an underestimation of BMI in this subset 
of patients. This could not have altered those patients BMI scores by more than 1 
point, however, which is unlikely to have substantially changed the associations 
between MNA and frailty scores found in the study. Our finding that frailty was 
not associated with age could be due to the due to the narrow age range of our 
study patients with most being octogenarians.   
 
Most subjects (75.0 %) were women. Compared to men, older women are more 
likely to be underweight (BMI <20 kg/m
2
) (443), have higher levels of frailty 
(210) and report poorer self-reported health in MNA questions than men (444). 
Similarly, the inclusion of patients with cognitive impairment into our study may 
have influenced our results, as cognitive impairment has been found to be 
associated with undernutrition (445) and frailty (322) in older people. 
Additionally, data collected from a proxy (31.0 % of our patients) could give an 
information bias. Another possible limitation is that our undernutrition and frailty 
rates could be overestimated as some patients were recovering from illness, and 






Our population was clinically unwell compared to community dwelling older 
people and as such, the Positive Predictive Value (PPV), which is dependent upon 
condition prevalence, may have been inflated. It is likely that the PPV would be 
lower in a population of community living older people with lower rates of 
undernutrition and frailty. Thus, our results may not apply to other groups of older 
people, and it would be useful to study larger, healthier population groups. It 
should also be noted that a positive frailty diagnosis by Fried‟s criteria is limited 
by its inclusion of only physical attributes of frailty. Frailty is known to be multi-




The MNA-SF appears to be a good tool for predicting both undernutrition and 







7 Nutritional Screening Tools and Anthropometric Measures 
Associate with Hospital Discharge Outcomes in Older 
People 
Submitted for publication as: „Dent E, Chapman I., Piantadosi C, Visvanathan R. 
Nutritional Screening Tools and Anthropometric Measures as Predictors of Hospital 
Discharge Outcomes in Older People.‟ Submitted to Australasian Journal on Ageing. 
Objectives: To examine the association of nutritional screening tools (NSTs) and 
anthropometric measures with adverse hospital discharge outcomes in hospitalised older 
people. Design: Longitudinal observational study. Methods: Consecutive patients aged 
 70 years admitted to a Geriatric Evaluation Management Unit (GEMU) at The Queen 
Elizabeth Hospital, South Australia were included. Anthropometric measures included 
calf circumference (CC), Mid-Arm Circumference (MAC) and Body Mass Index 
(BMI). NSTs studied were: Mini-Nutritional Assessment (MNA), MNA-short form 
(MNA-SF) using BMI (MNA-SF-BMI) and CC (MNA-SF-CC), Geriatric Nutritional 
Risk Index (GNRI) and Simplified Nutritional Appetite Questionnaire (SNAQ). 
ANCOVA and logistic regression analyses were performed to assess the predictive 
ability of NSTs and anthropometric measures in determining: (1) functional change 
measured using Barthel‟s Index (BI), (2) length of GEMU stay (LOS) and (3) discharge 
to a higher level of care. Results: 172 patients were examined; mean (SD) age of 
patients was 85.2 (6.4) years. Malnutrition according to the MNA, MNA-SF and GNRI 
occurred in 53 (31 %), 77 (45 %) and 83 (48 %) of patients respectively.  Functional 
change was associated with the GNRI (Beta coefficient (β), 95 % CI = 0.17, 0.001 to 
0.33) and CC (β, 95 % CI) = 0.17 (0.01 to 0.33); LOS was associated with the MNA-
SF-BMI (β, 95 % CI) = -0.02, -0.003 to -0.004, P = 0.015), the MNA-SF-CC (β, 95 % 
CI) = -0.02, -0.003 to -0.001, P = 0.039) and the MNA-II (β, 95 % CI) = -0.01, -0.02 to 
-0.001, P = 0.017. MAC was associated with discharge to higher level of care (OR, 95 
% CI) = 0.88, 0.81 to 0.96, P = 0.002). No other variables associated with outcomes. 
Conclusion: In hospitalised older people, admission NSTs and anthropometric 
measures are associated with outcomes, with different NSTs associated with different 
outcomes. 






Malnutrition is common in older persons and associated with functional decline 
and increased mortality, yet it often goes unrecognised in the hospital setting (13). 
Screening of hospital patients has therefore been recommended to identity those 
malnourished or at risk of malnourishment (13). Nutritional Screening Tools 
(NSTs) offer a fast and easy way to identify these at risk individuals, allowing 
referral for further nutritional evaluation and management (147, 447). 
 
Several NSTs have been validated for use in hospitalised older persons, including 
the Mini Nutritional Assessment (MNA) (149), the MNA-short form (MNA-SF) 
(157) and the Geriatric Nutritional Risk Index (GNRI) (170). The Simplified 
Nutritional Appetite Questionnaire (SNAQ) has also been validated in older 
persons to identify those at risk of weight loss (167). 
 
Considerable work has been done to identify which NST is the best in identifying 
malnutrition (137). Only limited research exists, however, in determining which 
NST best associates with adverse clinical outcomes in hospitalised older patients 
(170). An association with adverse outcomes is important for validation of a NST 
in the clinical setting, particularly when compared to other screening tools (9). 
 
To our knowledge, only three prospective studies have looked at NSTs and 
functional decline over hospitalisation (86, 98, 112), with mixed results, and none 
compared NSTs to each other. Additionally, anthropometric measures, such as 
Body Mass Index (BMI), calf circumference (CC), and mid arm circumference 
(MAC), have been reported to be associated with functional status (201), but their 
ability to predict in-hospital outcomes compared to NSTs is unknown. The aim of 
this study was to compare several NSTs and anthropometric measures in their 
relationships to discharge outcomes, including change in function, length of stay 
(LOS), and discharge to higher level of care, among patients in a Geriatric 





7.2.1 Setting and Sample 
Consecutively admitted patients aged 70 years or over admitted to the Geriatric 
Evaluation and Management Unit (GEMU) at The Queen Elizabeth Hospital, 
Adelaide, Australia (TQEH), from October 22, 2010 to December 23, 2011 were 
recruited within the first three days of GEMU admission. Informed consent was 
obtained from patients, or in cases of cognitive impairment, from a family 
member. The study was approved by the TQEH Human Research Ethics 
Committee (TQEH) and adhered to the Australian Code for the Responsible 
Conduct of Research. 
 
The GEMU at TQEH is a higher acuity, specialised geriatric unit providing 
comprehensive geriatric assessment and multi-disciplinary management, 
including rehabilitation where appropriate. The majority of patients are identified 
by the geriatric service in the Acute Medical Unit (short stay < 72 hours), where 
they have been admitted for management of an acute medical illness, and then 
transferred to the GEMU. The GEMU aims to undertake comprehensive geriatric 
assessment and management, to maximise functional independence and discharge 
patients home where possible. Nutrition management is a key focus.  
 
7.2.2 Assessments 
All assessments were completed within 72 hours of a patient‟s GEMU admission 
by the same researcher (ED) Function was assessed using Barthel‟s Index (BI) of 
Activities of Daily Living (ADL), with a total score of 100 indicating 
independence in all ADLs (394).  Interview data collected included health and 
lifestyle questions. Information obtained from patient medical records included 
nutritional blood markers (C-reactive protein (CRP), Lymphocytes, Haemaglobin, 
Albumin, Cholesterol (total), High-Density Lipoprotein (HDL), Low-Density 
Lipoprotein (LDL), micronutrients (Iron, Folate, Vitamin B12, Vitamin D),  
medications, Geriatric Depression Scale (GDS-15) (381), cognition using the 




Admission diagnosis was placed into one of five categories: chronic condition, 
infection, injury or musculoskeletal condition, non-musculoskeletal condition and 
unclassified (384). Charlson‟s Co-morbidity Index (CCI) was derived from patient 
medical records.  
 
7.2.2.1 Anthropometric Measures 
Measurements were performed on the right hand side of the body where possible 
to standardise measurements. CC was measured as the widest calf girth, and MAC 
measured as the circumference of the upper arm, mid way between the acromion 
process and the lateral epicondyle of the elbow. Each measurement was 
performed once (to the nearest 0.1 cm) per patient.  
 
Height was measured with a stadiometer to the nearest 0.5 cm for mobile patients 
and self-reported height recorded for non-mobile patients. The same calibrated 
weight chair was used to weigh all mobile patients to the nearest 0.01 kg. For 
immobile patients, a weigh sling was used. BMI was computed.  
 
7.2.2.2 Mini Nutritional Assessment 
The MNA is widely used and contains 18 questions covering four areas 
(anthropometry, diet, subjective health and overall assessment) (1). It classifies 
people as „malnourished‟ (scores 0-23), „at risk of malnutrition‟ (scores 17 - 23.5) 
or „well nourished‟ (scores 24-30) (147). A second MNA version (MNA-II), 
which excludes BMI, doubles CC score and triples MAC score, was also used 
(448). The MNA-II was recently validated in Taiwanese older persons and also 
has a total score of 30 (448). For the purposes of our study, standard CC and 
MAC cut-offs were used, not Taiwanese specific cut-offs. 
 
Also studied was the MNA-SF, which comprises six MNA questions and can be 




MNA-SF-CC respectively. MNA-SF classifications are: „malnourished‟ (scores 0-
7), „at risk of malnutrition‟ (scores 8-11) and „well nourished‟ (scores 8-12) (157). 
MNA-SF retains MNA‟s accuracy of nutritional status classification (1). 
 
7.2.2.3 The Geriatric Nutritional Risk Index 
The GNRI is both a nutrition-related risk index and NST for use in older persons 
(97). It is computed as: 
GNRI = (1.489 x albumin (g/L)) + (41.7 x (weight/WLo)) 
With WLo = Ideal Weight, using Lorentz equations as described by Boulianne et 
al. (170): 
Men: WLo = H -100 – ((H - 150)/4)  
Women: WLo = H - 100 – ((H - 150)/2.5)  
With H = height in cm; g = grams; L = Litre 
 
GNRI categories are: major risk (scores < 82), moderate risk (scores < 92), low 
risk (scores 92 to  98) and no risk (> 9) (170).  
 
7.2.2.4 Simplified Nutritional Appetite Questionnaire (SNAQ) 
The SNAQ is a weight loss prediction tool designed for use in older persons, with 
scores  14 / 20 indicating significant risk of at least 5 % weight loss within six 
months (167). It comprises four questions on appetite and food intake. 
 
7.2.3 Discharge Outcomes 
Discharge function was assessed using BI score. Functional decline and 
improvement were defined as a decrease or increase, respectively, in BI. Other 
discharge outcomes were GEMU length of stay (LOS) and discharge to a higher 
level of care. A higher level of care was defined as a move to a destination other 
than home, which included sub-acute care post-GEMU or move to an address that 




hospitalisation were classified as discharged to higher level care and were 
excluded from discharge function and LOS analyses. 
 
7.2.4 Statistical Analyses 
Normally distributed variables were expressed as means (SD) and non-normally 
distributed variables as medians (range). Categorical variables were expressed as 
number and percentage. Paired t-tests were performed to determine the difference 
between admission and discharge function. The association between NSTs, 
anthropometric variables, nutritional biomarkers and functional measures at 
admission were analysed using Spearman‟s rank correlations. 
LOS and functional outcomes were analysed as continuous variables. Their 
association with each NST was determined using ANCOVAs. Residual plots of 
regression models were assessed visually for normality, constant variance and 
outliers. LOS was non-normally distributed and subsequently log transformed. 
For functional change, BI at discharge controlling for BI at admission was used. 
Associations between each NST and „move to higher level of care‟ were assessed 
using logistic regression analyses.  
 
All regression models controlled for confounding variables found in previous 
research to be associated with hospital outcomes: age, gender, CCI, MMSE, 
Admission BI, and living alone. Due to limited statistical degrees of freedom, no 
further confounding variables could be included in the logistic regression analyses 
(move to higher level care). The ANCOVA models additionally controlled for 
GDS and C-reactive protein (CRP) (a measure of inflammation).  
 
Variables in each regression model were checked for multi-collinearity. All 
results were analysed using PASW Statistics 18 (IBM SPSS, Chicago, IL) 





7.3 Results  
During the study period, 427 new patients aged  70 years were admitted to the 
GEMU. Patients were excluded from the study for the following reasons: 
dementia or unresolved delirium within 72 hours of admission without a proxy (n 
= 77), did not speak English (with no proxy) (n = 67), treating physician advised 
against patient inclusion (medically unwell elder-abuse, physically aggressive: n = 
33), infectious (n = 11), missed by researcher (n = 4) and did not wish to 
participate (n = 63). 
 
6-1shows the baseline characteristics of patients recruited (n = 172). The mean 
(SD) age of patients was 85.2 (6.4 years). Weight, CC and MAC measures were 
performed for all patients. Height was self-reported in 71 (41 %) patients due to 
immobility.  
 
The median GEMU LOS for surviving patients was 12 days, with a median of 4 
days in hospital before GEMU admission. 129 (75 %) patients had functional 
improvement, with 76 patients (44 %) showing an improvement in BI of more 
than 10 %. 28 (16 %) had no change in function and 15 (8 %) had functional 
decline. 80 (47 %) of patients were discharged to a location other than home and 7 
(5 %) died during hospitalisation.  
 
Malnutrition according to the MNA, MNA-SF and GNRI occurred in 53 (31 %), 
77 (45 %), and 83 (48 %) patients respectively. Risk of malnutrition, by the MNA, 
MNA-SF, and GNRI, occurred in 84 (49 %), 67 (39 %) and 24 (14 %) patients 
respectively. Using the SNAQ, 109 (63 %) patients were classified at risk of 
weight loss. 
 
Correlations of NSTs scores, anthropometric variables, nutritional biomarkers, 
micronutrients and functional measures are shown in Table 7-2. All NSTs results 
were correlated significantly with each other with the exception of GNRI and 
SNAQ. All NSTs correlated with anthropometric measures with the exception of 




the MNA correlated with admission function, grip strength and MMSE. SNAQ 
associated with grip strength and GDS. GNRI was not associated with any 
functional measure. Table 7-3 shows the results of each regression model of 
individual NSTs against the outcome measures. MNA-II, MNA-SF-BMI and 
MNA-SF-CC scores associated significantly with length of hospital stay. Both 
GNRI and CC associated significantly with functional change. MAC was the only 
variable to show an association with a discharge to higher level care. MNA, BMI 





















Table 7-1: Descriptive Characteristics of Patients on Admission (n=172) 
Variable n (%) 
Gender (female) 129 (72) 
Age Group  
     70 -79 years 31 (18) 
     80-89 years  100 (58) 
     90-101 years 41 (24) 
BMI Category  
     < 22 kg/m
2 
58 (34) 
     22 – 30 kg/m
2
 75 (44) 
     > 30 kg/m
2
 39 (23) 
Calf Circumference (cm) 31.8 (5.0)
 †
 
Mid Arm Circumference (cm) 26.1 (4.9)
 †
 
Admission function (BI)  58.6 (21.1)
†
 
Charlson's Co-morbidity Index 3 (Range 0-12)
‡
 
Cognitive Impairment (MMSE < 24)  74 (43) 
Lives Alone 97(56) 
Depressive Risk (GDS score >5) 61 (40) 
Polypharmacy (≥ 6 Medications) 131 (76) 
Use of Dentures 84 (49) 
Problems with Food Supply  
     Cooking  96 (56)  
     Chewing or Swallowing  58 (34) 
     Cutting  54 (31) 
     Transportation to Shops 37 (22)  
     Financial Constraints 18 (11) 
Primary GEMU Admission Diagnosis¶   
     Chronic Condition 71 (41) 
     Infection  52 (30) 
     Injury or Musculoskeletal Condition 28 (16) 
     Non-musculoskeletal Symptoms 6 (4) 
     Unclassified  15 (9) 
†




 Classifications based on Hastings et al. 2010 (384) 
Abbreviations: MMSE = Mini Mental State Examination Score; BMI = Body Mass 
Index (weight/height
2




Table 7-2: Spearman's Rank Correlations of Nutritional Screening Tools and Anthropometric Measures with Nutritional and Functional 
Measures on Admission (n=172)
†
 
  Nutritional Screening Tool Anthropometric Measure 
  MNA MNA-II  MNA-SF-BMI MNA-SF-CC GNRI SNAQ CC MAC BMI 
Nutritional Screening Tool 
MNA-II  .964***                 
MNA-SF-BMI .893*** .854***               
MNA-SF-CC .857*** .858*** .912***             
GNRI .388*** .380*** .383*** .307***           
SNAQ .418*** .412*** .372*** .338*** .188         
CC .492*** .512*** .431*** .376*** .671*** .169       
MAC .366*** .379*** .346*** .334*** .711*** .246 .641***     
BMI .378*** .357*** .376*** .282*** .854*** .182 .723*** .772***   
Nutritional Biomarkers 
CRP -.043 -.062 -.046 -.044 -.111 -.137 .006 -.018 .024 
Lymph .162* .165* .155* .152* .148 .161* .081 .096 .129 
Hb .134 .135 .180* .169* .242** -.021 .116 .144 .109 
Albumin .190* .186* .197* .172* .549*** .096 .131 .133 .110 
Chol .002 .015 .043 .045 -.031 .081 -.032 -.041 -.064 
HDL -.106 -.097 -.056 -.058 -.089 -.018 -.149 -.115 -.152 
LDL .113 .131 .122 .132 -.112 .125 .009 -.069 -.065 
Micronutrients 
Iron .105 .087 .104 .106 .270** .042 .096 .208* .243** 
Folate  .093 .095 .114 .129 -.023 .017 -.083 -.060 -.109 
B12 -.107 -.122 -.140 -.139 -.086 -.202* .047 .023 -.039 
Vit D -.132 -.143 -.119 -.072 .024 -.085 -.020 .012 -.070 
Physical and Mental Functional Measures 
BI .208** .195* .151* .233** .057 -.013 .097 .082 .028 
Grip  .379*** .376*** .321*** .349*** .060 .242** .179* .232** .096 
MMSE .355*** .368*** .306*** .352*** .110 .138 .155* .202** .191* 
GDS -.197* -.192* -.188* -.236 .000 -.179* .001 -.050 .024 
* Indicates significance with P < 0.05; ** Indicates significance with P < 0.01; ** Indicates significance with P < 0.001 
† MNA = Mini-Nutritional Assessment; MNA-II = MNA version II without BMI; MNA-SF = MNA short form: GNRI = Geriatric Nutritional Risk Index; SNAQ = Simplified Appetite Nutritional 
Questionnaire; CC=calf circumference (cm); MAC = Mid-Arm Circumference (cm); BMI = Body Mass Index; CRP = C-Reactive Protein: Lymph = Lymphocyte; Hb = Haemaglobin; Chol = Cholesterol; 
HDL = HDL cholesterol; LDL = LDL cholesterol; B12 = Vitamin B-12; Vit D = 25OH-Vitamin D; BI = Barthel Index; Grip = Maximal Grip Strength; MMSe = Mini Mental State Examination; GDS = 









Functional Change (BI) (n=165) Length of GEMU Stay (log(days)) (n=165) Discharge to High Level Care (n=172) 
B‡ 95% CI P B 95% CI P OR¶ 95% CI P 
 Nutritional Screening Tool 
 MNA  0.38 -0.08 to 0.83 0.119 -0.01 -0.02 to 0.000 0.051 0.95 0.89 to 1.10 0.110 
 MNA-II 0.31 -0.13 to 0.74 0.168 -0.01 -0.02  to -0.001 0.017 0.96 0.90 to 1.02 0.163 
 MNA-SF-BMI  0.03 -0.02 to 0.07 0.352 -0.02 -0.03 to -0.004 0.015 0.92 0.83 to 1.02 0.114 
 MNA-SF-CC  0.37 -0.02 to 0.07 0.329 -0.02 -0.03 to -0.001 0.039 0.95 0.86 to 1.05 0.298 
 GNRI  0.17 0.01 to 0.33 0.038 -0.002 -0.01 to 0.001 0.233 0.98 0.96 to 1.01 0.164 
 SNAQ 0.44 -0.3 to 1.16 0.237 0.004 -0.01 to 0.001 0.590 0.98 0.89 to 1.08 0.641 
Anthropometric Measure  
 CC  0.48 0.02 to 0.93 0.041 -0.003 -0.12 to 0.01 0.466 0.94 0.88 to 1.004 0.064 
 MAC  0.41 -0.11 to 0.96 0.123 -0.01 -0.02 to 0.003 0.170 0.88 0.81 to 0.96 0.002 
 BMI  0.23 -0.13 to 0.60 0.208 -0.004 -0.01 to 0.003 0.321 0.96 0.91 to 1.01 0.109 
†
All regression analyses controlling for age, gender, Cognitive Impairment Risk (Mini Mental State Examination), Function (Barthel's Index), Charlson's Comorbitidy 
Index and Lives Alone. The multiple regression models (LOS and Functional Change) also controlled for Depressive Risk (Geriatric Depression Scale-15) and 
Inflammation (indicated by C-Reactive Protein levels). Each line represents a separate regression model. CI = Confidence Interval; MNA = Mini-Nutritional 
Assessment; MNA-II = MNA version II without BMI; MNA-SF = MNA short form: GNRI = Geriatric Nutritional Risk Index; SNAQ = Simplified Appetite 
Nutritional Questionnaire; CC=calf circumference (cm); MAC = Mid-Arm Circumference (cm): BMI = Body Mass Index; GEMU = Geriatric Evaluation and 
Management Unit. Bold Indicates Significance (P<0.05) 
‡ B = Unstandardised Beta Coefficient 





To our knowledge this is the first study to evaluate the use of NSTs and 
anthropometric measures as predictors of discharge outcomes for older people in a 
GEMU. Malnutrition rates were high: 31%, 45%, and 48% for the MNA, MNA-
SF and GNRI respectively, comparable to those in other studies of hospitalised 
older persons (111, 147, 170). 
 
Management of GEMU patients involves a balance between providing adequate 
time for functional rehabilitation and keeping LOS as short as possible, and thus 
reducing health care costs (378). The median LOS in our study was 12 days, in 
line with other GEMUs (378). Although we did not find MNA to be associated 
with LOS, lower scores on the shorter and easier to implement version, the MNA-
SF (with BMI), were associated with longer stays. Moreover, the MNA-SF-CC 
and the MNA-II, in which weight or BMI is not required, also showed a similar 
association with LOS. These findings have practical implications in the GEMU, 
as the often considerable burden of weighing frail older people in hospital may 
possibly be avoided (13).  
 
Lower MAC was the only measure associated with discharge to higher level care, 
a finding which agrees with previous reports (449). MAC is a measure of both fat 
and muscle mass and thus possibly indicative of late-stage muscle wastage and 
impending mortality (201, 450). It is  likely that factors other than MAC, 
including illness and family situation influence discharge destination (447). Our 
study, however, controlled for a range of covariates that could be influencing 
discharge destination including cognition, co-morbidity and living alone. No 
NSTs were associated with discharge to higher level of care, in keeping with the 
conflicting results of studies as outlined in a recent systematic review (447).  
 
For functional change, lower GNRI and CC measures, indicative of reduced 




other studies, to our knowledge, have looked at GNRI as a predictor of functional 
decline. Studies of CC have found it is linked to functional decline in 
institutionalized older persons (201), possibly because it reflects muscle wastage 
and an inability to walk (201, 450). In the present study, the GNRI may have 
shown an association with functional decline for a number of reasons. Firstly, it 
includes albumin, with lower levels linked to reduced physical function in older 
persons (451). Secondly, it was originally designed as a prognostic tool (170). 
Thirdly, in our study it showed high associations with both CC (r = 0.711) and 
MAC (r = 0.854). Finally, lower GNRI scores were associated with lower iron 
levels in our study which have been linked with functional decline (452).  
 
Perhaps surprisingly no other measures were associated with functional change. 
We had expected the MNA score to  show an association with function, as it has 
been found previously to associate with in-hospital functional decline (112), 
although not functional recovery (111). The MNA-SF score has also been found 
to be associated with in-hospital functional decline (98). It could be that the MNA 
and its versions may not have been sensitive enough in detecting functional 
change during the relatively short hospitalisation period (111). 
 
7.4.1 Strengths and Limitations 
This study recruited consecutive patients and eliminated inter-tester bias as one 
researcher performed all assessments. Many confounding variables were 
controlled for which improved the generalisability of results to other populations 
of hospitalised older persons.  
 
The current study was an observational study, so no inference about causation can 
be made. The sample size was also relatively small. Possible study bias could 
exist for several reasons, including proxy assistance in patient interview in the 
cases of cognitive impairment and/or language barrier, self-reported height was 
used in 41 % of patients due to immobility and CC may have been influenced by 




discharges to sub-acute care (rehabilitation). These patients may have returned 
home after spending time in such a setting, however, at the time of their discharge 
from the GEMU, they were not deemed functional enough for a direct discharge 
home.  
 
It should also be noted, that despite 75 % of patients improving in function, many 
of these patients were not discharged home. Reasons for this lack of discharge 
home included dementia, and the influence of external factors such as finances 
and familial wishes. It could also be that this improvement in function was not 
adequate to return to home immediately at discharge.   
 
7.4.2 Conclusion 
In hospitalised older persons, admission NSTs and anthropometric measures are 
associated with negative outcomes, but different measures are associated with 
different outcomes. The MNA-SF (using BMI or CC) and MNA-II were 
associated with LOS. MNA-SF is fast and rapid to implement and MNA-II does 
not involve the time-consuming measurement of weight. GNRI and CC were 
associated with functional decline during hospitalisation, perhaps because they 
reflected greater illness and muscle wastage, respectively. A lower MAC was 
associated with a greater need for discharge to a higher level of care, possibly 
because it is an indicator of end-stage decline. The use of a nutritional screening 
tool to detect both undernutrition and risk of adverse outcomes in hospital will 
assist time-pressured clinicians. Future research should focus on the predictive 
ability of NSTs post-hospitalisation and the efficacy of interventions in-hospital. 
 
7.4.3 Key Points 
 In hospitalised older people, nutritional screening tools and 
anthropometric measures are associated with adverse clinical outcomes, 





 Different measures are associated with different outcomes: GNRI and CC 
were both associated with functional change, MNA-II and MNA-SF were 
associated with length of hospital stay and MAC was associated with 
discharge to higher level care.  
 The use of a NST to detect both undernutrition and risk of adverse 










8 Performance of Nutritional Screening Tools in 
Predicting Poor Six Month Outcome in Hospitalised 
Older People  
Submitted for publication as: „Dent E, Chapman I., Piantadosi C, Visvanathan R. 
Performance of Nutritional Screening Tools in Predicting Poor Six Month 
Outcome in Hospitalised Older People.‟ Submitted to Journal of Nutrition Health 
and Ageing. 
Background/Objectives: Malnutrition is a major problem in hospitalised older 
people. Many nutrition screening tools are available for malnutrition 
identification, however little is known about their prognostic ability. This study 
investigated the prognostic value of three nutritional screening tools.  
Design: Prospective, observational study.  
Setting: Geriatric Evaluation and Management Unit (GEMU).  
Participants: 172 consecutive patients (72 % female; mean (SD) age = 85.2 (6.4) 
years).  
Measurements: Nutritional status was identified using the Geriatric Nutritional 
Risk Index (GNRI), the Mini Nutritional Assessment (MNA) and the MNA short 
form (MNA-SF) incorporating either Body Mass Index (BMI) (MNA-SF-BMI) or 
calf circumference (CC) (MNA-SF-CC). Poor six month outcome was defined as 
new admission to higher level residential care or mortality at six months post-
discharge. Predictive ability of poor outcome was assessed by logistic regression 
models, adjusting for age, gender and cognition. Predictive accuracy was 
determined by auROC values, sensitivity, specificity, predictive values (positive 
and negative) and Youden Index.  
Results: Malnutrition was identified by the MNA, MNA-SF-BMI, MNA-SF-CC 
and GNRI in 31 %, 45 %, 53 % and 48 % of patients respectively. Malnutrition 
was associated with a higher risk of poor six month outcome when identified by 
the MNA (OR, 95 % CI  = 3.29, 1.17 - 9.23) and the GNRI (OR, 95 % CI = 2.84, 
1.31 - 6.19), but not by either MNA-SF version. auROC values for all screening 




Conclusion: Malnutrition was common in GEMU patients. The MNA and GNRI 
were useful clinical predictors of poor six month outcome, although their accuracy 
of this prediction was low. Nutritional screening remains a priority in GEMU 
patients.   





Malnutrition, a major problem associated with hospitalisation in older people, has 
an extensive impact on mortality and morbidity (215). The incidence of 
malnutrition in hospitalised older people is high, with around 22 – 68% of patients 
diagnosed, depending on the population studied and the assessment method used 
(215). Malnutrition, despite this high prevalence,  often goes unrecognised in 
hospitals (13). 
 
Nutritional screening tests are at the forefront of identifying patients with 
malnutrition. Ideally, identified patients are referred for a full nutritional 
assessment, which includes diagnosis confirmation, and identification of specific 
nutritional deficits (147). A nutritional screening tool has additional clinical and 
research value if it also doubles as an index of nutritional risk and, by definition, 
is able to predict the probability of an adverse outcome occurring (170). Many 
nutritional screening tools exist, however, it is not yet clear which one performs 
best in predicting longer term outcomes in hospitalised older people (215). 
 
Three nutritional screening tools showing promise as indices of nutritional risk are 
the Mini Nutritional Assessment (MNA) (148), the MNA short form (MNA-SF) 
(157) and the Geriatric Nutritional Risk Index (97). The MNA is specifically 
designed for, and extensively validated in older people (147, 148). It includes 18 
questions in four domains: subjective assessment, nutritional assessment, 
anthropometric assessment and general assessment (147). The MNA shows 
prognostic ability in hospitalised older people (87, 88, 99, 104, 153), although not 
all studies agree (99, 105). A simpler version of the MNA, the MNA-SF (157) 
may also have potential as an index of nutritional risk, although studies of its 
prognostic ability are limited (215).  
 
The Geriatric Nutritional Risk Index (GNRI) was initially developed as a 




nutritional screening tool in its own right (97). The GNRI also shows promise as a 
predictor of morbidity and mortality in hospitalised older people (170, 453). 
However, its prognostic ability has only been compared to the MNA in one 
previous study, and that was conducted in residential care dwelling older people 
(97). 
 
The aim of this study was to investigate the predictive ability and accuracy of the 
MNA, MNA-SF and GNRI in determining poor six month outcome in older 









This was a longitudinal observational study of consecutive patients admitted to 
the 20-bed GEMU at The Queen Elizabeth Hospital (TQEH), South Australia. 
Patients were recruited between October 22, 2010 and December 23, 2011. The 
study was approved by the Human Research Ethics Committee (TQEH) and all 
patients (or authorised proxy) gave informed consent, in accordance with ethical 
standards from the 2000 Declaration of Helsinki.  
 
Data were collected from the patient (or proxy) in the first 72 hours of admission. 
Clinical information from patient records was also collected, including: diagnosis, 
biomarkers, Braden skin assessment score (383), Barthel‟s Index of Activities of 
Daily Living (394), Geriatric Depression Scale (381) and cognition assessment by 
the Mini Mental State Examination (MMSE) (382). One researcher (ED) collected 
all data and performed all nutritional screening tool assessments. Patient height 
was measured to the nearest centimetre using a stadiometer, and for patients 
unable to stand independently, self-reported height was recorded. Weight was able 
to be measured in all patients using a calibrated weigh chair (FVCS-150) to two 
decimal points.  
 
8.2.1 Mini Nutritional Assessment (MNA) 
The MNA is scored out of 30, with scores  24 considered to be well nourished, 
scores 17 – 23.5 as at risk of malnutrition and scores < 17 as malnourished (147). 
Inadequate nutrition was defined as either malnutrition or risk of malnutrition 
(scores < 24).   
 
8.2.2 Mini Nutritional Assessment Short Form (MNA-SF) 
The MNA-SF includes six questions of the MNA (157). Two versions of the 
MNA-SF exist: one including Body Mass Index (weight/height
2
) (BMI) (the 
MNA-SF-BMI) and the other including calf circumference (CC) (MNA-SF-CC). 




scores 8-11 as at risk of malnutrition and scores 12 - 14 as well nourished (157). 
Inadequate nutrition was defined as scores < 12. 
 
8.2.3 Geriatric Nutritional Risk Index (GNRI) 
GNRI is computed as follows: 
 
GNRI = (1.489 x albumin (g/L))] + (41.7 x (weight/WLo)) 
With WLo = Ideal Weight, using Lorentz equations as described by Boulianne et 
al. (170): 
Men: WLo = H -100 – ((H - 150)/4)  
Women: WLo = H - 100 – ((H - 150)/2.5)  
With H = height in cm; g = grams; L = Litre 
 
For the purposes of comparing the GNRI to the three categories of the MNA and 
MNA-SF, GNRI scores were placed into three categories as described previously 
(97, 170): severe/moderate risk (scores < 92), low risk (scores 92 – 98) and no 
risk (scores > 98). Inadequate nutrition was defined as scores  98. 
 
8.2.4 Outcome  
All patients (or proxy) were followed up at six months post-discharge by 
telephone interview and accessing the South Australian Health Department Open 
Architecture Clinical Information System system. Poor six month outcome was 
defined as a composite measure of one or more of the following occurring: (i) 
death (ii) new admission to a residential care facility or (ii) move from low level 
care to high level care within a residential care facility. A composite measure was 
chosen due to the impact of mortality on residential care admission.  
 
8.2.5 Statistics 
Statistics were analysed using SPSS for Windows 19.0 (SPSS Inc., Chicago, IL). 




significance. Data are presented as mean (standard deviation) or median (range) 
for normally and non-normally distributed data respectively. The predictive ability 
of each nutritional screening tool was determined by logistic regression analyses, 
both unadjusted and adjusted for age, gender and cognition.  
 
When assessing predictive ability, it is also important to look at the accuracy of 
each screening tool in correctly identifying patients at risk of poor outcome (154). 
In this study, predictive accuracy was assessed by sensitivity, specificity, 
predictive values (positive and negative), Youden Index (sensitivity + specificity 
– 1) and area under curve of Receiver Operating Characteristic (ROC) curves 
(auROC). ROC curves were derived from predicted probabilities, and a value > 0.7 





Of 427 new patients admitted to the GEMU during the study period, 127 were 
recruited. Exclusion reasons were: language barrier without proxy (n = 67), 
dementia or unresolved delirium within 72 hours of GEMU admission without 
proxy (n = 77), treating clinician advised against patient participation (elder 
abuse, physically aggressive or medically unwell: n = 33), infectious (n = 11), 
missed by researcher (n = 4) and did not wish to participate (n = 63).  
 
Table 7-1 shows patient admission characteristics. During the six month follow-
up period, including the period from the GEMU admission to hospital discharge, 
78 patients encountered a poor outcome: 28 (16 %) patients died, 48 (28 %) 
moved into residential care (low or high level care) and 2 people (1 %) moved 
from low level to high level care within a residential care facility.  
 
The unadjusted and adjusted odds ratio (OR) values for prediction of poor 
outcome is shown in Table 8-2. From this table it can be seen that, malnutrition 
classification at admission by the MNA, MNA-SF-CC, GNRI, but not the MNA-
SF-BMI, predicted poor six month outcome. However, after adjustment for age, 
gender and MMSE score, only MNA and GNRI classified malnutrition retained 
predictive ability. Risk of malnutrition classification failed to predict poor six 
month outcome for all screening tools in both unadjusted and adjusted analyses.  
 
Prognostic variables are shown in Table 8-3. From this table is can be seen that 
both positive and negative predictive values for all screening tool were low-
moderate. The MNA showed the highest predictive accuracy overall (indicated by 
its higher values for auROC and Youden Index). However, the auROC value for all 
nutritional screening tools, including the MNA, lacked adequate predictive 




Table 8-1: Baseline Characteristics of Patients on Admission (n=172) 
Variable n (%) 
Gender (Female) 123 
Age as of Admission
†
 85.2 (6.4) 
Length of GEMU stay‡  12 (1 – 91) 
Length of acute hospital stay before GEMU‡ 4 (0-53) 
Cognitive Impairment (MMSE < 24/30) 74 (43) 
Depression Symptoms (GDS > 5/15) 61 (40) 
Admission function (Barthel‟s Index) 58.6 ± 21.1 
Charlson‟s Co-morbidity Index
†
 3.0 (2.3) 
Medication Number
†
 9.6 (4.3) 
Calf Circumference (cm)
†  31.8 (5.0) 




 25.3 (6.5) 
Accommodation   
     Community Dwelling 151 (88) 
     Supported Residential Facility  12 (7) 
     Residential Care (Low Level) 5 (3) 





Folate  23.5 (0-1377) 
CRP (mg/L) 17.0 (0.5-320.0) 
Albumin (g/L) 31.0 (17-41) 
Creatinine (µmol/L) 83.5 (4-239) 
Lymphocyte 1.29 (0.4-188.0) 
Iron Stores (µmol/L) 10.0 (1-201) 
Vitamin B12 305 (7-1476) 
25OH Vitamin D (nmol/L) 64.0 (14-151) 
Haemaglobin (g/L) 120.0 (79-162) 
Abbreviations: GEMU = Geriatric Evaluation and Management Unit; MMSE = 
Mini Mental State Examination; GDS = Geriatric Depression Scale; BI = 
Barthel‟s Index of Activities of Daily Living; CRP = C-Reactive Protein  
† 






Table 8-2: Odds Ratios for Prediction of Poor Six Month Outcome by Nutritional Screening Tool Assessment on Admission to the 
Geriatric Evaluation and Management Unit (n =172)
†
 
Nutritional Screening Tool 
Poor 6 Month Outcome 
Unadjusted (n=98) 
Poor 6 Month Outcome 
Adjusted‡ (n=98) 
OR 95% CI P OR 95% CI P 
MNA       
   Malnourishment (Scores < 17) 3.73 1.52 - 9.17 0.004 3.29 1.17 - 9.23 0.024 
   Risk of Malnutrition (Scores 17 – 23.5) 1.12 0.49 - 2.56 0.786 1.15 0.45 - 2.98 0.769 
MNA-SF       
   Malnourishment (Scores < 8) 1.78 0.74 – 4.26 0.197 1.51 0.55 - 4.13 0.424 
    Risk of Malnutrition (Scores 8 - 11) 0.65 0.26 – 1.61 0.354 0.78 0.28 - 2.17 0.640 
MNA-SF-CC       
   Malnourishment (Scores < 8) 2.60 1.06 – 6.40 0.037 2.54 0.90 - 7.16 0.078 
   Risk of Malnutrition (Scores 8 - 11) 0.94 0.35 – 2.53 0.944 1.25 0.41 - 3.84 0.701 
GNRI       
   Severe/Moderate Risk (Scores < 92) 2.21 1.13 - 4.31 0.021 2.84 1.31 - 6.19 0.008 
   Low Risk (Scores 92 – 98) 1.96 0.76 - 5.06 0.167 1.68 0.55 - 5.14 0.364 
† 
Poor Six Month Outcome = Mortality, new admission to a residential care facility or move from low level care to high level care within a 
residential care facility.  
‡ Adjusted for age, gender and MMSE score 
Abbreviations: MNA = Mini Nutritional Assessment; MNA-SF-BMI = Mini Nutritional Assessment Short Form (Body Mass Index version); 
MNA-SF-CC: MNA-SF (Calf Circumference version); GNRI = Geriatric Nutritional Risk Index; CI= Confidence Interval; OR = Odds Ratio 











Died, n (%) 
Se Sp PPV NPV YI AUC (95 % CI) P 
Yes No 
MNA              
   Scores < 17 (Mal) 53 (31) 35 (66) 18 (34) 44.9 80.9 66.0 63.9 25.7 
0.634 (0.55 – 0.72) 0.003 
   Scores < 24 (IN)  137 (80) 66 (48) 71 (52) 84.6 24.5 48.2 65.7 9.1 
MNA-SF           
   Scores < 8 (Mal) 77 (55) 44 (57) 33 (43) 56.4 64.9 57.1 64.2 21.3 
0.610 (0.54 – 0.70) 0.007 
   Scores < 12 (IN) 144 (84) 66 (46) 78 (54) 84.6 17.0 45.8 57.1 1.6 
MNA-SF-CC           
   Scores < 8 (Mal) 92 (53) 52 (57) 40 (44) 66.7 57.4 56.5 67.5 24.1 
0.622 (0.54 – 0.71) 0.006    Scores < 12 (IN) 145 (84) 69 (48) 76 (52) 88.5 19.1 47.6 66.7 7.6 
GNRI           
   Scores < 92 (Mal) 83 (48) 44 (56) 39 (47) 56.4 58.5 53.0 61.8 14.9 
0.592 (0.51 – 0.68) 0.038 
   Scores  98 (IN)  107 (62) 56 (52) 51 (48) 71.8 45.7 52.3 66.2 17.5 
† 
Poor Six Month Outcome = Mortality, new admission to a residential care facility or move from low level care to high level care within a 
residential care facility. A poor six month outcome occurred in 78 patients.  
Abbreviations: MNA = Mini Nutritional Assessment; MNA-SF = Mini Nutritional Assessment Short Form; GNRI = Geriatric Nutritional Risk 
Index; BMI = Body Mass Index; PPV = Positive Predictive Value; NPV = Negative Predictive Value; Mal = Malnourished; IN = Inadequate 





In this study of older people hospitalised in a GEMU, malnutrition was common 
on admission, ranging from 31 – 48 % depending on the nutritional screening tool 
used. This high incidence of malnutrition is consistent with previous studies of 
hospitalised older people (86, 88, 105). This study evaluated the ability of 
nutritional screening tools to predict a poor six month outcome in GEMU patients. 
Malnutrition identified by the MNA, MNA-SF-CC, GNRI, but not the MNA-SF-
BMI was associated with poor six month outcome. However, after adjustment for 
confounding variables (age, gender and cognition), only MNA and GNRI 
maintained their predictive ability. Risk of malnutrition classification failed to 
predict poor six month outcome for all screening tools. 
 
This is the first study, to our knowledge, to compare the MNA and GNRI with 
respect to adverse outcomes in hospitalised older people. A previous study 
comparing MNA and GNRI in residential care residing older people found a 
malnutrition classification by both screening tools was predictive of mortality, 
infection and bedsores (97). Their study was inconclusive as to which screening 
tool performed best, although the GNRI appeared to outperform the MNA when 
all adverse complications were pooled together (97). In our study, malnutrition 
identified by the MNA showed higher predictive ability of poor six month 
outcome than the GNRI (adjusted OR values of 3.29 and 2.84 for MNA and 
GNRI respectively). This higher predictive ability of the MNA was perhaps 
because the MNA contained more nutrition-related risk components such as self-
reported health, living status and neuropsychological problems than did the GNRI 
(147) Malnourishment by the MNA is generally considered to be predictive of 
mortality (87, 99, 104, 153), although not all studies agree (99, 105, 154).  
 
In the present study, risk of malnutrition classification for all nutritional screening 
tools failed to predict poor six month outcome. This finding does not indicate a 
person with an „at risk‟ classification will avoid encountering a poor outcome. It 




Geriatric Assessment, could have possibly helped prevent a poor outcome (455). 
Indeed, an „at risk‟ classification by the MNA has been found not to be associated 
with morbidity in hospitalised older people (105), although in community based 
studies, some studies have found an association (412, 422) whilst others have not 
(420). 
 
Also in our study, the MNA showed the highest prognostic accuracy in outcome 
prediction, based on its higher auROC and YI values. However, auROC values for 
all screening tools, including the MNA, lacked sufficient prognostic accuracy (all 
auROC values < 0.7). This lack of predictive accuracy disagrees with a study of 
hospitalised older people in which MNA showed adequate predictive accuracy for 
mortality prediction (auROC > 0.7) (105). It could perhaps be that our shorter 
length study and combination measure of mortality and admission to residential 
care diminished the accuracy of MNA. There are no other studies, to our 
knowledge, looking at predictive accuracy of nutritional screening tools in 
hospitalised older people (215). 
 
Study strengths were the inclusion of consecutive patients, the comprehensive 
admission data and the limited inter-tester bias. This study also recruited many 
patients with dementia and focused on the oldest old: both areas of growing 
research interest with the global expansion of the older demographic. 
Notwithstanding these strengths, our study had limitations. Our sample size was 
small and there was potential collection bias introduced by the use of a proxy to 
answer questions for patients with cognitive impairment and/or language barriers. 
Our analyses also did not account for nutritional support received by patients 
during and after hospitalisation. A further limitation is that our results only 
included GEMU patients and future studies should focus on multiple hospital 






Malnutrition was frequent in GEMU patients. The MNA and GNRI were useful 
clinical predictors of poor six month outcome, although their accuracy of 









9 Frailty and Functional Decline Indices Predict Poor 
Outcomes in Hospitalised Older People 
Submitted as: „Dent E, Chapman I., Piantadosi C, Visvanathan R. Frailty and 
Functional Decline Indices Predict Poor Outcomes of Hospitalised Older People.‟ 
Submitted to Age and Ageing. 
Background: Admission to a Geriatric Evaluation and Management Unit 
(GEMU) can optimise a patient‟s chance of functional recovery.  
Objective: To evaluate the ability of several commonly used frailty and 
functional decline indices to predict GEMU outcomes, both at discharge and at six 
months. 
Design: A prospective, observational study. 
Setting and Participants: Consecutive patients aged 70 years or older admitted 
to a GEMU. 
Methods: Patients were classified as „frail‟ or „at high risk of functional decline‟ 
using several different frailty and functional decline instruments. Predictive ability 
was evaulated using logistic regression and area under receiver operator 
characteristic (ROC) curves (auROC). 
Results: 172 patients (mean age (SD) of 85.2 (6.4) years; 72 % female) were 
included. Frailty prevalence varied from 24 - 94 % depending on the instrument 
used. Adequate discriminatory power for discharge outcome was achieved by the 
frailty index of accumulated deficits (FI-CD) (auROC = 0.735, P < 0.001) and 
adapted Katz score (auROC = 0.704, P = < 0.001). The FI-CD was the only 
instrument to show adequate discriminatory power for poor six month outcome 
(auROC = 0.702, P < 0.001). Negative predictive power (PPV) was generally high 
for all instruments in predicting poor outcome, however positive predictive power 
(PPV) was only low-moderate. 
Conclusion: Several frailty and functional decline instruments identified GEMU 




adapted Katz index showed the highest discriminatory power overall, although 
further research in a larger group of hospitalised older patients is warranted.   
 
Keywords: Frail Elderly; Geriatric Assessment/Methods; Aged, 80 and over; 
Prognosis 
 
Key Points:  
1. Frailty is common in hospitalised older people. 
2. Frailty and functional decline instruments can be used to identify older 
patients at risk of poor outcomes, both at hospital discharge and at six 
months post-discharge. 
3. The FI-CD showed the highest discriminatory power in predicting poor 













Frailty is a major contributor to morbidity and mortality in older people (245). It 
is estimated that individuals identified as frail are over twice as likely to encounter 
adverse health outcomes as their non-frail counterparts (229, 375). Although there 
is currently no reference standard definition for frailty, it is generally considered 
to be a multi-factorial condition characterized by a heightened vulnerability to 
changes in health status (241). Indices developed to identify frailty are generally 
of two types: phenotypic and multidimensional. Phenotypic indices measure the 
physical signs of frailty, and include the Cardiovascular Health Study (CHS) 
index (210) and the simpler Study of Osteoporotic Fractures (SOF) index (221). 
Multidimensional indices incorporate both the physical and psycho-social 
components of frailty, and include the frailty index of accumulated deficits based 
FI-CD (242) and the simper indices: Multidimensional Prognostic Index (MPI) 
(330), the ten-domain frailty index based on Comprehensive Geriatric Assessment 
(FI-CGA-10) (343) and FRAIL (Fatigue, Resistance Ambulation, Illness, Loss of 
Weight) (245). Indices used to measure functional decline can also be considered 
frailty indices (274); examples include the Katz score of activities of daily living 
(ADL) (331), Lawton‟s Instrumental ADL (IADL) scale (332), the Score 
Hospitalier d‟Evaluation du Risque de Perte d‟Autonomie (SHERPA) (333) and 
the Hospital Admissions Risk Profile (HARP) (327). 
 
Hospitalised older people are often frail. Accurate identification of which patients 
are likely to encounter poor health outcomes is important for discharge care 
planning and risk assessment for intended surgical or medical treatments (241). 
As yet, no consensus exists as to which frailty instrument most accurately 
identifies older hospitalised patients at risk of poor outcomes. The purpose of this 
study was to evaluate several common frailty and functional decline indices on 








Between October 22, 2010 and December 23, 2011, consecutive patients aged  
70 years were recruited from the GEMU at the Queen Elizabeth Hospital (TQEH), 
South Australia. The GEMU is a specialised ward designed to optimise a patient‟s 
chance of recovery following acute admission (378). GEMU patients are pre-
selected for entry predominantly from TQEH‟s Acute Medical Unit using the 
clinical judgement of geriatricians.  
 
All patients (or their authorised proxy) gave their informed consent, in accordance 
with ethical standards from the 2000 Declaration of Helsinki. The study was 
approved by the Human Research Ethics Committee (TQEH). Data were collected 
during the first 72 hours of GEMU admission. Patient (or proxy) interview was 
used to obtain socio-demographic and health data, including nutritional status by 
the Mini Nutritional Assessment (MNA) (147). Patient clinical records were used 
to obtain CGA items including medications, admission diagnosis, Geriatric 
Depression Scale-15 (GDS-15) (381), Mini-Mental State Examination (MMSE) 
(382) and Braden Skin Assessment (383).  
 
9.2.1 Single Markers 
Single markers of frailty used were grip strength and walking speed. Grip strength 
was assessed as the maximum of three attempts of the dominant hand using a 
hand held dyanmometer: low grip strength < 18 kg (women), < 30 kg men (456). 
Walking speed was meaured over 6 m, with or without the use of a walking aid. 
Slow walking speed was defined as unable to walk 6 m in 30 seconds (440). 
 
9.2.2 Phenotypic Frailty and Functional Decline Instruments 
9.2.2.1 Cardiovascular Health Study (CHS) Index 
The CHS index defines frailty as three or more of: shrinking, weakness, 




weight loss of  4.5 kg in the last year) and exhaustion (self report) were defined 
as per original CHS criteria (210) Weakness (low grip strength) and low physical 
activity were applied as per the Frailty Intervention Trial (456). Slow walking 
speed was defined as above (440). 
 
9.2.2.2 Study of Osteoporotic Fractures (SOF) Index  
The SOF index defines frailty as two or more of: weight loss (5 % loss either 
intentional or unintentional over the last year), self report of low energy and low 
mobility (unable to rise from a chair five times) (221). 
 
9.2.2.3 Fatigue, Resistance, Ambulation, Illness, Loss of Weight (FRAIL)  
For our study, the FRAIL index (245) classified frailty as  3 of: fatigue (self 
report), resistance (unable to rise from a chair five times), ambulation (slow 
walking speed); illnesses ( 5 illnesses on Charlson‟s Co-morbidity Index (CCI) 
(457)) and loss of weight of 5 % or more in the past year. 
 
9.2.3 Multidimensional Indices 
9.2.3.1 Frailty Index of Accumulated Deficits (FI-CD) 
The FI-CD involves the accumulation of 30 or more co-morbidities, disabilities 
and health deficiencies (242, 340). The number of deficits is then summed and 
divided by the total number of deficits (242, 340). For example, if 10 deficits are 
present in a list of 50, the frailty index is 0.2 (10/50) (340). The present study 
followed guidelines by Searle et al. (340) to select 50 multidimensional health 
deficits. Deficits were predominantly obtained from patient CGAs, thus the FI-CD 
in our study was akin to a CGA frailty index (FI-CGA) (339) (see Table 9-1). 
 
The FI-CD is a continuous score and thus a cut-off point to categorise frailty is 




cut-off point possibly distinguishes robust from pre-frail categories (340, 458). 
Only 11 (6 %) of patients in our study scored < 0.2. Thus, to allow for comparison 
with other frailty instruments, a score > 0.45 was graded as (373). This cut-off can 
be clinically considered to be „severely frail‟ (284). 
 
9.2.3.2 Frailty Index Based on Comprehensive Geriatric Assessment with  
Ten Domains (FI-CGA-10) 
The CGA was used to construct a ten-domain FI-CGA (termed FI-CGA-10 for 
this study), based on the FI-CGA definition operationalised by Jones et al. (343, 
344) as applied by Pilotto et al. (345). The FI-CGA-10 is distinct from the more 
comprehensive 52 component FI-CGA described by Rockwood et al. (339).  FI-
CGA-10 components were: cognition (MMSE), mood and motivation (GDS-15), 
hearing or sight problem, mobility (6 m walk time), balance (standing ability), 
bowel function, bladder function, function, ADLs, IADLs, nutritional status 
(MNA) and social resources (343).  Problems for each component were classified 
as: major (2 points), minor (1 point) and none (0 points) (343).  Scores were 
summed and frailty defined as scores > 13/20 (345). 
 
9.2.3.3 Multidimensional Prognostic Index (MPI) 
MPI components include: ADL, IADL, MMSE, CCI, MNA, Braden skin 
assessment,  medication number and living status (330). Problems for each 
component were classified as: major (1 point), minor (0.5 points) and none (0 
points) (330). Scores were summed, divided by eight (330) and scores > 0.66 
graded as frailty (345). 
 
9.2.3.4 Score Hospitalier d’Evaluation du Risque de Perte d’Autonomie 
(SHERPA) 
Weighted SHERPA components are: falls in the previous year, MMSE (first 21 




and frailty defined as scores > 6/11.5,  corresponding with SHERPA‟s „high risk 
of functional decline‟ (333). 
 
9.2.3.5 Hospital Admissions Risk Profile (HARP) 
HARP‟s weighted components are: age (scored 0-2 points), MMSE-21 (scored 0-
1 points) and IADL (scored 0-2 points) (327). Scores  4  were classified as 
frailty, equivalent to „high risk of functional decline‟ on HARP (327). 
 
9.2.4 Functional Decline and Co-morbidity Indices 
9.2.4.1 Activities of Daily Living (ADL) 
ADL evaluation instruments included Lawton‟s IADL scale and an adapted Katz 
index. For Lawton‟s scale, frailty was defined as dependency on others to perform 
 3 IADLs: telephoning, shopping, food preparation, housekeeping, laundry, 
transport, medication and finances (332). For the adapted Katz score, frailty was 
defined as dependency for  1 of: feeding, washing, grooming, dressing, toileting, 
transferring from a bed or chair, and walking (459). 
 
9.2.5 Charlson’s Co-morbidity Index (CCI) 
CCI (457) was used to assess co-morbidity, with scores  5 chosen as the cut-off 
to compare against frailty indices, based on FRAIL‟s „illness‟ criteria (245). 
 
9.2.6 Outcomes 
A composite outcome measure of „poor outcome‟ was defined as one or more of 
(1) death; (2) admission to a residential care facility; and (3) move from low level 
care to high level care within residential care. Outcomes were considered both at 
discharge and at six months follow-up. Six month outcome data were obtained 
both by telephone (patient or proxy) and accessing the South Australian Health 





9.2.7 Statistical Analyses 
Normally distributed variables were expressed as mean (standard deviation) and 
non-normally distributed variables as median (range). Bivariate logistic regression 
analyses controlling for age and gender were used to identify which instruments 
were most predictive of poor outcomes. Due to the low prevalence of patients 
classified as “robust” and for comparision purposes, scores for each instrument 
were dichotomised as “frail” and “not frail” (“pre-frail” or “robust”). Predicted 
probabilities from regression analyses were used to generate receiver operator 
characteristic (ROC) curves, with area under curve (auROC) computed to evaluate 
discriminative ability. Sensitivity, specificity, positive (PPV) and negative (NPV) 
predictive values and Youden Index (sensitivity + specificity – 1) were also 
calculated. Statistical tests were based on comparisons of auROC, and the 
instrument with the largest auROC was considered to be the most accurate; an 
auROC of 0.7 was set as the threshold for adequate predictive accuracy (454). 
Bootstrap techniques were used to generate a sample of 1000 auROC for each 
frailty index. These were used to estimate 95 % confidence intervals and to 
perform pairwise comparisons between the frailty indexes. Significance was set at 
an alpha level of 0.001 to control for the increased risk of a Type 1 error 
associated with performing multiple statistical tests. Analyses were performed 
using SAS Version 9.3 (SAS Institute Inc., Cary, NC) and SPSS for Windows 







Table 9-1: Variables Included in the Frailty Index of Cumulative Deficits (FI-CD)
†
 
Deficit Count Variable 
1 Help Bathing 
2 Help Dressing 
3 Help Transferring From a Bed to Chair and Back 
4 Help Walking Around Home 
5 Help Eating 
6 Help Grooming  
7 Help Toileting 
8 Help Using Telephone 
9 Help Shopping 
10 Help Food Preparation 
11 Help Housekeeping 
12 Help Laundry 
13 Help with Transportation  
14 Help taking Medications 
15 Help with Finances 
16 Psychological Stress/Acute Disease in Last 3 Months 
17 Previous Myocardial Infarction 
18 Chronic Heart Failure 
19 Peripheral Vascular Disease 
20 Previous Stroke 
21 Chronic Obstructive Pulmonary Disease 
22 Renal Failure 
23 Tumour 
24 Diabetes 
25 Orthostatic Hypotension 
26 Pressure Sore or Skin Ulcer 
27 Depression 
28 Anxiety 
29 Hearing Difficulty 
30 Unable to Drive 
31 Difficulty Chewing or Swallowing 
32 Poor Dentition 
33 Self-Reported Poor Health 
34 Weight Loss > 4.5 kg in past year 
35 Appetite 
36 Self Report: "Everything is an effort" 
37 Self Report: "Could not get going" 
38 Low Physical Activity  
39 Lives Alone 
40 Low Community Mobility 
41 Slow Walking Speed 
42 Falls in Previous Year 
43 Low Quality of Life 
44 Mini Mental State Examination 
45 Low Mid-Arm Circumference 
46 Low Calf Circumference 
47 Low Body Mass Index 
48 Grip Strength 
49 Low Protein Consumption 
50 Self Reported Malnutrition 
†
 The present study followed guidelines by Searle et al. (340) to construct the FI-CD, including 





427 new patients aged  70 years were admitted to the GEMU during the study 
period. Study exclusion reasons were: dementia/unresolved delirium within 72 
hours of GEMU admission without proxy (n = 77), language barrier without 
proxy (n = 67), clinician advised against inclusion (elder-abuse, physically 
aggressive, medically unwell: n = 33), infectious (n = 11), missed by researcher (n 
= 4) and declined participation (n = 63). Table 9-2 shows admission 
characteristics of the 172 patients recruited. Frailty prevalence ranged from 24 to 
94 % depending on the instrument used.  
 
Results from logistic regression analyses used to assess which frailty instrument 
was most predictive of poor outcome are shown in Table 9-3. For all instruments, 
strength of prediction was stronger at discharge than at six month follow-up. Grip 
strength, adapted Katz index, FI-CD and SOF were most predictive of poor 
discharge outcome. The FI-CD, SOF, adapted Katz index and grip strength were 
most predictive of poor outcome at six months. IADL, CHS and SHERPA were 
also predictive of outcomes both at discharge and at six months. Gait speed was 
predictive of poor outcome at six months but not at discharge. The simpler 
multidimensional indices (FRAIL, FI-CGA-10, MPI, HARP) and co-morbidity 
(CCI) were not predictive of any outcomes.  
 
To assess predictive accuracy, auROC curves were computed (see Table 9-4 and 
Figure 9-1). Overall, auROC was higher at discharge than at six months. FI-CD 
showed the highest auROC at both time-points (both auROCs > 0.7). The adapted 
Katz index showed adequate discriminatory power for poor outcome prediction at 
discharge, but not at six months. Age lacked discriminatory power for outcome 
prediction: auROC (discharge) = 0.571, P = 0.195; auROC (six months) = 0.540, P 
= 0.363. There were statistically significant differences between the auROC values 
of the majority of frailty instruments, although one notable exception was between 





For all instruments, NPV was high for discharge and moderate-high for six month 
outcomes; PPV was low for discharge and low-moderate for six month outcomes. 










Table 9-2: Admission Characteristics of Patients (n = 172) 
Variable Overall n (%) 
Age   
      70 -79 years 31 (18) 
      80-89 years  100 (58) 
      90-101 years 41 (24) 
Gender (women) 129 (72) 
Private Health Insurance 62 (36) 
Residing in Residential Care  8 (5) 
Education  
     Primary School or Less 73 (42) 
     Junior High School 83 (48) 
     Senior High School 10 (6) 
     Tertiary Education  5(3) 
Birthplace  
     Australia  118 (69) 
     UK/Europe 53 (31) 
     Other 1 (1) 
English as Primary Language 139 (81) 
Medical History  
     Polypharmacy (  6 medications) 131 (76) 
     Hearing Impairment 98 (57) 
     Lives Alone 97 (56) 
     Use of Dentures 84 (49) 
     Cognitive Impairment (MMSE <24) 74 (43) 
     Depressive Risk (GDS-15 >5) 61 (40) 
     Malnutrition (MNA < 17) 53 (31) 
     Falls in the previous year (self-reported) 111 (65) 
     Hospitalised (any reason) in the last 3 months 50 (29) 
     Hospital for falls in the previous year  36 (22) 
Activities of Daily Living (ADL)  
    Dependence Feeding 55 (32) 
    Dependence Washing 123 (72) 
    Dependence Grooming 75 (44) 
    Dependence Dressing 100 (58) 
    Dependence Toileting 84 (49) 
    Dependence Transferring 90 (52) 
    Dependence Walking 67 (39) 
    Dependence in any ADL (  Katz Score for frailty)
 †
 129 (75) 
    Dependence in > 3  ADL 90 (52) 
    Dependence in all ADL 29 (17) 
Medical Condition  
     Chronic Heart Failure 74 (43) 
     Diabetes 52 (30) 
     Renal Impairment 37 (22) 
     Tumour 33 (19) 
     Previous Myocardial Infarction 31 (18) 
     Previous Stroke 28 (16) 
     Pressure Sore or Skin Ulcer 27 (16) 





Variable Overall n (%) 
     CCI ( 5 illnesses) 38 (28) 
Frailty and Pre-Frailty Prevalence   
FI-CD - Frail (Index > 0.45) 65 (38) 
Pre-Frail  (Index 0.2 to 0.45)  96 (56) 
Robust (Index < 0.2) 11 (6) 
CHS - Frail (  3 components)  96 (56) 
         - Pre-frail (1-2 Components) 64 (7) 
         - Robust 12 (64) 
SOF - Frail (  2 components) 120 (70) 
         - Pre-frail (1 components) 44 (26) 
         - Robust  6 (4) 
 FRAIL - Frail (  3 components) 107 (62) 
         - Pre-frail (1-2 Components) 62 (36) 
         - Robust 3 (2) 
FI-CGA-10 - Frail (Scores > 13)  45 (26) 
         - Pre-frail (1-2 Components) 109 (63) 
         - Robust 18 (11) 
SHERPA - High Risk (Score > 6)
†
 87 (51) 
         - Moderate Risk (Scores 5 - 6) 41 (24) 
         - Low or Mild Risk (Scores 0 - 4.5) 43 (25) 
MPI  -Severe Mortality Risk (Index > 0.66)
 †
 42 (24) 
         - Moderate Risk (Index 0.34 – 0.66) 125 (73) 
         - Low Risk (Index  0.33) 5 (3) 
HARP - High ADL Decline Risk (Score  4)
†
 43 (25) 
         - Moderate ADL Decline Risk  (Scores 2 or 3)   91 (53) 
         - Low ADL Decline Risk (Scores 0 or 1) 38 (22) 
Lawton IADL - Frail (  3 dependencies in IADL) 98 (57) 
Low Grip Strength (< 18 kg F; < 30 kg M) 128 (74) 
Slow Walking Speed ( > 30 s/ 6 m) 46 (27) 
Outcomes  
Length of GEMU stay (days); Median (range) 12 (1-91) 
Poor Discharge Outcome 35 (20) 
     In-Hospital Mortality  7 (5) 
     New discharge to a Residential Care Facility 26 (15) 
     New discharge to High to Low Level Care 2 (1) 
Poor Six Month Outcome  78 (45) 
     Mortality (including in-hospital) 28 (16) 
    Residential Care Admission (including in-hospital) 50 (29) 
† Equivalent to frailty for the purposes of this study. Abbreviations: FI-CD = Frailty Index of 
Cumulative Deficits; CHS = Cardiovascular Health Study index (Fried); SOF = Study of 
Osteoporotic Fractures index; FRAIL = Fatigue, Resistance, Ambulation, Illness, Loss of Weight 
index; FI-CGA-10 = Frailty Index based on Ten Domain Comprehensive Geriatric Assessment; 
Katz = Adapted Katz index of 7 Activities of Daily Living; SHERPA = Score Hospitalier 
d‟Evaluation du Risque de Perte d‟Autonomie index; MPI = Multidimensional Index; HARP = 
Hospital Admissions Risk Profile; CCI = Charlson's Co-morbidity Index; GEMU = Geriatric 
Evaluation and Management Unit; MNA = Mini Nutritional Assessment; MMSE = Mini Mental 






Table 9-3: Results of Binary Logistic Regression Analyses Indicating the Contribution of 
Frailty Instruments to Study Outcomes
†





Poor Discharge Outcome  
(n = 35) 
Poor 6 Month Outcome  
(n = 98) 
OR 95 % CI P OR 95 % CI P 
Grip 128 (75) 6.47 1.46 - 28.60 0.014 2.65 1.23 - 5.69 0.013 
Katz 129 (75) 5.55 1.56 - 11.73 0.008 3.17 1.45 - 6.91 0.004 
FI-CD 65 (38) 5.09 2.23 - 11.62 < 0.001 4.25 2.18 - 8.31 < 0.001 
SOF 120 (70) 3.44 1.21 - 9.78 0.020 3.26 1.55 - 6.87 0.002 
Lawton 98 (57) 3.06 1.28 - 7.29 0.012 2.21 1.18 - 4.16 0.014 
CHS 96 (56) 2.98 1.28 - 6.97 0.012 2.17 1.15 - 4.09 0.017 
SHERPA 87 (51) 2.54 1.06 - 6.07 0.037 2.54 1.06 - 6.07 0.037 
Gait Speed 46 (27) 2.18 0.94 - 5.06 0.068 2.06 1.01 - 4.20 0.046 
HARP 43 (25) 2.04 0.89 - 4.68 0.091 1.91 0.93 - 3.92 0.079 
FRAIL 107 (62) 1.81 0.78 - 4.19 0.166 1.68 0.87 - 3.22 0.120 
CCI 38 (28) 1.10 0.44 - 2.73 0.847 1.48 0.71 - 3.10 0.295 
FI-CGA-10 45 (26) 1.01 0.42 - 2.43 0.976 1.59 0.79 - 3.19 0.195 
MPI 42 (24) 0.94 0.38 - 2.33 0.901 1.68 0.83 - 3.42 0.152 
†
Poor Outcome = Mortality, admission to a residential care facility, or move from low level care 
to high level care within a residential care facility.  
‡
 Frail and Not Frail categories were compared, with Not Frail = Pre-Frail or Robust 
n=172 for all outcomes, except hospital discharge, where two patients were excluded as they 
were already residing in high level care at baseline. 
OR = Odds Ratio; CI = Confidence Interval; FI-CD = Frailty Index of Cumulative Deficits; 
CHS = Cardiovascular Health Study index (Fried); SOF = Study of Osteoporotic Fractures 
index; FRAIL = Fatigue, Resistance, Ambulation, Illness, Loss of Weight index; FI-CGA-10 = 
Frailty Index based on Ten Domain Comprehensive Geriatric Assessment; Katz = Adapted Katz 
index of 7 Activities of Daily Living; SHERPA = Score Hospitalier d‟Evaluation du Risque de 
Perte d‟Autonomie index; MPI = Multidimensional Index; HARP = Hospital Admissions Risk 
Profile; CCI = Charlson's Co-morbidity Index 





Table 9-4: Diagnostic Values for Frailty, Functional Decline and Co-morbidity Indices for the Prediction of Poor Outcomes at Both Discharge and 
at Six Month Follow-Up
†
 
Poor Discharge Outcome (n=35) Poor 6 Month Outcome (n=98) 
Index auROC P 95% CI Se Sp PPV NPV YI auROC P 95% CI Se Sp PPV NPV YI 
FI-CD 0.735 < 0.001 0.64 - 0.83 65.7 70.4 36.5 88.8 36.1 0.702 < 0.001 0.62 - 0.78 55.1 76.6 66.2 67.3 31.7 
Katz 0.704 < 0.001 0.60 - 0.81 91.4 29.6 25.2 93.0 21.1 0.646 0.001 0.56 - 0.73 84.6 33.0 51.2 72.1 17.6 
SHERPA 0.697 < 0.001 0.59 - 0.80 74.3 56.3 30.6 89.4 30.6 0.657 < 0.001 0.58 - 0.74 65.4 61.7 58.6 68.2 27.1 
Lawton 0.694 0.000 0.59 - 0.80 77.1 48.9 28.1 89.2 26.0 0.635 0.002 0.55 - 0.72 67.9 52.1 54.1 66.2 20.1 
Grip  0.690 0.001 0.59 - 0.79 94.3 31.1 26.2 95.5 25.4 0.627 0.004 0.54 - 0.71 84.6 34.0 51.6 72.7 18.7 
SOF 0.679 0.001 0.58 - 0.78 85.7 33.6 25.2 90.0 19.3 0.657 < 0.001 0.58 - 0.74 85.7 33.6 25.2 90.0 19.3 
CHS 0.675 0.001 0.57 - 0.78 74.3 49.6 27.7 88.2 23.9 0.627 0.004 0.54 - 0.71 65.4 52.1 53.1 64.5 17.5 
Gait  0.643 0.009 0.53 - 0.75 37.1 76.3 28.9 82.4 13.4 0.613 0.011 0.53 - 0.70 33.3 78.7 56.5 58.7 12.1 
HARP 0.639 0.011 0.53 - 0.75 37.1 79.3 31.7 82.9 16.4 0.600 0.024 0.52 - 0.69 32.1 80.9 58.1 58.9 12.9 
FRAIL 0.638 0.012 0.53 - 0.74 71.4 40.7 23.8 84.6 12.2 0.608 0.015 0.52 - 0.69 67.9 42.6 49.5 61.5 10.5 
MPI 0.617 0.033 0.50 - 0.73 22.9 76.3 20.0 79.2 -0.8 0.599 0.025 0.51 - 0.68 29.5 79.8 54.8 57.7 9.3 
FI-CGA-10 0.617 0.033 0.50 - 0.73 25.7 74.8 20.9 79.5 0.50 0.588 0.047 0.50 - 0.67 30.8 77.7 53.3 57.5 8.4 
CCI 0.579 0.074 0.49 - 0.67 25.6 80.9 52.6 56.7 6.50 0.592 0.039 0.51 - 0.68 80.9 52.6 56.7 45.3 <0.1 
†
Poor Outcome = Mortality, admission to a residential care facility, or move from low level care to high level care within the residential facility. 
n=172 for all outcomes, except hospital discharge, where two patients were excluded as they were already residing in high level care at baseline. 
auROC = Area Under Receiver Operating Characteristic Curve (adjusted for age and gender); CI = Confidence Interval; Se = sensitivity; Sp = Specificity; 
PPV = Positive Predictive Value; NPV = Negative Predicitive Value; YI = Youden Index; FI-CD = Frailty Index of Cumulative Deficits; CHS = 
Cardiovascular Health Study index (Fried); SOF = Study of Osteoporotic Fractures index; FRAIL = Fatigue, Resistance, Ambulation, Illness, Loss of Weight 
index; FI-CGA-10 = Frailty Index based on Ten Domain Comprehensive Geriatric Assessment; Katz = Adapted Katz index of 7 Activities of Daily Living; 
SHERPA = Score Hospitalier d‟Evaluation du Risque de Perte d‟Autonomie index; MPI = Multidimensional Index; HARP = Hospital Admissions Risk 
Profile; CCI = Charlson's Co-morbidity Index 





Table 9-5: Contrast Values of Area Under Receiver Operating Characteristic Curves 
for Poor Outcome at (A) Hospital Discharge and (B) Six Months Post-Discharge in 
Hospitalised Older People (n = 172).  
 
(A) Hospital Discharge 
  Katz ADL CGA CCI FI-CD FRAIL CHS Gait Speed Grip Strength IADL MPI SOF 
Katz ADL n/a <0.001 <0.001 0.8618 <0.001 <0.001 <0.002 <0.001 <0.001 <0.001 <0.001 
FI-CGA-10 <0.001 n/a <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
CCI <0.001 <0.001 n/a <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
FI-CD 0.8618 <0.001 <0.001 n/a <0.001 <0.001 0.005 <0.001 <0.001 <0.001 <0.001 
FRAIL <0.001 <0.001 <0.001 <0.001 n/a <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
CHS <0.001 <0.001 <0.001 <0.001 <0.001 n/a <0.001 <0.001 <0.001 <0.001 <0.8569 
Gait Speed <0.002 <0.001 <0.001 0.005 <0.001 <0.001 n/a <0.001 0.0133 <0.001 <0.001 
Grip Strength <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 n/a <0.001 <0.001 <0.001 
Lawton <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.0133 <0.001 n/a <0.001 <0.001 
MPI <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 n/a <0.001 
SOF <0.001 <0.001 <0.001 <0.001 <0.001 <0.8569 <0.001 <0.001 <0.001 <0.001 n/a 
            (B) Six Months Post-Hospitalisation  
  Katz ADL CGA CCI FI-CD FRAIL CHS Gait Speed Grip Strength IADL MPI SOF 
Katz ADL n/a <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
FI-CGA-10 <0.001 n/a <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
CCI <0.001 <0.001 n/a <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
FI-CD <0.001 <0.001 <0.001 n/a <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
FRAIL <0.001 <0.001 <0.001 <0.001 n/a <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
CHS <0.001 <0.001 <0.001 <0.001 <0.001 n/a 0.0772 <0.001 0 1727 <0.001 <0.001 
Gait Speed <0.001 <0.001 <0.001 <0.001 <0.001 0.0772 n/a <0.001 0.0069 <0.001 <0.001 
Grip Strength <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 n/a <0.001 <0.001 <0.001 
Lawton <0.001 <0.001 <0.001 <0.001 <0.001 0.1727 0.0069 <0.001 n/a <0.001 <0.001 
MPI <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 n/a <0.001 
SOF <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 n/a 
Abbreviations: FI-CD = Frailty Index of Cumulative Deficits; CHS = Cardiovascular 
Health Study index (Fried); SOF = Study of Osteoporotic Fractures index; FRAIL = 
Fatigue, Resistance, Ambulation, Illness, Loss of Weight index; FI-CGA-10 = Frailty 
Index based on Ten Domain Comprehensive Geriatric Assessment; Lawton= Lawton‟s 
scale of Instrumental Activities of Daily Living; Adapted Katz = Adapted Katz score of 
seven Activities of Daily Living; SHERPA = Score Hospitalier d‟Evaluation du Risque de 
Perte d‟Autonomie index; MPI = Multidimensional Index; HARP = Hospital Admissions 




9.4 Discussion  
This study found frailty and functional decline instruments identified GEMU 
patients at increased risk of poor outcomes, both at discharge and six months. 
Predictive of poor outcome at both time-points were: grip strength, FI-CD, the 
adapted Katz score, SOF, CHS, SHERPA and Lawton‟s IADL index. Gait speed 
was predictive of poor outcome at 6 months but not at discharge. Some indices 
(FRAIL, FI-CGA-10, MPI and HARP) were not predictive of any study 
outcomes, perhaps because our study included many severely frail patients. Age 
and co-morbidity did not predict poor outcomes, which confirms findings from a 
recent study of older rehabilitation patients (375). As such, age and illnesses per 
se should not be barriers for rehabilitation access.  
 
The FI-CD showed the strongest discriminatory power for outcome prediction at 
both discharge (auROC = 0.735) and six months (auROC = 0.702). This good 
discriminatory ability agrees with a previous epidemiological study looking at 
mortality prediction (217) and is likely to be the result of the multidimensional 
nature of the FI-CD (340)FI-CD is also advantageous because it can identify early 
frailty risk (340, 373). 
 
The adapted Katz index also showed adequate discriminatory power for prediction 
of poor discharge outcome (auROC = 0.704). Katz is advantageous in a clinical 
setting due to its fast and simple application (5 minutes per patient) and it can be 
applied in more general hospital wards where CGAs are not routine. However, the 
Katz index does not identify early frailty risk or encompass frailty‟s 
multidimensional nature. 
 
The phenotypic frailty indices (CHS and SOF), even though predictive of poor 
outcomes at both time-points, lacked sufficient discriminatory power in their 
predictions, which agrees with some studies of hospitalised people (229, 269, 345) 




perhaps unexpectedly, as a recent study of hospitalised older persons found MPI 
out-performed other frailty instruments (345). 
 
Overall predictive ability in our study was higher at discharge than at six months, 
which was also found in a recent study of hospitalised older persons (345). NPV 
was generally high for all instruments in predicting outcomes, which indicates that 
almost all frail patients were identified. PPV on the other hand was generally only 
low-moderate, indicating a high number of false positives tests occurred.   
 
Study results should be interpreted with caution as the cut-point for frailty 
classification by the FI-CD (> 0.45) may have identified more severely frail 
patients than other instruments. There was also the potential for over-estimation of 
performance-based frailty components. For example, patients unable to walk due 
to injury/illness were deemed “low mobility”. An additional limitation was the 
low number of patients classified as “robust”, which precluded a comparison of 
all three frailty categories (frail, pre-frail and robust). Study results may also lack 
generalisation to other wards as GEMU patients are highly selected prior to their 
admission. Study strengths included the wide range of indices evaluated, the 
prospective design and the comprehensive admission dataset.  
 
Future research should focus on the clinical application of frailty instruments in a 
larger group of patients across multiple ward areas - particularly with regards to 
practicality (342), detection of frailty change (340) and ability to distinguish pre-
frailty from frailty (342). 
 
9.4.1 Conclusion 
Frailty and functional decline instruments can be used to identify older 
hospitalised patients at risk of poor discharge and six month outcomes. The FI-CD 
































10 Inflammatory Cytokines and Appetite in Healthy People 
Dent E, Yu S, Visvanathan R, Piantadosi C, Adams R, Lange K, Chapman I. 
Inflammatory Cytokines and Appetite in Healthy People. The Journal of Aging 
Research & Clinical Practice. 2012;1(1):40-3. 
 
Background and Objectives: Inflammation has been associated with reduced 
appetite and body composition changes in populations with established diseases. 
However, it is not known if an association exists between appetite, body 
composition and inflammation in healthy people. Design: To explore associations 
of appetite with markers of inflammation and body composition, data from the 
Cytokines, Adiposity, Sarcopenia and Ageing (CASA) study was analysed. 
Setting: Western suburbs, Adelaide, Australia.  
Participants: 180, population representative, healthy participants, aged 18 – 82 
years, were studied.  
Measurements: Body composition was measured by both Dual X-ray 
absorbiometry (DXA) and bioelectrical impedance analysis (BIA). Appetite was 
assessed by the Simplified Nutritional Appetite Questionnaire (SNAQ). 
Circulating cytokine concentrations were measured. Results: Multiple regression 
analysis showed appetite scores were increased in non-smokers (P = 0.031) and 
men (P = 0.024), negatively associated with serum levels of the pro-inflammatory 
IL-1 ( coefficient = - 0.379, P = 0.007), and positively associated with serum 
levels of the anti-inflammatory cytokine IL-10 ( coefficient = 0.25, P = 0.010). 
There was no association between appetite and body composition.  
Conclusions: Appetite loss may reflect background inflammation even in 
apparently healthy people, and probably occurs before consequent changes in 
body composition. Further explorations of longer term appetite changes with 
respect to inflammation and body composition changes are needed.   





Undernutrition is common among older people, even in developed countries (147, 
421, 433, 460), and is associated with serious consequences, including more 
frequent and prolonged hospital admissions (139) increased infection risk (95), 
functional decline (196) and reduced life expectancy (147).  It is important to 
identify factors that might predict those older people more likely to lose weight 
and become under-nourished, so prevention and early treatment measures can be 
implemented. 
 
Multiple methods have been used to define and diagnose undernutrition in older 
people, but features commonly seen in this condition are weight loss (particularly 
muscle loss), reduced body weight, reduced appetite and sometimes cachexia 
(17). Ageing is associated with decline in appetite and food intake which is 
probably physiological, but may contribute to the development of pathological 
anorexia and undernutrition. Indeed, reduced appetite is a reliable predictor of 
future weight loss in older people; appetite scores obtained from the Simplified 
Nutritional Appetite Questionnaire (SNAQ) have been found to predict future 
weight loss in older people (167). 
 
Appetite loss may be caused by inflammation. Inflammation is the immune 
system‟s response to an acute infection or illness and is the result of the 
production of several pro-inflammatory cytokines including interleukin-1 (IL-1), 
IL-2, IL-6, IL-8, tumour necrosis factor- (TNF-) and interferon- (IFN) (461). 
These pro-inflammatory cytokines, when persistently elevated, can reduce 
appetite by actions on the hypothalamus and other neural centres, by altering 
gastric function and by modifying the regulation of appetite controlling hormones 
(461). Anti-inflammatory cytokines, such and IL-4 and IL-10 act to down-regulate 
pro-inflammatory cytokine production (67). An imbalance between pro-
inflammatory and anti-inflammatory cytokines is thus thought to lead to the 





Ageing itself may be a low-level pro-inflammatory state (463). It might therefore 
be that the anorexia of ageing is due, at least in part, to increased inflammation. If 
so, it might be expected that there would be a positive connection between pro-
inflammatory markers and reduced appetite even in apparently healthy individuals 
across the adult age range. Little is known about these possible connections.  
 
This study explored the associations of appetite with markers of inflammation and 
body composition in healthy adults. It was hypothesised that there would be 
associations between increased inflammation and reduced appetite even in this 
group of healthy individuals, but probably not between markers of inflammation 






10.2.1 Participants  
Healthy subjects (ages 18 to 82 years) were recruited from the western suburbs of 
Adelaide into the Cytokine, Adiposity, Sarcopenia and Ageing Study (CASA). 
The recruitment methodology is similar to that described for other larger 
population studies conducted in the same catchment area, the North West 
Adelaide Health Study (464). Telephone numbers from the Electronic White 
Pages were randomly selected, and willing subjects, aged 18 or over, with no 
exclusion criteria, were invited to participate. Subjects able to comply with the 
study protocol and who reported weight stability over the preceding 3 months 
were included in the study. Those with confirmed inflammatory diseases, 
pregnant and those who had been ill in the preceding 3 months or in the 2 weeks 
following blood sampling, were excluded. This study had ethics approval from the 
Central Northern Adelaide Health Service Ethics of Human Research Committee 
and all participants provided written informed consent. 
 
10.2.2 Body Composition Measures 
Body composition was assessed by measurement of height; weight; waist 
circumference; Fat Mass (FM) and Fat Free Mass (FFM) by Dual X-Ray 
Absorbiometry (DXA) (Lunar PRODIGY whole body scanner; GE Medical 
Systems, Madison, WI) scan; and Biolectrical Impedence Analysis (BIA) 
(Quantum II BIA Analyser, RJL system). 
 
10.2.3 Appetite 
Participants completed the SNAQ questionnaire, giving one of five responses to 
four questions regarding appetite, satiety, taste and meal frequency (167).  SNAQ 
gives a score out of 20, with higher scores indicating greater appetite. SNAQ has 
been found to predict weight loss over a six month period with 81.6 % sensitivity 





10.2.4 Exercise Score 
Exercise was assessed using Australian National Health Survey questions (465). 
Scores for exercise intensity were 3.5 for walking, 5.0 for moderate activity and 
7.5 for high intensity activity.  Each exercise intensity score was multiplied by 
minutes per fortnight to give total exercise level. This total level was classified as 
„sedentary‟ (< 100), „low level‟ (100 < 1600), „moderate level‟ (1600 – 3200 or > 
3200 and less than 2 h of vigorous exercise) or „high level‟ (> 3200)‟. 
 
10.2.5 Data Collection  
Fasting blood samples were collected and body composition measured by BIA in 
the morning, and body composition by DXA was measured either the afternoon of 
the same day or on another day but within 2 weeks. Plasma samples were stored at 
–80C until analysis. Cytokine concentrations were measured using LINCOplex 
kits. Trace values < 0.08 pg/L for cytokines were recorded as zero values.   
 
10.2.6 Statistical Analysis 
SNAQ scores were normally distributed. Other continuous study variables were 
non-normally distributed and are presented as medians (inter-quartile range). 
Categorical variables are presented as frequencies. Relationships between the total 
SNAQ score and the study variables were assessed using Spearman rank 
correlation tests for non-parametric variables. Cytokines and anthropometric 
variables were included in a multiple regression analysis along with for age, 
gender and smoking status. Continuous data were log transformed prior to 
inclusion in this analysis. Statistical analysis was carried out using SPSS statistical 




10.3 Results  
180 subjects with complete results were included in the study. Median age was 52 
years with a range of 18-82 years. SNAQ total scores ranged from 12-20 (out of 
20), with a median score of 17. 15 participants (7.8 %) had low SNAQ scores 
(defined as  14). Table 10-1shows baseline subject characteristics.   
 
The results of the univariate regression analysis of the relationship between 
SNAQ appetite scores and continuous study variables are shown in Table 10-2. 
Both IL-6 and IL-10 concentrations were positively related to appetite. There 
were also strong significant associations between concentrations of a number of 
cytokines, including IL-6 with both IL-1 (r = .353, P <0.001) and IL-10 (r = 
.410, P<0.001). By multivariate analysis (Table 10-3) non-smokers had higher 
appetite scores than smokers and men higher scores than women.  IL-1 
concentrations were negatively and IL-10 concentrations positively associated 
with appetite. None of the body composition variables showed any association 









Table 10-1: Baseline Participant Characteristics (n=180) 
Continuous Variables Median (Inter-Quartile Range) 
Background Variables  
Age (years) 52 (40-62) 
SNAQ appetite scores 17.0 (16.0-18.0) 
Circulating Cytokine Concentrations 
     IL-1 (pg/ml) 0.50 (0.0-1.8) 
     IL-2 (pg/ml) 1.46 (0.0 - 8.0) 
     IL-4 (pg/ml) 0.0 (0.0 - 15.8) 
     IL-6 (pg/ml) 1.95 (0.25-5.9) 
     IL-10 (pg/ml) 3.9 (0.0-13.8) 
     TNF- (pg/ml) 3.5 (1.9 - 5.4) 
     hs-CRP (mg/L) 1.2 (0.6 - 2.3) 
Anthropometric Measures 
     BMI (kg/m
2
) 25.6 (23.0 - 28.7) 
     Waist Circumference (cm) 87.2 (76.3 - 96.7) 
     Total Lean Mass DXA (kg) 44.5 (38.1 - 56.8) 
     Total Fat DXA (Kg) 24.1 (17.1 - 30.2) 
Nutritional Biomarkers  
     Haemoglobin (g/L) 140.0 (129.0 - 150.0) 
     Lymphocyte (g/L) 1.8 (1.6-2.2) 
     Albumin (g/L) 39.0 (37.0 - 41.0) 
Categorical Variables n (%) 
Background Variables  
Gender (Female) 106 (58.9 %) 
Smoking Status 19 (10.6%) smokers 
Exercise Level  
     Sedentary 31 (17.2 %) 
     Low Level 75 (41.7 %) 
     Moderate Level 39(21.7 %) 
     High Level 35(19.4 %) 
Abbreviations: SNAQ = Simplified Nutritional Appetite Questionnaire; IL = 
Interleukin; TNF = Tumor Necrosis Factor alpha; hs-CRP = High Sensitivity C-
Reactive Protein; BMI = Body Mass Index (height/weight
2








Table 10-2: Univariate Regression Analysis of relationships between total 
SNAQ appetite score and Continuous Study Variables (n=180) 
Variable R P 
Background Variables   
     Age (years) 0.016 0.836 
     Exercise Score  0.062 0.407 
Nutritional Biomarkers   
     Haemaglobin (g/L) 0.053 0.463 
     Lymphocyte (g/L) 0.040 0.585 
     Albumin (g/L) 0.038 0.601 
Cytokines   
     IL-1 (pg/ml) 0.033 0.637 
     IL-2 (pg/mL)  0.034 0.652 
     IL-4 (pg/mL)  0.041 0.584 
     IL-6 (pg/mL) 0.153 0.041 
     IL-10 (pg/mL)  0.210 0.005 
     TNF- (pg/mL)  0.089 0.222 
     hs-CRP  (mg/mL)  0.086 0.239 
Anthropometric Measures   
     BMI (kg/m
2
) 0.039 0.599 
     Waist Circumference (cm) 0.058 0.425 
     Total Lean Mass DXA (kg) 0.064 0.374 
     Total Fat DXA (kg) 0.050 0.494 
Abbreviations:  IL = Interleukin; TNF = Tumor Necrosis Factor alpha; hs-CRP = 
High Sensitivity C-Reactive Protein; BMI = Body Mass Index (height/weight
2
); 













Table 10-3: Multivariate Analysis of relationship between Study Variables 
and total SNAQ score (n=180) 
Variable  Coefficient t P 
Background Variables   
     Age (years)  0.042  0.472 0.638 
     Gender -0.367 -2.287 0.024
 
     Smoking Status -0.172 -2.176 0.031
†
 
Cytokines    
     IL-1 (pg/ml) -0.379 -2.739 0.007 
     IL-2 (pg/mL)   0.157  1.018 0.310 
     IL-4 (pg/mL)   0.057  0.535 0.593 
     IL-6 (pg/mL)  0.085  0.806 0.422 
     IL-10 (pg/mL)   0.248  2.598 0.010 
     TNF- (pg/mL)   0.035  0.392 0.696 
     hs-CRP  (mg/mL)  -0.165 -1.868 0.064 
Anthropometric Measures   
     BMI (kg/m
2
) -0.227 -0.971 0.333 
     Waist Circumference (cm)  0.372  1.739 0.084 
     Total Lean Mass DXA (kg)  0.281  1.631 0.105 
     Total Fat DXA (kg) -0.058 -0.255 0.799 
Exercise Score  0.117  1.471 0.143 
Abbreviations: SNAQ = Simplified Nutritional Appetite Questionnaire; IL = 
Interleukin; TNF = Tumor Necrosis Factor alpha; hs-CRP = High Sensitivity C-
Reactive Protein; BMI = Body Mass Index (height/weight
2
); DXA = Dual X-Ray 
Absorbiometry.  
SNAQ scores higher in men than women. 
†













In this novel study of appetite in healthy people, appetite as measured by the 
SNAQ questionnaire was associated negatively with circulating serum levels of 
IL-1β and positively with IL-10 levels, but was not associated with any measure 
of body composition or nutritional biomarker – albumin, lymphocyte count and 
haemoglobin.  
 
The negative association between IL-1β and appetite found in this study is 
consistent with previous reports in humans with inflammatory conditions such as 
cancer (466), renal failure (467) eating disorders (468) and depression (469). Our 
finding is also consistent with the known pro-inflammatory effects of IL-1 and 
the results of animal studies. In rodents, food intake is suppressed in a dose-
dependent manner by IL-1β (461, 470). Additionally, IL-1β knock-out mice are of 
normal size and weight, but resistant to inflammation-induced weight loss (461). 
Of interest older mice lose more weight in response to IL-1 administration than 
young adult mice (471). 
 
The positive association between IL-10 and appetite is consistent with the anti-
inflammatory actions of this cytokine. IL-10 is believed to suppress immune 
responses by inhibiting pro-inflammatory cytokine production (67, 472).  For 
example, IL-10 has been found to be protective against weight loss induced by 
both pro-inflammatory cytokines (473) and bacteria-mimicked infection (474) in 
rodent studies. 
 
The finding that IL-6 was associated with appetite in the univariate analysis, but 
not associated in the multivariate analysis is probably because IL-6 concentrations 
are significantly associated with those of other cytokines, such as IL-1 and IL-10 
which have more powerful effects on appetite. Consistent with the strong 




<0.001), IL-6 has been found to up-regulate IL-10 during acute inflammation 
(475). 
 
In the present study there was no association between appetite and circulating 
levels of either TNF- or, CRP. TNF- is a pro-inflammatory cytokine which has 
been associated with reduced appetite in patients with chronic diseases such as 
renal failure (476) and levels of CRP, an inflammatory marker, have been 
associated with appetite decline in patients with chronic disease (477, 478). The 
lack of an association with appetite in the present study is perhaps because our 
subjects were healthy and TNF and CRP effects on appetite occur later in the 
pathways of chronic and inflammatory diseases.  
 
Low appetite leads to reduced food intake, which in turn, often results in weight 
loss (167). Loss of appetite due to inflammation might therefore result in reduced 
lean tissue stores. We found, however, no such association in our study, a finding 
supported by a recent study of community elders in Malaysia, where appetite was 
also not associated with body composition (479). 
 
Our results may provide some insight into the order in which changes leading to 
undernutrition occur.  It is not known if the muscle mass loss that often follows 
appetite reduction in older people leads to a pro-inflammatory state, or if 
inflammation leads to reduced appetite and food intake and subsequently to 
adverse body composition changes. Our findings support the latter sequence, at 
least in certain circumstances. In apparently healthy people there appears to be 
already present an association between inflammation and reduced appetite, 
without adverse effects on body composition, which we postulate would only 






This study was limited by a relatively small sample size. Nevertheless, subjects 
were randomly chosen from the community and thus reflect the situation in 
apparently healthy adults.  A further limitation is that dietary background was also 
not assessed in this study and that SNAQ has not yet been validated against 
objective food intake (480), although it has been shown to predict future weight 
loss (167). Also Dietary intake was not assessed in this study. Because it is 
possible that body composition and weight loss may reflect long term nutrition, 
whereas appetite and inflammation reflect short term nutrition (64), it would be 
interesting to follow these subjects to assess longer-term relationships between 
inflammation, appetite, body weight change and nutritional status and we are now 
planning such a follow-up study.  
 
An additional limitation is that there were a large number of comparisons in this 
study with only two positive results. It is possible that these positive results are 
the result of a Type I statistical error. Therefore results from this study should be 
interpreted with caution and further studies performed to confirm findings.  
 
10.4.2 Conclusion 
In summary, the major finding of the present study is that appetite in healthy 
people is associated with several inflammatory markers but not with any measures 
of body composition or nutritional bio-markers.  Further follow-up is needed to 
explore the possibility that this may predict future weight loss and increased 






11 Thesis Summary, Limitations and Conclusion 
11.1 Summary  
With the rapid global increase in the number of older people, it is becoming 
increasingly important to focus research on conditions affecting this age group. 
Importantly, if we are able to predict which older individuals are more likely to 
encounter poor health outcomes, this will have an impact on prevention, treatment 
and care given to older people. Two common conditions associated with poor 
outcomes in older people are frailty and malnutrition. This doctoral thesis 
examined the ability of frailty measurements and Nutritional Screening Tools 
(NSTs) to predict adverse clinical outcomes in hospitalised older people. The 
main research project was prospective and observational by design, and included 
172 patients aged seventy years or over consecutively admitted to the Geriatric 
Evaluation and Management Unit (GEMU) at The Queen Elizabeth Hospital, 
South Australia.  
 
Chapter 5 presented a systematic review of 37 prospective studies examining 
NSTs as predictors of adverse clinical outcomes in older people across a variety 
of settings: community, residential care, sub-acute care and hospital. Malnutrition 
identified by NSTs was found to be associated with mortality in 23 out of 28 
studies (82 %), functional decline in 9 out of 12 studies (75 %) and with 
admission to high level care (nursing home) in 4 out of 7 studies (57 %).  NSTs 
tended to show a good negative predictive power for mortality prediction, 
meaning that a person identified as well nourished had a high probability of not 
having an increased likelihood of mortality. This finding was particularly true for 
the Mini Nutritional Assessment (MNA), MNA-short form (MNA-SF) and the 
Geriatric Nutrition Risk Index (GNRI). However, positive predictive power 
(precision) was relatively low for these NSTs, indicating that malnourished 
patients were over-identified for mortality risk. Similar trends were also seen for 
the outcomes of functional decline and high level care admission. Overall, the 
systematic review concluded that there is evidence that NSTs are predictive of an 
increased likelihood of mortality, functional decline and to a lesser extent, 




were: (i) the lack of studies performed in the hospital setting, (ii) the lack of 
studies comparing nutritional screening tools and (iii) the need to study predictive 
accuracy, which is the ability to correctly identify patients likely to encounter 
adverse health outcomes.  
 
To address these literature gaps, the work described in Chapters 7 and 8 looked at 
the predictive ability of NSTs when applied to older people hospitalised in a 
Geriatric Evaluation and Management Unit (GEMU). In Chapter 7, NSTs were 
considered as continuous variables. It was found that the MNA-SF and the MNA-
II were both predictive of GEMU length of stay (LOS); GNRI and CC were 
associated with functional decline over hospitalisation; and a lower MAC was 
associated with discharge to higher level care. In Chapter 8, the malnutrition 
category of various NSTs was considered as a predictor of poor six month 
outcome, defined generally as admission to a higher level care facility or 
mortality. Malnutrition identified by both the MNA (OR = 3.29) and GNRI (OR = 
2.84) was associated with poor six month outcome, however the diagnostic ability 
of these screening tools was too low to be clinical useful (auROC values < 0.7).    
 
No consensus yet exists as to which frailty instrument most accurately predicts 
older hospitalised patients at risk of poor outcomes. Chapter 9 addressed this issue 
and looked at poor discharge outcome in the same cohort of hospitalised older 
people. The Comprehensive Geriatric Assessment (CGA) derived Frailty Index of 
Accumulated Deficits (FI-CD) showed the highest predictive accuracy at both 
discharge (auROC = 0.735) and at six months post-discharge (auROC = 0.702). 
Also an accurate predictor of poor six month outcome (with an auROC value of 
0.704), was dependency in one or more of seven ADLs (feeding, washing, 
grooming, dressing, toileting, transferring from a bed or chair, and walking) as 
assessed by the adapted Katz index.  
 
Of additional clinical importance is the overlap between malnutrition and frailty. 




assess this relationship, Chapter 6 examined the ability of the MNA and the 
MNA-SF to identify frailty as using the Cardiovascular Health Study (CHS) 
frailty criteria. Results from this study revealed that the MNA showed a high 
specificity (> 90 %) but a low sensitivity (< 60 %) in identifying frailty, regardless 
of whether the standard MNA cut-off score for malnutrition (< 17) or its optimal 
cut-off for frailty as identified from this study (< 17.5) was used. The MNA-SF 
(using BMI) out-performed the full MNA with respect to sensitivity: 64 % at the 
standard cut-off point and 80 % at the optimal cut-off point, with 77 % specificity 
at this cut-off point. Therefore, the MNA-SF can be used to identify frailty. The 
MNA-SF also has the advantage over the full MNA with respect to its simpler and 
faster application. 
 
Linking frailty and malnutrition is inflammation. Chapter 10 explored the 
relationship between inflammation, body composition and appetite in a healthy 
cohort of 180 adults with ages ranging from 18 – 82 years from the CASA study. 
Results from this study show that poor appetite identified by the Simplified 
Nutritional Appetite Questionnaire (SNAQ) was negatively associated with serum 
levels of the pro-inflammatory IL-1 ( coefficient = - 0.379, P = 0.007) and 
positively associated with serum levels of the anti-inflammatory cytokine IL-10 ( 
coefficient = 0.25, P = 0.010). There were no associations between appetite and 
body composition. Findings from this paper suggested that appetite loss may 
result from background inflammation, even in healthy people, and therefore 
possibly occurs before consequent changes in body composition. 
 
11.2 The Importance of Measuring Frailty in Hospitals  
Frailty status provides a more accurate quantification of health status in older 
people than chronological age (210, 481, 482). Frailty measurement is also useful 
in identifying older people at increased risk of encountering adverse outcomes 
(481). As such, frailty measures can be used by clinicians to assist with decision 
making in older patients (482), for example, by optimising any medical treatment 




support (8). Importantly, frailty measurement is not used to deny any older people 
treatment (8, 9).  
 
Frailty is most amenable to responding to interventions in its early stages (286). 
Older people identified as frail may be beyond nutritional and/or exercise 
interventions and as such, palliative interventions may be the only management 
pathway possible (238).  
 
The lack of a standard operational definition for frailty hinders its translation into 
the clinical setting (484). Even at the GEMU at TQEH, frailty status is not 
measured operationally, but rather with geriatrician judgement. Although 
geriatrician judgement is accurate in identifying frailty, it does not allow for a 
consistent diagnosis of frailty from patient to patient (267, 483, 485). 
Incorporation of an operational frailty measurement into clinical practice will 
allow for a much needed consistent, standard and precise identification of frailty. 
 
11.3 The Purpose of Nutritional Screening  
The purpose of nutritional screening is to identify patients with malnutrition or at 
risk of developing malnutrition for the referral for a full nutritional assessment 
and interventions where appropriate (126, 127). Nutritional screening is thus the 
important pre-cursor step to the cyclic Nutritional Care Process (16), which 
includes nutritional assessment, nutritional diagnosis, intervention, monitoring 
and evaluation (129). Nutritional interventions can include protein/calorie 
supplements, social support at mealtime, physical assist with eating, prescribing 
orexigenic medications, improving the appeal of the food and enteral/parenteral 
tube feeding (208). At the GEMU at TQEH, patients identified as malnourished or 
at risk of malnourishment are referred to the hospital dietician for a full nutritional 
assessment and subsequent entry to the Nutritional Care Process. All patients in 





11.4 Thesis Limitations  
11.4.1 Observational Cohort Study 
The project was an analytical study, designed to identify and evaluate NSTs and 
frailty instruments as predictors of adverse outcomes in hospitalised older people.  
As such, the project design was an observational cohort study (486). Whilst 
results from an observational study can be used to inform clinical practice, these 
results cannot be used alone to comment on their effectiveness in clinical practice 
(486). Results from this thesis should therefore be interpreted with this limitation 
in mind. Any influence on clinical practice and public health policy would require 
research into the effectiveness of combined screening and interventions as well as 
identifying where in the causative pathway screening and interventions would 
have the most influence.  
 
11.4.2 Selection Bias 
Patients in the GEMU are pre-selected for entry from the Acute Medical Unit at 
TQEH by hospital geriatricians. Decisive factors for GEMU entry include the 
potential of patients to benefit from the rehabilitative style nature of the ward. 
This pre-selection limits the generalisation of study results to other settings. 
Additionally, there is the high likelihood that patients in the GEMU who did not 
participate in the study were more unwell with higher malnutrition and frailty than 
study participants. This would likely render an underestimation of the relationship 
of frailty and malnutrition with adverse hospital outcomes in this study. 
Therefore, this limitation should be considered when interpreting the results.     
 
11.4.3  Research Protocol 
The six month follow-up period was counted as the time from hospital discharge 
to six months post-discharge. It did not account for the time period between 
patient assessment and hospital discharge, which was a median of 12 days. This 
time difference may have impacted on the number of events that occurred, 
although to a small extent. The comparison of nutritional screening tools and 




Twelve month follow-up was not performed due to time constraints. For instance, 
baseline data collection took 14 months alone to collect.  Another a limiting factor 
was that, because of the observational nature of the project, it was not possible to 
track compliance to or influence of any nutritional or physiotherapy interventions 
both during and after hospitalisation. Nor were any follow-up visits performed to 
assess function and nutritional status, due to the time and financial restrictions of 
the project.  
 
A further limitation to the research protocol was that, due to the large amount of 
data collected at baseline, not all frailty instruments and nutritional screening tools 
could be included in the study. Frailty scales such as the Edmonton‟s Frail Scale 
(364) and Tilburg Frailty Indicator (270) and NSTs such as the Malnutrition 
Universal Screening Tool (MUST) (163) and the Malnutrition Screening Tool 
(MST) (171) were not used. Moreover, a full nutritional assessment was not 
completed due to time constraints. It would have been beneficial to compare the 
efficacy of NSTs assessed in this thesis against a full nutritional assessment. 
Nonetheless, the MNA was used instead and it can be used as a nutritional 
reference standard (147). 
 
Of note, a further limitation of research design is that the project used only one 
cohort of hospitalised older people which would limit the generalisation of results 
to other settings. 
 
11.5 Overall Significance and Contribution to Knowledge 
This doctoral thesis contributed towards a better knowledge and understanding of 
the predictive ability of frailty instruments and nutritional screening tools in the 
hospital setting, with several papers published or submitted for publication. Such 
knowledge may be useful to guide risk stratification, intervention planning and 
health forecasting in older people. It must be emphasised that identifying older 




it is used to offer appropriate support (8). Results from this thesis could also be 
used to assist in standardising definitions for both frailty and malnutrition.  
 
This is the first research to compare the MNA and GNRI with respect to outcomes 
in hospitalised older people. A previous study comparing MNA and GNRI in 
residential care residing older people found a malnutrition classification by both 
screening tools was predictive of mortality, infection and bedsores (97). Their 
study was inconclusive as to which screening tool performed best, although the 
GNRI appeared to outperform the MNA when all adverse complications were 
pooled together (97). In our study, malnutrition identified by the MNA showed 
higher predictive ability of poor six month outcome than the GNRI (adjusted OR 
values of 3.29 and 2.84 for MNA and GNRI respectively). 
 
This doctoral thesis project also showed that it is possible to use frailty indices to 
predict outcomes of hospitalised older people. Only one prior study to date 
(Pilotto et al. 2012) (345) has compared frailty indices with respect to their ability 
and accuracy to predict adverse clinical outcomes in the hospital setting (345). In 
this previous study, the Multidimensional Prognostic Index (MPI) showed a 
higher ability to predict mortality than other frailty instruments studied. These 
results are in contrast to those found in this thesis, which found that the FI-CD and 
the adapted Katz indices both predicted adverse outcome (mortality or admission 
to high level care) whilst the MPI did not. Differences in our results could be 
because our study population was different – indeed our population was more 
unwell than in this previous study. Future research is needed to confirm which 
frailty instrument is best in predicting poor outcome. Additional research 
directions are discussed in the following section. 
 
11.6 Future Research Directions 
The research presented in this thesis provides a platform for ongoing research. 




post-hospitalisation. Such interventions could include nutritional supplements, 
physical activity and medical interventions, with the outcome of these 
interventions assessed by the change in NST and frailty index scores. 
Additionally, there is a need to focus on identifying which frailty measurement 
best predicts which outcome (250). For example, it is not yet known if different 
frailty instruments predict different outcomes in hospitalised older people, with 
outcomes including falls, admission to residential care, mortality and hospital 
readmission. 
 
Importantly, despite the strong link between malnutrition and frailty, frailty 
indices rarely use malnutrition as one of their components. A research focus on 
the clinical implementation of frailty indices that include a nutritional component 
is therefore needed. Moreover, as frailty and malnutrition are both transient 
processes, incorporating multiple time-point analysis should also be a focus of 
future research.  
 
11.7 Clinical Practice Recommendations  
11.7.1 Nutritional Screening  
Without using nutritional screening tools, clinical staff can frequently miss 
idendifying malnourished older patients (124). Therefore, it is highly 
recommended that all patients receive nutritional screening on hospital admission 
(123, 130, 143). Additionally, as older patients are at high risk of weight loss in 
hospital, nutritional screening should be regularly performed (123, 143). Patients 
identified as malnourished or at risk of malnourishment should be referred to an 
appropriate specialist for a full nutritional assessment and an appropriate 
intervention given (126, 127). Nutritional screening is therefore a crucial 
precursor to the Nutrition Care Process (NCP) (128, 129).  
 
A requirement of the majority of NSTs considered in this study was that patient 




inherently difficult. For example many patients were classified as requiring a „two 
person lift assist‟. Compounding the immobility of patients was dementia, 
delerium, incontinence, hearing loss and poor eyesight. Given these difficulties, it 
is recommended that a NST for frail, immobile older people in the hospital setting 
offer an alternative anthropometric measure other than weight.  
 
Results from this thesis show NSTs do predict adverse clinical outcomes in 
hospital patients, however the prognostic ability of these predictions is low.  
 
11.7.2 Frailty Measurement 
Results from this thesis show that frailty operationalisations are predictive of an 
increased likelihood of adverse clinical outcome in hospitalised older people. Two 
frailty indices showed adequate prognostic ability: the FI-CD and the adapted 
Katz score. Of clinical advantage, the FI-CD and adapted Katz score can be 
derived from a Comprehensive Geraitric Assessment, which is routinely perfomed 
for each patient in the GEMU. Moreover, both the FI-CD index and the adapted 
Katz score can be used by clinicans to guide patient management. For example, 
they can be used to advise whether a patient will tolerate surgery or medical 
treatment, or if these interventions will cause harm. The FI-CD does take some 
time to compute, so in the busy hospital setting, the adapted Katz score provides 
an easy and simple alternative measure of frailty. 
 
11.8 Conclusion  
This doctoral thesis highlighted the importance of research into the predictive 
ability and accuracy of both nutritional screening tools and frailty instruments in 
hospitalised older people. This research will be of assistance in the areas of 
gerontology research, clinical practice and public health policy, particularly in the 
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Table 5-2: Nutritional Screening Tools as Predictors of Mortality in Older People in (i) Acute Hospital (ii) Sub-Acute Care (iii) Residential Care (iv) 
Community and (v) Composite Settings 
Author Objective (stated by the authors) n 
µ Age; 
%F 







(i) Acute Hospital     
Chang et al. 
2010 (86) 
Evaluate the outcomes of hospitalised elderly with geriatric 
syndromes and identify the influencing factors in different 
hospitals participating in this project across the country. 









Estimate the prevalence of malnutrition in elderly patients 
hospitalised with an acute illness, as well as to assess the 
clinical usefulness of standardised nutritional assessment 
upon admission by means of the MNA scale. 




et al. 2005 
(88) 
To identify risk factors for development of malnutrition in 
very old hospitalised patients and to evaluate the total MNA 
score and MNA subscores as predictors of in-hospital and 
long-term mortality. 














Evaluate the validity of SGA and MNA in geriatric patients 
against objective nutritional indicators and to assess the 
ability of these techniques to predict mortality. 






To verify, in a sample of elderly subjects admitted to long 
term care, the impact of malnutrition according to the 
MNA, on mortality and on the occurrence of Adverse 
Clinical Events in a 3-12 month follow-up study. 
167 83; 79 Italy MNA,M
NA-P0  
Discharge; 3-
12 mo with µ 
7.5 mo 
M 68.0  6 19 
Van Nes et 
al. 2001 
(99) 
To determine whether the MNA can predict the outcome of 
hospital stay in older individuals 
1319 84; 70 Switzer-
land 










Verify the agreement between the complete and short 
versions of the MNA and to examine in more depth the 
association between the MNA, biological markers and the 
levels of co-morbidities. 
444 85; 74 Sweden MNA Discharge, 1 
yr, 4 yr  
M 26; 
AR 51 
22 1 yr; 51 
4 yr 
24 




To validate our adaption of NRI (ie GNRI) to elderly 
patients...to estimate the prevalence of nutrition-related 
complications in elderly hospitalized patients with the use 
of the GNRI.  




To test the hypothesis that 'MUST' could be undertaken on 
all admissions to elderly care wards. 
150 85; 67 UK MUST Discharge, 3 
mo, 6 mo 
HR 44; 
MR  17 
21 Dis; 30 




et al. 2007 
(113) 
To describe the association between the different 
sociodemographic and medical variables and those 
obtained through geriatric assessment (ie fixed time 
variables) as well as the prognostic impact of functional 
and nutritional variables (ie time-dependent variables), and 
6 mo mortality of a cohort of frail elderly patients aged 
over 75 who were hospitalised for an acute event. 
165 84; 69 Spain MNA 1, 3 & 6 
months 
NR.  11 1 mo, 23 




et al. 2008 
(415) 
Test whether the MUST and BNR scores were able to 
predict mortality and length of stay in a cohort of older 
patients admitted to a specialist Medicine for the Elderly 
hospital. 
115 82; 66 UK BNR,M
UST 
2 yrs+ (not 
standardised) 
MUST: HR 
35, MR 14, 
BNS: HR 





Compare the sensitivity of the MPI and m-MPI in 
stratifying elderly patients into groups at varying risk of 






1, 12 mo NR.  7 1 mo, 15 






To determine if nutritional parameters and discharge setting 
are associated with mortality in older male veterans on a 
Geriatric Rehabilitation Unit. 
77 77; 0 US NSS  2 yr M 42 14 Dis; 39 







(iii) Residential Care     
Sharifi et al. 
2012 (416) 
To develop a practical, easy and non-expensive model for 
predicting mortality in the elderly residents of KCF (charity 
foundation).  
247 77; 59  Iran MNA 39 mo NR 30 20 
Kaiser et al. 
2009 (153) 
To compare the results of two different modes of MNA 
application in nursing homes: resident interviews vs 
assessment by nursing staff 
200 87; 74 Germany MNA, 
MNA-
SF  
6 mo Nurse: M 9. 
AR 54 
Resident M 
15 AR 53  
13 21 
Lok et al. 
2009 (385) 
Provide further validation of the CNS tool by following 
some of the subjects assessed in the original study in terms 
of mortality over a 12 month period....to determine whether 
the CNS cut-off score derived from the first study is able to 
predict 12 month mortality, and to compare the sensitivity 
and specificity of the SGA...among Hong Kong population. 
515 81; 61 China CNS 12 mo M 32 13 18 
Chan et al. 
2010 (386) 
To study the nutritional status of nursing home residents in 
a multi-racial Asian society and its role in predicting short-
term mortality independent of functional status and co-
morbidities. 
154 77; 52 Singa-
pore 
MNA 2 yr M 39 25 24 
 et al. 2008 
(417) 
To test the association 
of this new index (GNRI) with long-term mortality. 
245 84; 79  Italy GNRI 1,2,3 yr SR 6; 
MR 24, 
LR 35 
11 1 yr, 30 
2 yr, 40 3 
yr. 
26 
Tsai & Ku 
2008 (418) 
To determine the effectiveness of a modified Mini-
Nutritional Assessment (MNA) for assessing the nutritional 
status and predicting follow-up mortality of instituitionised 
elderly Taiwanese. 
308 80; 59 Taiwan MNA-
T1 
6, 12 mo M 22; AR 
59; (self 
assess). M 






Investigate ability of the GNRI to assess nutritional status 
and predict the outcome of home-care resident elderly, 
when compared to the MNA. 
241 60; 61 Italy MNA, 
GNRI 










(iv) Community     
Beck et al. 
1999 (419) 
Evaluate the capacity of the „Determine your nutritional 
health‟ checklist (NSI checklist) and „the MNA‟ methods 






5 yr MNA M 
79; AR 
22. NSI 
HR 19; 51 
MR 
24 21 
Beck et al. 
(2001) (420) 
To assess the prevalence of old people at risk of 
undernutrition according to the Mini Nutritional 
Assessment (MNA), characterise the at risk group with 
regard to nutritional state, energy intake, and physical and 
mental functioning, and to assess the consequences of the 
MNA score over a 6 month period. 
61 75; 70 Denmark MNA 6 mo M 0: 
AR 38 
3 18 
Boult et al. 
1999 (172) 
To measure the validity of the DETERMINE checklist as 
a marker for future functional disability, depressive 
symptoms, and mortality among high-risk older adults. 




To evaluate the Nutritional Screening Initiative (NSI) 
checklist as a screening and awareness/educational tool in 
an elderly population. 
581 NR; 
67 





Saletti et al. 
(2005) (422) 
To evaluate nutritional status and long term outcome in 
elderly living at home. 
353 83; 
NR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
Sweden MNA 3 yr M 8; 
AR 41
35 24 
Tsai et al. 
2010 (412) 
Attempted to use this indicator (long term survivability) to 
validate the grading ability of the two modified versions 













et al. 2003 
(421) 
To identify predictors and consequences of nutritional risk 
as determined by the MNA in elderly individuals 
receiving domiciliary care services. 
250 67+; 
69 
Australia MNA 1 yr M 5; 










To evaluate the difference in the nutritional status of 
elderly patients hospitalized in different types of care in the 
same hospital, and to evaluate its relationship with risk 
factors. 
918 83; 67 France MNA Discharge  M 26; 
AR 50 
6 17 
Abbreviations: NST = Nutritional Screening Tool; MNA = Mini Nutritional Assessment; MNA-SF = MNA-Short Form; MNA-td = MNA time dependent; MNA-P0 (MNA - Proportional 
and Objective); MNA-T1 = MNA-Taiwanese version 1, MNA-T2 = MNA-Taiwanese version 2; Malnourished (MNA), AR = At Risk of Malnourishment (MNA); WN = Well Nourished 
(MNA); MUST = Malnutrition Universal Screening Tool; NSI = Nutritional Screening Initiative checklist, GNRI = Geriatric Nutritional Risk Index, HR = High Risk, MR = Moderate Risk; 
LR = Low Risk; NSS= Nutritional Status Score, CNS = Chinese Nutritional Screening Tool, BNR = Birmingham Nutritional Risk, RS = Rapid Screen; ; HR = High Nutritional Risk; MR 
=Moderate Nutritional Risk; LR = Low Nutritional Risk; LOS = Length of Stay; NS = Not significant; Dis=Discharge; NR = Not Reported; BI = Barthel Index; ADL = Activity of Daily 




Table 5-3: Outcomes and Efficacy Values of Nutritional Screening Tools as Predictors of Mortality in Older People in (i) Acute Hospital (ii) Sub-
Acute Care (iii) Residential Care (iv) Community and (v) Composite Settings 
Author Outcome (Results) NST Categories Sens Spec PPV NPV 
(i) Acute Hospital  
Chang et al. 
2010 (86) 
Lower MNA total score associated with mortality: OR (95% CI) = 0.93 (0.88-
0.98), P=0.009 with gender, age, lives alone, LOS, cognition, depression, BI and 
IADL used as covariates. 




Lower Mean (SD) MNA in those who died than those who survived: 20.9(4.8) vs 
14.1 (5.6) respectively (P<0.01). Mortality rates different between: M (7 died), 
AR (4 died) &WN (0 died) (P=0.001). 
MNA (M)  vs (AR+WN)  0.64 0.81 0.18 0.97 




Lower Mean (SD) MNA in those who died than those who survived: 14.9(5.2) vs 
18.5(5.5) respectively (P<0.001)). MNA associated with mortality OR (95% CI) = 
1.64(1.23-2.17), (P=0.001). MNA-3 (nutrition questions from MNA) OR (95% 
CI) = 2.05 (1.08-3.91), P=0.028. AUC (MNA) = 0.744 AUC(MNA-3) = 0.755. 




MNA(M +AR) associated with mortality: OR (95% CI) = 3.3 (1.11-9.79). 
Adjusted for age + CVD presence. 
*** *** *** *** *** 
Donini et al. 
2003 (104) 
Lower mean (SD) MNA score in those who died than those who survived: 10.4 
(4)  vs 15 (4) respectively (P=0.001). Lower mean (SD) MNA-PO in those who 
died than those who survived: 0.39 (0.2) vs 0.55 (0.1) respectively (P=0.002). 
MNA (M)  vs (AR+WN)  0.90 0.34 0.08 0.98 
MNA (M +AR) vs WN 1.00 0.03 0.06 1.00 
MNA-PO (M) vs (AR+WN)  0.90 0.53 0.11 0.99 
MNA-PO (M +AR) vs WN 1.00 0.09 0.07 1.00 
Van Nes et 
al. 2001 
(99) 
Malnutrition associated with higher mortality: M (11.3% died), AR (6.8% died) 
and WN (3.7% died) (P=0.01). 
MNA (M) vs (AR+WN)  0.30 0.82 0.11 0.94 




MNA-SF categories not associated with  mortality at discharge, 1 yr or 4 yr 
follow-up. M (28.32% died), AR (19.4% died) & WN (20.56% died) (P=NS). 
MNA (M) against mortality: HR (95% CI) = 1.19 (9.82-1.71), P=0.355 & MNA 
(AR): 0.96 (0.69-1.32), P=0.786. 
1 yr: M  vs (AR+WN)  0.33 0.77 0.28 0.80 
1 yr: (M +AR) vs WN 0.77 0.24 0.22 0.79 
4 yr: M vs (AR+WN)  0.28 0.77 0.55 0.51 









Mortality risk for major risk (GNRI < 82): OR (95% CI) = 29 (95% CI: 5.2, 
161.4), P<0.001; For moderate risk  (GNRI: 82 to <92): 6.6 (95% CI: 1.3, 33.0), 
P~0.02 and for low risk (GNRI: 92 to < or =98), 5.6 (95% CI: 1.2, 26.6), P~0.02. 
GNRI <82 vs Others 0.29 0.95 0.50 0.88 
GNRI <92 vs Others 0.57 0.72 0.27 0.90 




Mortality at discharge, 3 and 6 months was sig greater for those with medium to 
high risk on the MUST when compared to low risk patients (P<0.01). Discharge: 
M (28.32% died), AR (19.4% died) and WN (20.56% died), P=NS. 
Discharge: HR vs (MR+LR) 0.62 0.69 0.52 0.77 
Discharge: (HR +MR) vs LR 0.85 0.56 0.51 0.87 
3mo: HR vs (MR+LR) 0.79 0.64 0.24 0.95 
3mo: (HR +MR) vs LR 0.84 0.46 0.18 0.95 
6mo: HR vs (MR+LR) 0.63 0.63 0.27 0.89 
6mo: (HR +MR) vs LR 0.70 0.45 0.22 0.87 
Espaulella 
et al. 2007 
(113) 
Low MNA (time dependent) score associated with mortality in multiple 
regression & bivariate analysis. Adjusted HR (95% CI) for MNA (td)  = 
0.87(0.81-0.94) &  0.68(0.81-0.93) for unadjusted HR.  
*** *** *** *** *** 
Henderson 
et al. 2008 
(415) 
MUST category associated with mortality (log rank test, P=0.022) but BNR 
category not (log Rank, P=0.35). HR (95% CI) for MUST (MR) = 1.91(0.95-
3.83); MUST (HR) = 1.98 (1.15-3.52); BNR (MR) = 1.74(1.01-3.01); BNR (HR) 
=1.17(0.68-2.05). All HR adjusted for age & gender, P =NR. 
MUST: HR vs (MR + LR) 0.38 0.74 0.78 0.33 
MUST (HR + MR) vs LR 0.55 0.67 0.80 0.38 
BNR: HRvs (MR + LR) 0.31 0.68 0.67 0.32 
BNR:(HR + MR) vs LR 0.64 0.46 0.71 0.38 
Sancarlo et 
al. 2011(90) 
MNA 1 month mortality OR (1.15, 1.13-1.17) P <0.001 ; MNA 12 month OR 
1.14(1.13-1.15); MNA-SF 1 month mortality (1.26, 1.23-1.30) and 12 month 
MNA-SF OR = 1.35 (1.22-1.27). All P's < 0.001.  




Low NSS associated with mortality at 2 years (P=0.03) in univarite but not in 
multivariate analysis (actual numerical results not shown but revealed in Kapler-
Meier Curves).  





(iii) Residential Care  
Sharifi et al. 
2012 (416) 
Mean MNA score lower in those who died vs those who survived (22.0 vs 
23.1 respectively). For MNA total score against mortality, HR (95% CI) = 
1.74 (1.19-2.54) unadjusted and 1.72 (1.15-2.57) adjusted, both P's <0.05. 
For MNA (M), HR (95% CI) = 0.59(0.47-0.74) unadjusted and 0.62 (0.49-
0.78) adjusted, both P's NS. For MNA (AR), HR (95% CI) = 2.18 (1.32-
3.60) unadjusted and 1.92 (1.15 -3.18) adjusted, both P's <0.05.  
*** *** *** *** *** 
Kaiser et al. 
2009 (153) 
Malnutrition associated with higher mortality: For nursing-staff assessed 
MNA, M (33.3% died), AR (9.3% died), WN (3.9% died). For resident-
assessed MNA, M (19.0% died), AR (12.3%), WN (0% died), (P<0.05). 
Nurse Assessed:M vs (AR+WN)  0.08 0.91 0.06 0.93 
Nurse Assessed: (M + AR) vs WN 0.77 0.38 0.08 0.96 
Resident: M  vs (AR+WN)  0.10 0.95 0.14 0.92 
Resident:  (M+AR) vs WN 1.00 0.39 0.13 1.00 
Lok et al. 
2009 (385) 
Malnourishment classification by CNS showed higher mortality rate. 
Logistical regression: CNS score associated with mortality (P<0.001). 
Specific regression results not reported, but 
sensitivity/specificity/PPV/NPV values were. 
Mortality at 12 mo. Sens/Spec reported in 
study.  
0.61 0.73 0.26 0.92 
Chan et al. 
2010 (386) 
MNA (M) associated with mortality (OR 3.03, 95% CI = 1.43-6.41), P=0.004 but not after 
adjusting for age, gender, BI, co-morbidity (OR 2.35 (0.83-6.60), P=0.106. MNA-SF <12 
not associated with mortality (OR 1.02, 95% CI = 0.10-10.1), P=0.988 




Severe Risk (GNRI <82) associated with mortality OR (95% CI) of 5.29 
(1.53-19.57, P=0.0127) when compared with GNRI „no risk‟ (GNRI >9.8). 
Cox regression also found HR (95% CI) = 2.76 (1.89-4.03), P=0.0072 (etc). 
1yr mortality GNRI < 82 0.14 0.95 0.29 0.90 
2 yr mortality GNRI < 82 0.10 0.96 0.50 0.71 
3 yr mortality GNRI < 82 0.10 0.97 0.71 0.61 
1yr mortality GNRI < 92 0.46 0.66 0.15 0.91 
2 yr mortality GNRI < 92 0.47 0.70 0.40 0.75 
3 yr mortality GNRI < 92 0.45 0.72 0.52 0.66 
1yr mortality GNRI < 98 0.68 0.28 0.11 0.87 
2 yr mortality GNRI < 98 0.78 0.31 0.33 0.77 





Tsai & Ku 
2008 (418) 
MNA (M) (caregiver assessed) associated with higher 6 & 12 mo mortality 
than MNA (AR), P<0.01 & MNA (M), P<0.05, (survival curves). MNA 
(self assessed by cognition normal older people) not associated with 
mortality. No difference between nutritional groups regarding mortality, 
regardless of caregiver or patient assessed or patient cognition.  
3 mo: MNA M vs (AR + WN) - self 
assessed, normal cognition 
0.33 0.79 0.05 0.97 
3 mo: MNA IN vs WN - self assessed, 
normal cognition 





MNA (M) associated with mortality (OR, 95% CI) = 38.1, 2.0-607.11, P 
<0.002. MNA(AR) not associated with mortality (OR, 95% CI) = 6.3 (0.3-
2320), P = NS. GNRI < 92 associated with mortality (OR, 95% CI) = 30.5 
(1.7-941), P<0.001. 
*** *** *** *** *** 
(iv) Community  
Beck et al. 
1999 (419) 
MNA (AR) associated with higher mortality (49% died) than MNA(WN) 
(17% died), P<0.01 (t-test), RR (95% CI) = 0.35 (0.18-0.66), P<0.01. NSI 
not associated with mortality: RR (95% CI) = 1.45, 0.78-2.71), P=NS. 
Mortality rates did not significantly differ between NSI categories: HR 
(36% died) vs LR/MR (23% died), P=NS.  
MNA: AR vs WN (none were WN) 0.44 0.86 0.49 0.84 
NSI Checklist: HR vs LT/MR 0.27 0.83 0.36 0.77 
Beck et al. 
2001 (420) 
MNA (AR) not significantly associated with higher mortality (3.3%) than 
MNA(WN) (0%), P=NS.  
MNA: AR vs WN  1.00 0.64 0.09 1.00 
Boult et al. 
1999 (172) 
NSI high nutritional risk not associated with higher mortality (2.8% died) 
than low nutritional risk (4.4% died), P = 0.30.  




NSI score not significantly associated with higher mortality: RR (95% CI) 
= 1.10 (1.04-1.17), P = 0.05-0.10.  




MNA categories associated with mortality: OR (95% CI) = 1.89(1.18-
3.01),P=0.007. MNA class associated with mortality: (50% died), AR (40% 
died), WN (27% died), P<0.05. 
MNA (M)  vs (AR+WN)  0.11 0.94 0.50 0.67 
MNA (M +AR) vs WN 0.32 0.56 0.33 0.55 
Tsai et al. 
2010 (412) 
MNA (M) and MNA (AR) associated with higher mortality risk (all P's 
<0.001). HR (95% CI) values against mortality: MNA (M) = 6.59 (4.94-
8.79), MNA (AR) = 2.39 (1.99-2.88), MNA-T1(M) = 6.40(4.63-8.85), 
MNA-T1(AR) = 2.55(2.11-3.08), MNA-T2(M) = 6.79(4.83-9.53), MNA-
T2(AR)=2.66(2.20-3.21). 
1 yr: MNA (M) vs (AR + WN)  0.19 0.98 0.37 0.95 
1 yr:MNA (M+AR) vs WN  0.56 0.81 0.15 0.97 
1 yr: MNA-T1 M vs (AR + WN)  0.17 0.99 0.46 0.95 





1 yr:MNA-T2 M vs (AR + WN)  0.12 0.99 0.39 0.95 
1 yr: MNA-T2 (M+AR) vs WN  0.49 0.87 0.18 0.97 
4 yr: MNA M vs (AR + WN)  0.10 0.99 0.71 0.81 
4 yr: MNA (M+AR) vs WN  0.42 0.85 0.42 0.85 
4 yr: MNA-T4 M vs (AR+WN)  0.07 0.99 0.74 0.80 
4 yr: MNA-T4 (M+AR) vs WN  0.35 0.89 0.46 0.84 
4 yr:MNA-T2 M vs (AR + WN)  0.07 1.00 0.80 0.80 
4 yr: MNA-T2 (M+AR) vs WN  0.35 0.90 0.48 0.84 
Visvanthan 
et al. 2003 
(421) 
MNA(AR+M) not associated with mortality. Unadjusted RR (95% CI) = 
1.11(0.48-2.58), P=0.8096; Adjusted RR (95% CI) = 1.02 (0.44-2.38) 
MNA (AR + M) vs (WN) 0.45 0.57 0.08 0.92 




Lower Mean (SD) MNA in those who died than those who survived: 
20.1(0.1) vs 11.8(0.9) respectively for combined mortality (sub-acute + 
acute care), P = sig. but NR. MNA class associated with mortality: M 
(16.1% died), AR (2.5% died) & WN (0% died), P= sig. but NR. MNA 
nutritional status highly correlated with mortality in sub-acute/acute care 
(P<0.0001) - correlation statistic NR. 
MNA (M) vs (AR + WN) 0.79 0.75 0.16 0.98 
MNA (M + AR) vs (WN) 1.00 0.24 0.07 1.00 
Abbreviations: NST = Nutritional Screening Tool; MNA = Mini Nutritional Assessment; MNA-SF = MNA-Short Form; MNA-td = MNA time dependent; MNA-P0 
(MNA - Proportional and Objective); MNA-T1 = MNA-Taiwanese version 1, MNA-T2 = MNA-Taiwanese version 2; Malnourished (MNA), AR = At Risk of 
Malnourishment (MNA); WN = Well Nourished (MNA); MUST = Malnutrition Universal Screening Tool; NSI = Nutritional Screening Initiative checklist, GNRI = 
Geriatric Nutritional Risk Index, HR = High Risk, MR = Moderate Risk; LR = Low Risk; NSS= Nutritional Status Score, CNS = Chinese Nutritional Screening Tool, BNR 
= Birmingham Nutritional Risk, RS = Rapid Screen; ; HR = High Nutritional Risk; MR =Moderate Nutritional Risk; LR = Low Nutritional Risk; LOS = Length of Stay; 
NS = Not significant; Dis=Discharge; NR = Not Reported; BI = Barthel Index; ADL = Activity of Daily Living; IADL = Instrumental Activity of Daily Living; CVD = 









Table 5-4: Nutritional Screening Tools as Predictors of Functional Decline in Older People in (i) Acute Hospital (ii) Sub-Acute Care and (iii) 
Community 
Author Objective (stated by the authors) n µ Age; 
% F 












Evaluate the outcomes of hospitalised 
elderly with geriatric syndromes and 
identify the influencing factors in different 
hospitals participating in this project across 
the country. 













Salvi et al. 
(2008) 
(98) 
This study aimed at evaluating whether 
MNA-SF alone or integrated with albumin 
is a valid screening tool for (protein-
energy) malnutrition and a reliable 
predictor of functional decline in older 
patients admitted to an acute medical ward. 




ADL (BI) Discharge M 46 15 24 
(ii) Sub-Acute Care 
         
Chen et al. 
(2008) 
(112) 
To describe functional trajectory during 
and 6 months post-hospitalisation and to 
ascertain the predictors that signal different 
classes of functional trajectory, using latent 
class analysis. 










74; 6 mo 32 
22 
Chen et al. 
(2010) 
(111) 
Investigate potential prognostic factors for 
functional improvement in a GEMU. 








To describe the association between the 
different sociodemographic and medical 
variables and those obtained through 
geriatric assessment (ie fixed time 
variables) as well as the prognostic impact 
of functional and nutritional variables (ie 
time-dependent variables), and 6 mo 
mortality of a cohort of frail elderly 
patients aged over 75 who were 
hospitalised for an acute event. 







1, 3 & 6 
months 




To assess the nutritional status and 




ADL (BI) 90 days 




Beck et al. 
(1999) 
(419) 
Evaluate the capacity of the „Determine your 
nutritional health‟ checklist (NSI checklist) 
and „the MNA‟ methods to predict nutrition-








Need of Help (ie 










Beck et al. 
(2001) 
(420) 
To assess the prevalence of old people at risk 
of undernutrition according to the Mini 
Nutritional Assessment (MNA), characterise 
the at risk group with regard to nutritional 
state, energy intake, and physical and mental 
functioning, and to assess the consequences 
of the MNA score over a 6 month period. 
61 75; 70 Denmark MNA 
Start of home 
care, MOW 
6 months 






To measure the validity of the DETERMINE 
checklist as a marker for future functional 
disability, depressive symptoms, and 
mortality among high-risk older adults. 
251 79; 45 US NSI PDF:SIP 
12 
months 









Examine the functional status-predictive 
ability of the MNA in a large population-





















Determine predictors of death or functional 
decline in basic ADL in this group of oldest 











Determine predictors of functional decline in 
nonagenarians' basic ADL after 1 year 
follow-up. 72 93; 74 Spain MNA-SF ADL (BI) 
12 
months 
NR 40 22 
Abbreviations: NST = Nutritional Screening Tool; MNA = Mini Nutritional Assessment; MNA-SF = MNA-Short Form; MNA-td = MNA time dependent; MNA-P0 
(MNA - Proportional and Objective); MNA-T1 = MNA-Taiwanese version 1, MNA-T2 = MNA-Taiwanese version 2; Malnourished (MNA), AR = At Risk of 
Malnourishment (MNA); WN = Well Nourished (MNA); MUST = Malnutrition Universal Screening Tool; NSI = Nutritional Screening Initiative checklist, GNRI = 
Geriatric Nutritional Risk Index, HR = High Risk, MR = Moderate Risk; LR = Low Risk; HR = High Nutritional Risk; MR =Moderate Nutritional Risk; LR = Low 
Nutritional Risk; PDF:SIP – Physical Functioning dimension of the sickness impact profile; LOS = Length of Stay; NS = Not significant; Dis=Discharge; NR = Not 






Table 5-5: Outcome and Efficacy Values of Nutritional Screening Tools as Predictors of Functional Decline in Older People in (i) Acute Hospital (ii) Sub-Acute 
Care and (iii) Community 
Author Outcome (Results) Outcome Sens Spec PPV NPV 
(i) Acute Hospital      
Chang et al. 
(2010) (86) 
Lower MNA total score associated with ADL decline, OR (95%CI) =0.94 (0.89-0.99), P=0.01, 
but not IADL decline OR (95% CI) =1.00 (0.95-1.05) P = 0.98. Adjusted for baseline BI & 
IADL, gender, age, lives alone, LOS, cognition, depression. 
ADL (BI), IADL 
(L &B) 
*** *** *** *** 
Salvi et al. 
(2008) (98) 
MNA-SF (M + AR) associated with BI Decline. OR (95% CI) = 4.25 (1.83-99), P=0.001. MNA-
SF (M +AR), with albumin: OR (95% CI) = 16.19 (4.68-56.03), P<0.001. Analyses adjusted for 
age, gender, co-morbidity, emergency dept. provenance. 
ADL (BI)  *** *** *** *** 
(ii) Sub-Acute Care 
Chen et al. 
(2008) (112) 
MNA associated with BI decline. Controlled for LOS, gender, surgical diagnosis. OR (95% CI) = 
1.68 (1.33-2.13), P<0.005 for good vs poor BI & 1.04 (0.92-1.18) P<0.05 good vs moderate BI. 
Controlled for LOS, gender, surgical diagnosis. 
ADL (BI)  *** *** *** *** 
Chen et al. 
(2010) (111) 
No sig. difference between total MNA score in functional recovery (FR) group (MNA 
mean(SD)=20.2(4.2)) and no FR group (MNA mean (SD) = 21.2(6.0), P>0.10 (t-test). 




MNA(time dependent) associated with BI decline. Adjusted HR (95% CI) for MNA(td) = 
0.87(0.81-0.94), & 0.68(0.81-0.93) for unadjusted HR. Both P's <0.05. 




MNA-SF(M + AR) & MNA(M +AR ) associated with BI decline (ANCOVAS controlling for 
baseline ADL & QOL): mean (SD) MNA-SF =86(18) vs MNA-SF(WN) = 97.7(7), P=0.001 
MNA(IN) = 85(19) vs MNA(WN) =96(7), P=0.002. 
ADL (BI)  *** *** *** *** 
(iii) Community 
Beck et al. 
(1999)(419) 
Significant association: AR 15% needed help vs 6% WN,  P < 0.05 (t-test). Need of Help *** *** *** *** 
Beck et al. 
(2001)(420) 
Non significant association: MNA (AR ) non-significantly used more home care than those well 
nourished (27% 18% respectively), P=NS. 





Boult et al. 
1999 (172) 
NSI score correlated with 12 month disability (r=0.41, P<0.01), but not associated  after 
controlling for baseline disability, depressive symptoms and health: AOR (95% CI)=1.00 (0.35-
2.87), P = NR. 
HR vs LR 0.69 0.59 0.13 0.94 
Lee & Tsai 
(2011) (413) 
MNA-T2 associated with  decline: Excluding people dependent at baseline: OR (95% CI) = 1.07 
(1.02-1.13), P=0.009 ADL decline & 1.13 (1.08-1.19), P<0.001 IADL decline. MNA-T2-SF also 
associated with decline: 1.08 (1.00-1.17), P=0.046 ADL decline & 1.20 (1.12-1.29), P<0.001 for 
IADL decline. Controlled for sex, age, education, living status, CVD.  
ADL: M vs 
(AR+WN) using 
MNA-SF-T2 
0.02 0.99 0.14 0.91 
ADL: (M + AR) 
vs WN (MNA-T2 
0.26 0.90 0.20 0.93 
IADL: M vs 
(AR+WN)  
0.02 1.00 0.81 0.67 
Ferrer et al. 
(2008) (425) 
MNA-SF associated with more decline (BI decline or death): mean (SD) =10.5 (2.5) for those 
with decline vs 12(2) for those without decline, P=0.0001 (t-test). MNA-SF not significant in 




*** *** *** *** 
Formiga et al. 
(2007) (426) 
MNA-SF scores did not sig.  differ between those with BI loss > 9 points & those with BI loss < 
10 points; mean (SD) of 12.0 (1.8) vs 12.4 (1.1) respectively, P=0.23.  
ADL (BI) *** *** *** *** 
Abbreviations: NST = Nutritional Screening Tool; MNA = Mini Nutritional Assessment; MNA-SF = MNA-Short Form; MNA-T1 = MNA-Taiwanese version 1, MNA-
T2 = MNA-Taiwanese version 2; Malnourished (MNA), AR = At Risk of Malnourishment (MNA); WN = Well Nourished (MNA); MUST = Malnutrition Universal 
Screening Tool; NSI = Nutritional Screening Initiative checklist, GNRI = Geriatric; HR = High Risk, MR = Moderate Risk; LR = Low Risk; HR = High Nutritional Risk; 
MR =Moderate Nutritional Risk; LR = Low Nutritional Risk; PDF:SIP – Physical Functioning dimension of the sickness impact profile; LOS = Length of Stay; NS = Not 
significant; Dis=Discharge; NR = Not Reported; BI = Barthel Index; ADL = Activity of Daily Living; IADL = Instrumental Activity of Daily Living; RR = Relative Risk 





Table 5-6: Nutritional Screening Tools as Predictors of Move to Higher Level Care in (i) Acute Hospital (ii) Sub-Acute Care and (ii) Community 


















Estimate the prevalence of malnutrition in 
elderly patients hospitalised with an acute 
illness, as well as to assess the clinical 
usefulness of standardised nutritional 
assessment upon admission by means of the 
MNA scale. 
175 80; 65 Belgium MNA 
Destination other 






Van Nes et 
al. 2001 
(99) 
To determine whether the MNA can predict 
the outcome of hospital stay in older 
individuals. 




(ii) Sub-Acute Care 
     
Visvanathan 
et al. 2004 
(174) 
To determine the prevalence of under-
nutrition using brief screening methods and 
to determine the relation between these 
results and (1) those of a more standard 



















To test the hypothesis that 'MUST' could be 
undertaken on all admissions to elderly care 
wards... 















To assess the nutritional status and 
outcomes of older adults in rehabilitation 





higher level care 
Discharge













To assess the effect of nutritional status on 
the risk of institutional placement in an 
elderly population of 318 patients with 
Alzheimer's disease 











et al. 2003 
(421) 
To identify predictors and consequences of 
nutritional risk as determined by the MNA 







change in living 




M 5 AR 
38 
34 24 
Abbreviations: NST = Nutritional Screening Tool; MNA = Mini Nutritional Assessment; MNA-SF = MNA-Short Form; Malnourished (MNA), AR = At Risk of 
Malnourishment (MNA); WN = Well Nourished (MNA); MUST = Malnutrition Universal Screening Tool; HR = High Risk, MR = Moderate Risk; LR = Low Risk; RS= 
Rapid Screen; HR = High Nutritional Risk; MR =Moderate Nutritional Risk; LR = Low Nutritional LOS = Length of Stay; NS = Not significant; Dis=Discharge; NR = 




Table 5-7: Outcomes and Efficacy Values of Nutritional Screening Tools as Predictors of Move to Higher Level Care in Older People in (i) Acute Hospital (ii) 
Sub-Acute Care and (ii) Community 
Author Outcome (Results) Outcome Sens Spec PPV NPV 
(i) Acute Hospital   
Gazotti et al. 
2000 (87) 
No association with destination: MNA mean (SD): 20.3(4.9) vs 21.7 (4.6) for those 
transferred home vs other destination: respectively, P=0.089. 
NH: M vs (AR+WN) 0.21 0.83 0.55 0.53 
NH: (M + AR) vs WN  0.76 0.39 0.54 0.63 
Van Nes et al. 
2001 (99) 
For patients living at home at baseline: M (20.3% NH admission),  AR (18.3% NH 
admission), WN (7.7% NH admission), P<0.001. 
NH: M vs (AR+WN)  0.22 0.83 0.20 0.85 
NH: (M + AR) vs WN  0.89 0.22 0.16 0.92 
(ii) Sub-Acute Care   
Visvanathan et 
al. 2004 (174) 
MNA (AR) associated with poor discharge outcome: MNA (AR) (50% poor 
outcome) vs MNA (WN) (21.6% poor outcome), P=0.017. RS categories  
associated with poor discharge outcome, P=0.004. 
NH: (M + AR) vs WN 
using MNA 
0.75 0.25 0.12 0.88 
NH: (M + AR) vs WN using 
RS 
0.63 0.68 0.22 0.93 
Stratton et al. 
2006 (91) 
MUST category not associated with destination (51% of M returned home vs 40% 
of WN returned home, P=NS. 
Did not return home *** *** *** *** 
Neumann et al. 
2005 (96) 
Increased likelihood of NH admission with MNA-SF (IN) OR (95%) CI = 2.22 
(1.02-4.82) & MNA (IN) = 2.29(1.09-4.80), P < 0.05. 
Higher Level Care *** *** *** *** 
(iii) Community   
Andrieu et al. 
2001(428) 
MNA < 25.2 (median score) associated with NH admission. Age/gender adjusted 
OR (95% CI) = 2.3 (1,07-5.00), P=0.03. Age-adjusted OR (95% CI) = 2.19 (1.00-
4.77), P=0.049. 
NH: MNA<25.2 vs MNA 
25.2 
0.71 0.46 0.21 0.88 
Visvanthan et 
al. 2003 (421) 
MNA (AR+M) not associated with NH admission. MNA (AR +M) = 12.9% to NH; 
MNA (WN) = 7.9% to NH. Unadjusted RR (95% CI) = 1.64 (0.74-3.63), 
P=0.2236; Adjusted RR (95% CI) = 1.32 (0.59-2.95), P=0.493. 
Increased Care: (M + AR) 
vs WN 
0.55 0.58 0.11 0.93 
Abbreviations: NST = Nutritional Screening Tool; MNA = Mini Nutritional Assessment; MNA-SF = MNA-Short Form; Malnourished (MNA), AR = At Risk of Malnourishment (MNA); 
WN = Well Nourished (MNA); MUST = Malnutrition Universal Screening Tool; HR = High Risk, MR = Moderate Risk; LR = Low Risk; RS= Rapid Screen; HR = High Nutritional Risk; 
MR =Moderate Nutritional Risk; LR = Low Nutritional LOS = Length of Stay; NS = Not significant; Dis=Discharge; NR = Not Reported; HC = Higher Level Care; RR = Relative Risk or 




















University of Adelaide, Adelaide, South Australia,   
2
Royal Adelaide Hospital, Adelaide, South Australia 
3
The Queen Elizabeth Hospital, Adelaide, South Australia 
 
Objectives: To identify factors associated with frailty in hospitalised older 
persons and study the discharge outcomes of this condition.  
Methods: Consecutive patients admitted to the Geriatric Evaluation and 
Management Unit (GEMU) at The Queen Elizabeth Hospital (TQEH), South 
Australia were recruited. Data collected included health and lifestyle factors, 
nutritional factors, clinical details, socio-demographic data and biomarkers. 
Frailty was identified on admission using Fried‟s frailty criteria. Logistic 
regression analyses were performed to determine factors associated with frailty 
adjusting for age and gender. Frailty was assessed against GEMU length of stay 
(LOS) and admission to a nursing home using logistic regression, adjusting for 
age, gender, cognition and co-morbidity.  
Results: 172 patients (age 85.2 ± 6.4 years, 71.5% female) were included. The 
prevalence of frailty was 56% and was greater in women (60 %) than in men (45 
%). 22 patients (13 %) were discharged to a nursing home. Median LOS was 12 
days. Factors associated with frailty were: malnutrition assessed by the Mini-
Nutritional Assessment (OR (95% CI) = 9.90 (3.62-27.08), P<0.001), dependency 
in Instrumental Activities of Daily Living (IADL) assessed by Lawton and 
Brody‟s scale (OR (95% CI) = 0.78 (0.67-0.90), P<0.001) and number of 
medications (OR (95% CI) = 1.13 (1.02-1.24) P = 0.13). Frail patients were more 
likely to be discharged to a nursing home (OR (95% CI) = 3.36 (1.01-10.48), 
P=0.037) and to have a long LOS (> median LOS) (OR (95% CI) = 2.04 (1.05-
3.96, P=0.036). 
Conclusions: In older hospitalised persons, frailty on admission was related to 
malnutrition, pre-admission dependency in IADLs and number of medications. 
Frail patients were more likely to be admitted into a nursing home and to have a 
long LOS. Results suggest that systematic screening for frailty should be carried 















Abstract 2: Nutritional Status at Admission Predicts Functional Outcomes in 
Older South Australians Admitted to a Higher Acuity Geriatric Evaluation 












1 Department of Medicine, The University of Adelaide, Adelaide, South Australia 
2 Aged and Extended Care Services, The Queen Elizabeth Hospital, Adelaide, 
South Australia 
3 Department of Medicine, Royal Adelaide Hospital, Adelaide, South Australia 
 
Aims: To examine the usage of nutritional screening tools as predictors of 
discharge clinical outcomes in older persons admitted to a higher acuity Geriatric 
Evaluation and Management Unit (GEMU).  
 
Methods: Consecutive patients aged  70 years admitted to the GEMU at the 
Queen Elizabeth Hospital, South Australia were included in this longitudinal 
study. Nutritional status was determined using Body Mass Index (BMI), the Mini-
Nutritional Assessment (MNA) and the MNA-short form (MNA-SF). Multivariate 
logistic and multiple linear analyses were performed to measure the association 
between nutritional status and discharge outcomes including length of stay (LOS), 
discharge destination, body weight and functional decline (defined as an increased 
dependency in a modified Katz Activities of Daily Living (ADL) score). Analyses 
were performed both unadjusted and adjusted for confounding variables. 
 
Results: 150 patients were examined; mean age (SD) of 85.3(6.3) years; 75.0% 
female. Undernutrition prevalence was: 33.3% (BMI <22.0 kg/m
2
), 31.4% (MNA 
< 17), 44.2% (MNA-SF < 8), Multiple regressions showed both BMI (p=0.026) 
and MNA (p=0.026) were associated with functional decline after controlling for 
baseline ADL, but only MNA showed an association after controlling for 
confounders (p=0.035). No other associations between nutritional status and 
clinical outcomes existed. 
 
Conclusions The MNA was the best nutritional screening tool in this study for 
identifying patients at risk of functional decline during hospitalisation. 
Identification of such patients can guide comprehensive geriatric assessment, 
which in turn, can guide patient management.  Importantly, using one screening 






Abstract 3: Frailty and Functional Decline Indices as Predictors of Poor 
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Introduction: Admission to a Geriatric Evaluation and Management Unit 
(GEMU) can optimise a patient‟s chance of functional recovery. The aim of this 
study was to evaluate several common frailty and functional decline indices on 
their ability to predict poor GEMU outcomes, both at discharge and at six months. 
Methods: This was a prospective observational study of consecutive patients aged 
70+ years admitted to the GEMU at the Queen Elizabeth Hospital, Adelaide, 
Australia. Patients were classified as „frail‟ or „at high risk of functional decline‟ 
using several different frailty and functional decline indices. The predictive ability 
of indices was evaluated using logistic regression and area under Receiver 
Operating Characteristic curves (auROC). A poor outcome was considered as 
mortality or residential care admission. 
Results: 172 patients (mean age 85.2 years; 72% female) were included. Frailty 
prevalence varied from 24 - 94 % depending on the index used. Several 
instruments were predictive of poor outcome at both discharge and 6 months. 
Adequate predictive accuracy for discharge outcome was achieved by the FI-CD 
(auROC = 0.735, P < 0.001) and modified Katz score (auROC = 0.704, P = < 
0.001). The FI-CD was the only index to show discriminatory power in predicting 
poor six month outcome (auROC = 0.702, P < 0.001). 
Conclusion: Frailty and functional decline instruments are a feasible application 
for identifying GEMU patients at risk of poor discharge and six month outcomes. 
The FI-CD is best predictor overall, and is recommended for research purposes. 
Pragmatically, the modified Katz index is the most valuable predictive instrument. 
Keywords: Frail Elderly; Geriatric Assessment/Methods; Patient Care Planning; 






Abstract 4: Evaluation of Frailty Indices for the Prediction of Adverse Post-
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Background: Following hospital discharge, older people are at an increased risk 
of adverse clinical outcomes. We examined the predictive ability of five frailty 
indices in identifying patients with increased risk of mortality, emergency 
rehospitalisation and rehospitalisation due to falls. 
Methods: In this prospective study of consecutive patients admitted to a Geriatric 
Evaluation and Management Unit, we identified frailty using Fried's Index, Study 
of Osteoporotic Fractures (SOF) Index, Frailty Index of Cumulative Deficits (FI-
CD), Multidimensional Prognostic Index (MPI), Score Hospitalier d‟Evaluation 
du Risque de Perte d‟Autonomie (SHERPA) and Katz index of Activities of Daily 
Living (ADL). Logistic regression and area under curve (AUC) of Receiver 
Operating Characteristic (ROC) curves were analysed, adjusting for age and 
gender.  
Results: 172 patients (mean (SD) age of 85.2 (6.4) years; 72% female) were 
included. During 6 month follow-up, 28 (16 %) patients died, 92 (53 %) were re-
hospitalised for emergencies and 43 (25 %) were re-hospitalised for falls. Frailty 
identified by all instruments, excluding the MPI, was associated with mortality 
(odds ratio (OR) values all > 2.50, P < 0.005). Frail patients had a high risk of 
emergency rehospitalisation, when identified by Fried‟s Index (OR = 2.47, P = 
0.010) and SHERPA (OR = 1.97, P = 0.038). No indices associated with 
rehospitalisation due to falls. AUC results showed FI-CD had the highest 
discriminatory power for mortality (AUC= 0.803), followed by SHERPA (AUC = 
0.792) and Katz Index (AUC = 0.757). All other AUC values lacked adequate 
discriminative power for outcome prediction (AUC values < 0.7).  
Conclusion: Frailty instruments are a feasible way to identify older patients with 
an increased likelihood of mortality and rehospitalisation, although not 
rehospitalisation due to falls. The FI-CD and the simpler to use SHERPA and 
Katz indices are recommended for prediction of mortality. Our findings can guide 
patient care and discharge planning. 




Abstract 5: Evaluation of Frailty Conceptualisations for the Prediction of Adverse 
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Rationale: During and after hospitalisation, older people are at an increased risk of 
adverse clinical outcomes. We examined the predictive ability of five frailty indices in 
identifying patients with increased risk of: long length of hospital stay (LOS), discharge 
to residential care (RC), 6 month emergency rehospitalisation and mortality.  
 
Methods: In this prospective study of consecutive patients admitted to a Geriatric 
Evaluation and Management Unit (GEMU), we identified frailty using Fried's Index, 
Study of Osteoporotic Fractures (SOF) Index, Frailty Index of Cumulative Deficits (FI-
CD), Multidimensional Prognostic Index (MPI) and Katz score. Logistic regression and 
area under curve (AUC) of Recevier Operating Characteristic (ROC) curves were 
analysed, adjusting for age and gender. 
  
Results: 172 patients (mean age 85 years; 72% female) were included. Median LOS 
was 12 days. On discharge, 27 (16 %) patients were admitted to RC. During follow-up, 
28 (16 %) patients died and 92 (53 %) were hospitalised for emergencies. Frailty 
identified by all instruments, excluding the MPI, was associated with mortality (odds 
ratio values all > 2.50). AUC results showed the FI-CD had the highest discriminatory 
power for mortality (AUC= 0.803) and RC admission (AUC= 0.712), followed by the 
Katz index (AUC for mortality and RC admission = 0.757 and 0.693 respectively).  
 
Conclusion: The FI-CD and the simpler to use Katz index are recommended for 
prediction of adverse outcomes in older hospitalised persons, particularly mortality. Our 
findings can guide patient care and discharge planning. 
Lay Description 
During and after hospital discharge, many older patients experience poor health 
outcomes, such as a long hospital stay, a need for long term care, a return to hospital 
and death. Our study looked to see if we could predict which patients were more likely 
to encounter these poor outcomes. To do this, we investigated 5 different types of frailty 
tests. We studied 172 older patients and found those we identified as frail (in all but one 
of the frailty tests) were more than twice as likely to die in the 6 months following 
hospital than a patient who was not frail. Knowing which patients are frail can assist 
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Background: Malnutrition is common in older people and can influence hospital 
outcomes.  
Aims: To examine the use of nutritional screening tools (NSTs) as predictors of 
discharge clinical outcomes in older people admitted to a higher acuity Geriatric 
Evaluation and Management Unit.  
Methods: Consecutive patients aged  70 years admitted to the GEMU at the Queen 
Elizabeth Hospital, South Australia were included in this longitudinal study. Nutritional 
status was determined using the Mini-Nutritional Assessment (MNA), MNA-short form 
(MNA-SF), Malnutrition Universal Screening Tool (MUST) and the Geriatric 
Nutritional Risk Index (GNRI). Regression analyses were performed to measure the 
association between nutritional status and discharge outcomes including length of stay 
(LOS), functional decline (defined as a decrease in Barthel Index (BI) score for 
Activities of Daily Living (ADL)), and discharge to a higher level of care. All analyses 
were adjusted for confounding variables.  
Results: 172 patients were examined with a mean age (SD) of 85.2 (6.4) years; 71.5% 
female. Malnutrition according to the MNA, MNA-SF and GNRI occurred in 53(31 %), 
77(45 %) and 83(48 %) of patients respectively. For the MUST, all patients were 
classified as malnourished. NSTs associating with LOS (> than the median of 12 days) 
were the MNA (OR: 1.09; 95% CI 1.01-1.18; P=0.031) and the MNA-SF (OR 1.19; 
95% CI 1.04-1.35; P = 0.012). The MNA was also associated with discharge to higher 
level care (OR: 0.93; 95% CI 0.86-0.99; P=0.044). No other associations between 
nutritional status and clinical outcomes existed.  
Conclusion: The MNA and MNA-SF were the best NSTs in this study for identifying 
patients at risk of higher length of stay.  Identification of such patients can guide 
comprehensive geriatric assessment, which in turn, can guide patient management.  
Importantly, using one screening tool to detect both undernutrition and risk of adverse 













Abstract 7: The Mini Nutritional Assessment as a Predictor of Fried’s Frailty 
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Malnutrition and frailty are common problems in older people and are both 
associated with increased mortality and morbidity. This study aimed to: (1) 
determine the prevalence of malnourishment and frailty in the hospitalised older 
people and (2) evaluate both the Mini-Nutritional Assessment (MNA) screening 
tool and the MNA short form (MNA-SF) as predictors of frailty. Setting and 
Participants: 100 patients (75.0% female) admitted to the Geriatric Evaluation and 
Management Unit at The Queen Elizabeth Hospital. Measurements: Frailty was 
identified by Fried‟s frailty criteria and nutritional status by the MNA and MNA-
SF. Optimal cut-off scores to identify frailty were determined by Youden Index, 
Receiver Operating Characteristic Curves and area under curve (AUC). Results: 
40.0% of patients were malnourished and 66.0% were frail. The MNA identified 
frailty with specificity and sensitivity values of 91.2% and 51.6% respectively 
using the standard malnourishment cut-off (<17) and with specificity and 
sensitivity values of 91.2% and 59.1% with the optimal cut-off (<17.5). The 
MNA-SF predicted frailty with specificity and sensitivity values of 79.4% and 
63.6% respectively with its standard cut-off (<8), and with values of 76.5% and 
80.3% respectively with its optimal cut-off (<9). The optimal score for the MNA-
SF was better in identifying frailty than the optimal MNA score (Youden Index 
0.568 vs. 0.503). Conclusion: The MNA-SF can be used to screen both 
malnourishment and frailty in hospitalised older people. Further studies would 
show whether it also identifies frailty in other older populations. 
 
Lay Description (100 words) 
Malnutrition and frailty are both common, yet often undetected problems in older 
people. Identifying people with either of these conditions is crucial if 
interventions are to be implemented to reduce their incidence. Our study assessed 
how accurate a malnutrition screening tool, the Mini-Nutritional Assessment 
(MNA) was in identifying frailty. We studied 100 patients (75% female) aged 
over 70 years at The Queen Elizabeth Hospital and found the MNA was a good 
identifier of frailty. Thus both malnutrition and frailty could be screened for with 
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